molecule_chembl_id,target_chembl_id,target_pref_name,assay_description,smiles,readout,standard_value,standard_units,pActivity
CHEMBL511115,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D from peripheral blood mononuclear cells,COc1ccc([C@]2(C#N)CC[C@@H](C(=O)O)CC2)cc1OC1CCCC1,IC50,63.0,nM,7.200659450546418
CHEMBL74078,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D from peripheral blood mononuclear cells,O=C(O)c1ccc(-c2cc3cccnc3c(-c3cccc([N+](=O)[O-])c3)n2)cc1,IC50,1.0,nM,9.0
CHEMBL77826,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D from peripheral blood mononuclear cells,O=C(O)c1ccc(-c2cc3cccnc3c(-c3ccc4nonc4c3)n2)cc1,IC50,1.5,nM,8.823908740944319
CHEMBL97817,CHEMBL288,Phosphodiesterase 4D,Evaluated for its ability to inhibit PDE4D.,CCc1nc(-c2cc(OCC3CC3)cc(OCC3CC3)c2)c2cc(OC)c(OCCO)cc2n1,IC50,22.0,nM,7.657577319177793
CHEMBL511115,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against Phosphodiesterase 4D (PDE4D) from human source expressed in Saccharomyces cerevisiae,COc1ccc([C@]2(C#N)CC[C@@H](C(=O)O)CC2)cc1OC1CCCC1,IC50,79.0,nM,7.102372908709558
CHEMBL330641,CHEMBL288,Phosphodiesterase 4D,Evaluated for its ability to inhibit PDE4D.,COc1cc2nc(C)nc(-c3cc(O)cc(O)c3)c2cc1OC,IC50,2000.0,nM,5.698970004336019
CHEMBL420454,CHEMBL288,Phosphodiesterase 4D,Evaluated for its ability to inhibit PDE4D.,COc1nc(-c2cc(OCC3CC3)cc(OCC3CC3)c2)c2cc(OC)c(OCCO)cc2n1,IC50,140.0,nM,6.853871964321762
CHEMBL161115,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against Phosphodiesterase 4D (PDE4D) from human source expressed in Saccharomyces cerevisiae,O=C(O)c1ccc(-c2cc3cccnc3c(-c3cccc(Cl)c3)n2)cc1,IC50,2.0,nM,8.698970004336019
CHEMBL95979,CHEMBL288,Phosphodiesterase 4D,Evaluated for its ability to inhibit PDE4D.,COc1cc2c(-c3cc(OCC4CC4)cc(OCC4CC4)c3)nc(-c3cccs3)nc2cc1OCCO,IC50,3000.0,nM,5.522878745280337
CHEMBL161714,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against Phosphodiesterase 4D (PDE4D) from human source expressed in Saccharomyces cerevisiae,O=S(=O)(Oc1cc2cccnc2c(-c2cccc(Cl)c2)n1)C(F)(F)F,IC50,48.0,nM,7.318758762624412
CHEMBL351613,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against Phosphodiesterase 4D (PDE4D) from human source expressed in Saccharomyces cerevisiae,O=[N+]([O-])c1cccc(-c2nc(-c3cccnc3)cc3cccnc23)c1,IC50,3.0,nM,8.522878745280337
CHEMBL351915,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against Phosphodiesterase 4D (PDE4D) from human source expressed in Saccharomyces cerevisiae,O=[N+]([O-])c1cccc(-c2nccc3cccnc23)c1,IC50,4100.0,nM,5.3872161432802645
CHEMBL98662,CHEMBL288,Phosphodiesterase 4D,Evaluated for its ability to inhibit PDE4D.,COc1cc2c(-c3cc(OCC4CC4)cc(OCC4CC4)c3)nc(OCCO)nc2cc1OCCO,IC50,90.0,nM,7.045757490560675
CHEMBL158286,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against Phosphodiesterase 4D (PDE4D) from human source expressed in Saccharomyces cerevisiae,N#Cc1cccc(-c2nc(OS(=O)(=O)C(F)(F)F)cc3cccnc23)c1,IC50,72.0,nM,7.142667503568731
CHEMBL95715,CHEMBL288,Phosphodiesterase 4D,Evaluated for its ability to inhibit PDE4D.,CCc1nc(-c2cc(OCC3CC3)cc(OCC3CC3)c2)c2cc(OC)c(O)cc2n1,IC50,650.0,nM,6.187086643357144
CHEMBL318444,CHEMBL288,Phosphodiesterase 4D,Evaluated for its ability to inhibit PDE4D.,CCc1nc(-c2cc(OCC3CC3)cc(OCC3CC3)c2)c2ccc(OCCO)cc2n1,IC50,850.0,nM,6.070581074285707
CHEMBL99101,CHEMBL288,Phosphodiesterase 4D,Evaluated for its ability to inhibit PDE4D.,CCSc1nc(-c2cc(OCC3CC3)cc(OCC3CC3)c2)c2cc(OC)c(OCCO)cc2n1,IC50,700.0,nM,6.154901959985743
CHEMBL162188,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against Phosphodiesterase 4D (PDE4D) from human source expressed in Saccharomyces cerevisiae,O=[N+]([O-])c1cccc(-c2nc(-c3ccco3)cc3cccnc23)c1,IC50,8.0,nM,8.096910013008056
CHEMBL161740,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against Phosphodiesterase 4D (PDE4D) from human source expressed in Saccharomyces cerevisiae,N#Cc1cccc(-c2nc(-c3ccc(C(=O)O)cc3)cc3cccnc23)c1,IC50,4.0,nM,8.397940008672037
CHEMBL96034,CHEMBL288,Phosphodiesterase 4D,Evaluated for its ability to inhibit PDE4D.,COc1cc2nc(C)nc(-c3cc(OCC4CC4)cc(OCC4CC4)c3)c2cc1OC,IC50,800.0,nM,6.096910013008056
CHEMBL97785,CHEMBL288,Phosphodiesterase 4D,Evaluated for its ability to inhibit PDE4D.,COc1cc2c(-c3cc(OCC4CC4)cc(OCC4CC4)c3)nc(NCCCO)nc2cc1OCCO,IC50,230.0,nM,6.638272163982407
CHEMBL418785,CHEMBL288,Phosphodiesterase 4D,Evaluated for its ability to inhibit PDE4D.,CCCCc1nc(-c2cc(OCC3CC3)cc(OCC3CC3)c2)c2cc(OC)c(OCCO)cc2n1,IC50,300.0,nM,6.522878745280337
CHEMBL98730,CHEMBL288,Phosphodiesterase 4D,Evaluated for its ability to inhibit PDE4D.,COc1cc2c(-c3cc(OCC4CC4)cc(OCC4CC4)c3)nc(N3CCOCC3)nc2cc1OCCO,IC50,1200.0,nM,5.920818753952375
CHEMBL97866,CHEMBL288,Phosphodiesterase 4D,Evaluated for its ability to inhibit PDE4D.,CCc1nc(-c2cc(OCC3CC3)cc(OCC3CC3)c2)c2cc(OC)c(OCC3CC3)cc2n1,IC50,540.0,nM,6.267606240177031
CHEMBL345812,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against Phosphodiesterase 4D (PDE4D) from human source expressed in Saccharomyces cerevisiae,Nc1cc2cccnc2c(-c2cccc([N+](=O)[O-])c2)n1,IC50,1600.0,nM,5.795880017344075
CHEMBL161602,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against Phosphodiesterase 4D (PDE4D) from human source expressed in Saccharomyces cerevisiae,CN1CCN(C(=O)c2cc3cccnc3c(-c3cccc([N+](=O)[O-])c3)n2)CC1,IC50,2000.0,nM,5.698970004336019
CHEMBL97214,CHEMBL288,Phosphodiesterase 4D,Evaluated for its ability to inhibit PDE4D.,CCOc1nc(-c2cc(OCC3CC3)cc(OCC3CC3)c2)c2cc(OC)c(OCCO)cc2n1,IC50,60.0,nM,7.221848749616356
CHEMBL420999,CHEMBL288,Phosphodiesterase 4D,Evaluated for its ability to inhibit PDE4D.,COc1cc2nc(C)nc(-c3cc(OC(C)C)cc(OC(C)C)c3)c2cc1OC,IC50,1200.0,nM,5.920818753952375
CHEMBL161465,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against Phosphodiesterase 4D (PDE4D) from human source expressed in Saccharomyces cerevisiae,O=[N+]([O-])c1cccc(-c2nc(-c3ccccc3)cc3cccnc23)c1,IC50,2.0,nM,8.698970004336019
CHEMBL74078,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against Phosphodiesterase 4D (PDE4D) from human source expressed in Saccharomyces cerevisiae,O=C(O)c1ccc(-c2cc3cccnc3c(-c3cccc([N+](=O)[O-])c3)n2)cc1,IC50,1.0,nM,9.0
CHEMBL345360,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against Phosphodiesterase 4D (PDE4D) from human source expressed in Saccharomyces cerevisiae,Cc1ccccc1-c1cc2cccnc2c(-c2cccc([N+](=O)[O-])c2)n1,IC50,70.0,nM,7.154901959985743
CHEMBL96039,CHEMBL288,Phosphodiesterase 4D,Evaluated for its ability to inhibit PDE4D.,COc1cc2c(-c3cc(OCC4CC4)cc(OCC4CC4)c3)nc(OCCCO)nc2cc1OCCO,IC50,130.0,nM,6.886056647693163
CHEMBL351900,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against Phosphodiesterase 4D (PDE4D) from human source expressed in Saccharomyces cerevisiae,O=[N+]([O-])c1cccc(-c2nc(OS(=O)(=O)C(F)(F)F)cc3cccnc23)c1,IC50,11.0,nM,7.958607314841775
CHEMBL431806,CHEMBL288,Phosphodiesterase 4D,Evaluated for its ability to inhibit PDE4D.,COc1cc2c(-c3cc(OCC4CC4)cc(OCC4CC4)c3)nc(-c3cc(OCC4CC4)cc(OCC4CC4)c3)nc2cc1OCCO,IC50,8500.0,nM,5.070581074285707
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against Phosphodiesterase 4D (PDE4D) from human source expressed in Saccharomyces cerevisiae,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,390.0,nM,6.4089353929735005
CHEMBL351500,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against Phosphodiesterase 4D (PDE4D) from human source expressed in Saccharomyces cerevisiae,C=CCc1cc2cccnc2c(-c2cccc([N+](=O)[O-])c2)n1,IC50,7.0,nM,8.154901959985743
CHEMBL91571,CHEMBL288,Phosphodiesterase 4D,In vitro inhibitory activity on unpurified recombinant Phosphodiesterase 4D,COc1ccc(C(=O)NCC(=O)NO)cc1OC1CCCC1,IC50,15.6,nM,7.806875401645538
CHEMBL90375,CHEMBL288,Phosphodiesterase 4D,In vitro inhibitory activity on unpurified recombinant Phosphodiesterase 4D,COc1ccc(C(=O)NC(C)C(=O)NO)cc1OC1CCCC1,IC50,20.2,nM,7.694648630553377
CHEMBL91551,CHEMBL288,Phosphodiesterase 4D,In vitro inhibitory activity on unpurified recombinant Phosphodiesterase 4D,COc1ccc(C2=NOC(C)(C(=O)NO)C2)cc1OC1CCCC1,IC50,10.0,nM,8.0
CHEMBL42126,CHEMBL288,Phosphodiesterase 4D,In vitro inhibitory activity on unpurified recombinant Phosphodiesterase 4D,COc1ccc(C(=O)Nc2c(Cl)cncc2Cl)cc1OC1CCCC1,IC50,0.8,nM,9.096910013008056
CHEMBL307646,CHEMBL288,Phosphodiesterase 4D,In vitro inhibitory activity on unpurified recombinant Phosphodiesterase 4D,COc1ccc(C2=NOC(C(=O)NO)C2)cc1OC1CCCC1,IC50,2.7,nM,8.568636235841012
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,In vitro inhibitory activity on unpurified recombinant Phosphodiesterase 4D,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,31.6,nM,7.500312917381596
CHEMBL182703,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,O=C1Nc2c(Cl)cc(-c3ccccc3)cc2C2(CCCCC2)N1,IC50,1420.0,nM,5.847711655616943
CHEMBL361469,CHEMBL288,Phosphodiesterase 4D,In vitro inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,O=C1Nc2c(Cl)cc(-c3ccccn3)cc2C2(CCCCC2)N1,IC50,1800.0,nM,5.7447274948966935
CHEMBL184945,CHEMBL288,Phosphodiesterase 4D,In vitro inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,O=C1Nc2c(Cl)cc(-c3cccnc3)cc2C2(CCCCC2)N1,IC50,1550.0,nM,5.809668301829708
CHEMBL185208,CHEMBL288,Phosphodiesterase 4D,In vitro inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,O=C1Nc2c(Cl)cc(-c3ccncc3)cc2C2(CCCCC2)N1,IC50,1010.0,nM,5.995678626217357
CHEMBL185304,CHEMBL288,Phosphodiesterase 4D,In vitro inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,O=C1Nc2c(Cl)cc(-c3ccc(C(=O)O)cc3)cc2C2(CCCCC2)N1,IC50,470.0,nM,6.327902142064282
CHEMBL427505,CHEMBL288,Phosphodiesterase 4D,In vitro inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,O=C1Nc2c(Cl)cc(-c3cccc(C(=O)O)c3)cc2C2(CCCCC2)N1,IC50,740.0,nM,6.130768280269024
CHEMBL185588,CHEMBL288,Phosphodiesterase 4D,In vitro inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,CN1CCN(C(=O)c2ccccc2-c2cc(Cl)c3c(c2)C2(CCCCC2)NC(=O)N3)CC1,IC50,15700.0,nM,4.804100347590766
CHEMBL185296,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,NC(=O)c1ccc(-c2cc(Cl)c3c(c2)C2(CCCCC2)NC(=O)N3)cc1,IC50,690.0,nM,6.161150909262744
CHEMBL366149,CHEMBL288,Phosphodiesterase 4D,In vitro inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,CN(C)CCNC(=O)c1ccc(-c2cc(Cl)c3c(c2)C2(CCCCC2)NC(=O)N3)cc1,IC50,1630.0,nM,5.787812395596042
CHEMBL363084,CHEMBL288,Phosphodiesterase 4D,In vitro inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,CN(C)CCNC(=O)c1cccc(-c2cc(Cl)c3c(c2)C2(CCCCC2)NC(=O)N3)c1,IC50,1590.0,nM,5.798602875679549
CHEMBL427513,CHEMBL288,Phosphodiesterase 4D,In vitro inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,CN(C)CCCNC(=O)c1ccc(-c2cc(Cl)c3c(c2)C2(CCCCC2)NC(=O)N3)cc1,IC50,1500.0,nM,5.823908740944319
CHEMBL182617,CHEMBL288,Phosphodiesterase 4D,In vitro inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,CN(C)CCCNC(=O)c1cccc(-c2cc(Cl)c3c(c2)C2(CCCCC2)NC(=O)N3)c1,IC50,1460.0,nM,5.835647144215563
CHEMBL183465,CHEMBL288,Phosphodiesterase 4D,In vitro inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,CN1CCN(C(=O)c2ccc(-c3cc(Cl)c4c(c3)C3(CCCCC3)NC(=O)N4)cc2)CC1,IC50,1700.0,nM,5.769551078621726
CHEMBL185370,CHEMBL288,Phosphodiesterase 4D,In vitro inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,CN1CCN(C(=O)c2cccc(-c3cc(Cl)c4c(c3)C3(CCCCC3)NC(=O)N4)c2)CC1,IC50,1310.0,nM,5.882728704344236
CHEMBL184279,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 expressed in baculovirus infected Sf9 cells,N#CCOc1ccc(Cl)c2c1C1(CCCCC1)NC(=O)N2,IC50,1700.0,nM,5.769551078621726
CHEMBL183965,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 expressed in baculovirus infected Sf9 cells,O=C1Nc2c(Cl)ccc(OCCO)c2C2(CCCCC2)N1,IC50,12200.0,nM,4.913640169325252
CHEMBL359890,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 expressed in baculovirus infected Sf9 cells,CCOC(=O)c1ccc(COc2ccc(Cl)c3c2C2(CCCCC2)NC(=O)N3)o1,IC50,1020.0,nM,5.991399828238082
CHEMBL183280,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 expressed in baculovirus infected Sf9 cells,O=C(O)COc1ccc(Cl)c2c1C1(CCCCC1)NC(=O)N2,IC50,15000.0,nM,4.823908740944319
CHEMBL184837,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(Cl)cc2)s/c1=N\c1c(O)cccc1C(=O)O,IC50,58250.0,nM,4.234704070301944
CHEMBL363673,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cc1cccc(C(=O)O)c1/N=c1\sc(-c2ccc(Cl)cc2)nn1C,IC50,20500.0,nM,4.688246138944246
CHEMBL182227,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(Cl)cc2)s/c1=N\c1cccc(C(=O)O)c1O,IC50,14200.0,nM,4.847711655616943
CHEMBL182574,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(Cl)cc2)s/c1=N\c1ccc(F)c(C(=O)O)c1,IC50,39660.0,nM,4.401647290130716
CHEMBL184861,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 expressed in baculovirus infected Sf9 cells,O=C1Nc2c(Cl)ccc(OCc3nn[nH]n3)c2C2(CCCCC2)N1,IC50,320.0,nM,6.494850021680094
CHEMBL182536,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 expressed in baculovirus infected Sf9 cells,O=C1Nc2c(Cl)ccc(OCc3noc(O)n3)c2C2(CCCCC2)N1,IC50,820.0,nM,6.086186147616283
CHEMBL365447,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 expressed in baculovirus infected Sf9 cells,O=C1Nc2c(Cl)ccc(OCc3ccc(C(=O)O)o3)c2C2(CCCCC2)N1,IC50,1130.0,nM,5.94692155651658
CHEMBL360627,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 expressed in baculovirus infected Sf9 cells,O=C1Nc2c(Cl)ccc(OCCCS(=O)(=O)O)c2C2(CCCCC2)N1,IC50,2410.0,nM,5.617982957425132
CHEMBL184334,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(Cl)cc2)s/c1=N\C1CCCCC1,IC50,57000.0,nM,4.2441251443275085
CHEMBL182681,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(Cl)cc2)s/c1=N\C1CCC1,IC50,6300.0,nM,5.200659450546418
CHEMBL182788,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(Cl)cc2)s/c1=N\C1CCCC1,IC50,81500.0,nM,4.088842391260023
CHEMBL184017,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(Cl)cc2)s/c1=N\c1ccc(O)c(C(=O)O)c1,IC50,7050.0,nM,5.151810883008601
CHEMBL361706,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccccc2O)s/c1=N\C1CCCCC1,IC50,71000.0,nM,4.1487416512809245
CHEMBL184470,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,COC(=O)c1ccccc1-c1nn(C)/c(=N/C2CCCCC2)s1,IC50,30000.0,nM,4.522878745280337
CHEMBL360434,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccccc2Cl)s/c1=N\C1CCCCC1,IC50,40000.0,nM,4.3979400086720375
CHEMBL367135,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2cccc(O)c2)s/c1=N\C1CCCCC1,IC50,22170.0,nM,4.654234306885511
CHEMBL182294,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,COC(=O)c1cccc(-c2nn(C)/c(=N/C3CCCCC3)s2)c1,IC50,19000.0,nM,4.721246399047171
CHEMBL184057,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2cccc(S(N)(=O)=O)c2)s/c1=N\C1CCCCC1,IC50,15050.0,nM,4.822463500070138
CHEMBL184016,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2cccc(C(N)=O)c2)s/c1=N\C1CCCCC1,IC50,19250.0,nM,4.71556926615548
CHEMBL359562,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2cccc(C(=O)O)c2)s/c1=N\C1CCCCC1,IC50,22250.0,nM,4.652669984683049
CHEMBL365659,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,COc1c(O)cc(-c2nn(C)/c(=N/C3CCCCC3)s2)cc1O,IC50,11880.0,nM,4.925183559354825
CHEMBL185502,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(Cl)cc2)s/c1=N\C1CN2CCC1C2,IC50,79000.0,nM,4.102372908709558
CHEMBL185523,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 expressed in baculovirus infected Sf9 cells,O=C1Nc2c(Cl)ccc(OCCN3CCOCC3)c2C2(CCCCC2)N1,IC50,7350.0,nM,5.133712660915805
CHEMBL185275,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 expressed in baculovirus infected Sf9 cells,NCCOc1ccc(Cl)c2c1C1(CCCCC1)NC(=O)N2,IC50,10500.0,nM,4.978810700930062
CHEMBL184979,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 expressed in baculovirus infected Sf9 cells,CNCCOc1ccc(Cl)c2c1C1(CCCCC1)NC(=O)N2,IC50,53200.0,nM,4.274088367704952
CHEMBL184903,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 expressed in baculovirus infected Sf9 cells,CN(C)CCOc1ccc(Cl)c2c1C1(CCCCC1)NC(=O)N2,IC50,3280.0,nM,5.484126156288321
CHEMBL185108,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 expressed in baculovirus infected Sf9 cells,CN(C)CCCOc1ccc(Cl)c2c1C1(CCCCC1)NC(=O)N2,IC50,23700.0,nM,4.6252516539898965
CHEMBL369541,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,CC(C)/N=c1\sc(-c2ccc(Cl)cc2)nn1C,IC50,17000.0,nM,4.769551078621726
CHEMBL183816,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,CCC/N=c1\sc(-c2ccc(Cl)cc2)nn1C,IC50,26000.0,nM,4.585026652029182
CHEMBL363236,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(Cl)cc2)s/c1=N\C(C)(C)CO,IC50,37000.0,nM,4.431798275933005
CHEMBL184806,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(Cl)cc2)s/c1=N\c1ccccc1,IC50,38000.0,nM,4.42021640338319
CHEMBL185604,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(Cl)cc2)s/c1=N\c1cccc(C(=O)O)c1,IC50,21330.0,nM,4.671009144550571
CHEMBL263311,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(Cl)cc2)s/c1=N\c1cccc(-c2noc(O)n2)c1,IC50,5630.0,nM,5.249491605148654
CHEMBL184701,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 expressed in baculovirus infected Sf9 cells,NCCOCCOc1ccc(Cl)c2c1C1(CCCCC1)NC(=O)N2,IC50,99000.0,nM,4.00436480540245
CHEMBL364200,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 expressed in baculovirus infected Sf9 cells,CNCC(O)COc1ccc(Cl)c2c1C1(CCCCC1)NC(=O)N2,IC50,12000.0,nM,4.920818753952375
CHEMBL184013,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 expressed in baculovirus infected Sf9 cells,CN(C)CC(O)COc1ccc(Cl)c2c1C1(CCCCC1)NC(=O)N2,IC50,55000.0,nM,4.259637310505756
CHEMBL363658,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 expressed in baculovirus infected Sf9 cells,O=C(O)CNCCOc1ccc(Cl)c2c1C1(CCCCC1)NC(=O)N2,IC50,14700.0,nM,4.8326826652518236
CHEMBL185203,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(Cl)cc2)s/c1=N\c1cccc(-c2nn[nH]n2)c1,IC50,4260.0,nM,5.370590400897282
CHEMBL360874,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(Cl)cc2)s/c1=N\c1cccc(CC(=O)O)c1,IC50,23000.0,nM,4.638272163982407
CHEMBL363709,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(Cl)cc2)s/c1=N\c1cccc(C#N)c1,IC50,36330.0,nM,4.439734602137285
CHEMBL184960,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(Cl)cc2)s/c1=N\c1cccc(C(N)=O)c1,IC50,44500.0,nM,4.351639989019068
CHEMBL361512,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(Cl)cc2)s/c1=N\c1ccc(O)cc1,IC50,13000.0,nM,4.886056647693163
CHEMBL185439,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(O)cc2)s/c1=N\C1CCCCC1,IC50,12230.0,nM,4.912573542963715
CHEMBL362264,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,COC(=O)c1ccc(-c2nn(C)/c(=N/C3CCCCC3)s2)cc1,IC50,95500.0,nM,4.019996628416254
CHEMBL183119,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(S(N)(=O)=O)cc2)s/c1=N\C1CCCCC1,IC50,10970.0,nM,4.959793372425289
CHEMBL185446,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(C(N)=O)cc2)s/c1=N\C1CCCCC1,IC50,15300.0,nM,4.815308569182402
CHEMBL365634,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(C(=O)O)cc2)s/c1=N\C1CCCCC1,IC50,32250.0,nM,4.491470281028714
CHEMBL185144,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(S(C)(=O)=O)cc2)s/c1=N\C1CCCCC1,IC50,25000.0,nM,4.6020599913279625
CHEMBL362033,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(N)cc2)s/c1=N\C1CCCCC1,IC50,25750.0,nM,4.5892227666227905
CHEMBL363097,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,CC(=O)Nc1ccc(-c2nn(C)/c(=N/C3CCCCC3)s2)cc1,IC50,34250.0,nM,4.465339424171556
CHEMBL184089,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cc1cc(-c2nn(C)/c(=N/C3CCCCC3)s2)ccc1C(N)=O,IC50,44660.0,nM,4.350081281264581
CHEMBL183952,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(C(N)=O)c(O)c2)s/c1=N\C1CCCCC1,IC50,19330.0,nM,4.713768145971447
CHEMBL363118,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(C(N)=O)c(N)c2)s/c1=N\C1CCCCC1,IC50,26000.0,nM,4.585026652029182
CHEMBL186615,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(Cl)c(S(N)(=O)=O)c2)s/c1=N\C1CCCCC1,IC50,5900.0,nM,5.229147988357855
CHEMBL184829,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,CCNS(=O)(=O)c1cc(-c2nn(C)/c(=N/C3CCCCC3)s2)ccc1Cl,IC50,5840.0,nM,5.2335871528876
CHEMBL184154,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cn1nc(-c2ccc(C(=O)NCCN3CCOCC3)cc2)s/c1=N\C1CCCCC1,IC50,8770.0,nM,5.057000406633959
CHEMBL187201,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,CN(C)CCNC(=O)c1ccc(-c2nn(C)/c(=N/C3CCCCC3)s2)cc1,IC50,33330.0,nM,4.47716468633947
CHEMBL186868,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D3 expressed in baculovirus infected Sf9 cells,Cc1nc(N)c2ccc(-c3nn(C)/c(=N/C4CCCCC4)s3)cc2n1,IC50,92330.0,nM,4.034657164439378
CHEMBL32442,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against PDE4D,COc1ccc([C@H](Cc2ccncc2)c2ccccc2)cc1OC1CCCC1,IC50,2.1,nM,8.67778070526608
CHEMBL198722,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against PDE4D,CC(c1cc(-c2cccc(/C=C(\c3ccc(S(C)(=O)=O)cc3)c3ncc(C(C)(C)O)s3)c2)c2ncccc2c1)S(C)(=O)=O,IC50,2.0,nM,8.698970004336019
CHEMBL198527,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against PDE4D,CC(C)NC(=O)/C(=C/c1cccc(-c2cc(C(C)(C)S(C)(=O)=O)cc3cccnc23)c1)c1ccc(S(C)(=O)=O)cc1,IC50,2.3,nM,8.638272163982407
CHEMBL198732,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against PDE4D,Cc1noc(/C(=C\c2cccc(-c3cc(C(C)(C)S(C)(=O)=O)cc4cccnc34)c2)c2ccc(S(C)(=O)=O)cc2)n1,IC50,1.9,nM,8.721246399047171
CHEMBL372575,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against PDE4D,Cc1noc(/C(=C/c2cccc(-c3cc(C(C)(C)S(C)(=O)=O)cc4cccnc34)c2)c2ccc(S(C)(=O)=O)cc2)n1,IC50,1.2,nM,8.920818753952375
CHEMBL198853,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against PDE4D,CC(C)NC(=O)/C(=C\c1cccc(-c2cc(C(C)(C)C#N)cc3cccnc23)c1)c1ccc(S(C)(=O)=O)cc1,IC50,0.5,nM,9.301029995663981
CHEMBL371037,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against PDE4D,CC(C)NC(=O)/C(=C/c1cccc(-c2cc(C(C)(C)C#N)cc3cccnc23)c1)c1ccc(S(C)(=O)=O)cc1,IC50,0.7,nM,9.154901959985743
CHEMBL371089,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against PDE4D,CC(C)NC(=O)/C(=C/c1cccc(-c2cc(C(C)C)cc3cccnc23)c1)c1ccc(S(C)(=O)=O)cc1,IC50,0.6,nM,9.221848749616356
CHEMBL197386,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against PDE4D,CC(C)c1cc(-c2cccc(/C=C(/C(=O)O)c3ccc(S(C)(=O)=O)cc3)c2)c2ncccc2c1,IC50,0.5,nM,9.301029995663981
CHEMBL381681,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against PDE4D,Cc1noc(/C(=C/c2cccc(-c3cc(C(C)C)cc4cccnc34)c2)c2ccc(S(C)(=O)=O)cc2)n1,IC50,0.2,nM,9.698970004336019
CHEMBL198674,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against PDE4D,CC(C)c1cc(-c2cccc(/C=C(/c3ccc(C(C)(C)O)cc3)c3ccc(S(C)(=O)=O)cc3)c2)c2ncccc2c1,IC50,0.5,nM,9.301029995663981
CHEMBL197392,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against PDE4D,Cc1ccc(/C(=C/c2cccc(-c3cc(C(C)C)cc4cccnc34)c2)c2ccc(S(C)(=O)=O)cc2)nc1,IC50,0.2,nM,9.698970004336019
CHEMBL196969,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against PDE4D,CC(C)c1cc(-c2cccc(/C=C(\c3ccc(S(C)(=O)=O)cc3)c3nccs3)c2)c2ncccc2c1,IC50,0.19,nM,9.721246399047171
CHEMBL197494,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against PDE4D,Cc1noc(/C(=C/c2cccc(-c3cc(C(C)C)cc4cccnc34)c2)c2ccccn2)n1,IC50,0.6,nM,9.221848749616356
CHEMBL198564,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against PDE4D,CC(C)c1cc(-c2cccc(CC(c3ccncc3)C(C)(C)O)c2)c2ncccc2c1,IC50,4.4,nM,8.356547323513812
CHEMBL198464,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against PDE4D,CC(C)c1cc(-c2cccc(C(Cc3cc[n+]([O-])cc3)c3ccc(Cl)cc3)c2)c2ncccc2c1,IC50,45.0,nM,7.346787486224656
CHEMBL382545,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against PDE4D,CC(C)c1cc(-c2cccc(C(Cc3ccncc3)c3ccc(Cl)cc3)c2)c2ncccc2c1,IC50,38.0,nM,7.42021640338319
CHEMBL370220,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against PDE4D,O=S(=O)(Nc1cccc(-c2cc(Cc3ccncc3)cc3cccnc23)c1)c1ccccc1,IC50,2.0,nM,8.698970004336019
CHEMBL198432,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against PDE4D,COc1cccc(-c2cc(Cc3ccncc3)cc3cccnc23)c1,IC50,2.5,nM,8.602059991327963
CHEMBL199015,CHEMBL288,Phosphodiesterase 4D,Inhibitory activity against PDE4D,[O-][n+]1cccc(C[C@@H](c2ccc(OC(F)F)c(OC3CC3)c2)c2cnc(C(O)(C(F)(F)F)C(F)(F)F)s2)c1,IC50,0.4,nM,9.397940008672037
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,33.0,nM,7.481486060122112
CHEMBL204449,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,C[C@@H](NC(=O)c1cccnc1Oc1ccc(F)cc1)c1cccs1,IC50,4.0,nM,8.397940008672037
CHEMBL199015,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,[O-][n+]1cccc(C[C@@H](c2ccc(OC(F)F)c(OC3CC3)c2)c2cnc(C(O)(C(F)(F)F)C(F)(F)F)s2)c1,IC50,0.4,nM,9.397940008672037
CHEMBL383762,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,[O-][n+]1cccc(C[C@H](c2ccc(OC(F)F)c(OC3CC3)c2)c2cnc(C(O)(C(F)(F)F)C(F)(F)F)s2)c1,IC50,43.0,nM,7.366531544420413
CHEMBL208236,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,CC(C)(c1cc(-c2cccc(NC(=O)c3ccc(S(C)(=O)=O)cc3)c2)c2ncccc2c1)S(C)(=O)=O,IC50,2.3,nM,8.638272163982407
CHEMBL206592,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,CC(c1cccc(-c2cc(C(C)(C)S(C)(=O)=O)cc3cccnc23)c1)N(C(=O)c1cccnc1)c1ccc(S(C)(=O)=O)cc1,IC50,1.7,nM,8.769551078621726
CHEMBL380933,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,CC(c1cccc(-c2cc(C(C)(C)S(C)(=O)=O)cc3cccnc23)c1)N(C(=O)c1ccc(C(C)(C)O)cc1)c1ccc(S(C)(=O)=O)cc1,IC50,0.5,nM,9.301029995663981
CHEMBL208382,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,CC(c1cccc(-c2cc(C(C)(C)S(C)(=O)=O)cc3cccnc23)c1)N(C(=O)c1ccc(F)cc1)c1ccc(S(C)(=O)=O)cc1,IC50,0.7,nM,9.154901959985743
CHEMBL208382,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,CC(c1cccc(-c2cc(C(C)(C)S(C)(=O)=O)cc3cccnc23)c1)N(C(=O)c1ccc(F)cc1)c1ccc(S(C)(=O)=O)cc1,IC50,7.0,nM,8.154901959985743
CHEMBL208382,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,CC(c1cccc(-c2cc(C(C)(C)S(C)(=O)=O)cc3cccnc23)c1)N(C(=O)c1ccc(F)cc1)c1ccc(S(C)(=O)=O)cc1,IC50,1.8,nM,8.744727494896694
CHEMBL379768,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,CC(c1cccc(-c2cc(C(C)(C)S(C)(=O)=O)cc3cccnc23)c1)N(C(=O)C1CC1)c1ccc(S(C)(=O)=O)cc1,IC50,1.4,nM,8.853871964321762
CHEMBL204522,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,CC(=O)N(c1ccc(S(C)(=O)=O)cc1)C(C)c1cccc(-c2cc(C(C)(C)S(C)(=O)=O)cc3cccnc23)c1,IC50,6.7,nM,8.173925197299173
CHEMBL207559,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,CC(C)NC(=O)N(c1ccc(S(C)(=O)=O)cc1)C(C)c1cccc(-c2cc(C(C)(C)S(C)(=O)=O)cc3cccnc23)c1,IC50,1.9,nM,8.721246399047171
CHEMBL208100,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,CC(C)NC(=O)N(Cc1cc(-c2cc(C(C)(C)S(C)(=O)=O)cc3cccnc23)ccc1F)c1ccc(S(C)(=O)=O)cc1,IC50,0.8,nM,9.096910013008056
CHEMBL207424,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,CC(C)NC(=O)N(Cc1cc(-c2cc(C(C)(C)S(C)(=O)=O)cc3cccnc23)ccc1Cl)c1ccc(S(C)(=O)=O)cc1,IC50,10.0,nM,8.0
CHEMBL377709,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,CC(C)NC(=O)N(Cc1cccc(-c2cc(C(C)(C)S(C)(=O)=O)cc3cccnc23)c1)c1ccc(S(C)(=O)=O)cc1,IC50,0.1,nM,10.0
CHEMBL209295,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,CC(C)OC(=O)N(Cc1cccc(-c2cc(C(C)(C)C#N)cc3cccnc23)c1)c1ccc(S(C)(=O)=O)cc1,IC50,0.3,nM,9.522878745280337
CHEMBL380321,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,CC(C)(C#N)c1cc(-c2cccc(CN(C(=O)Nc3ccccc3)c3ccc(S(C)(=O)=O)cc3)c2)c2ncccc2c1,IC50,0.1,nM,10.0
CHEMBL382168,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,CC(C)NC(=O)N(Cc1cccc(-c2cc(C(C)(C)C#N)cc3cccnc23)c1)c1ccc(S(C)(=O)=O)cc1,IC50,0.1,nM,10.0
CHEMBL206968,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,Cc1cc(C(=O)N(Cc2cccc(-c3cc(C(C)(C)C#N)cc4cccnc34)c2)c2ccc(S(C)(=O)=O)cc2)no1,IC50,0.1,nM,10.0
CHEMBL383225,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,CC(C)(C#N)c1cc(-c2cccc(CN(C(=O)c3ccccc3)c3ccc(S(C)(=O)=O)cc3)c2)c2ncccc2c1,IC50,0.3,nM,9.522878745280337
CHEMBL378681,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,CC(C)(C#N)c1cc(-c2cccc(CN(Cc3ccc(F)cc3)c3ccc(S(C)(=O)=O)cc3)c2)c2ncccc2c1,IC50,0.5,nM,9.301029995663981
CHEMBL207996,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,CC(C)(c1cc(-c2cccc(C(=O)Nc3c(Cl)cncc3Cl)c2)c2ncccc2c1)S(C)(=O)=O,IC50,0.7,nM,9.154901959985743
CHEMBL383837,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,CC(C)(c1cc(-c2cccc(C(=O)Nc3ccncc3)c2)c2ncccc2c1)S(C)(=O)=O,IC50,3.0,nM,8.522878745280337
CHEMBL207775,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,CC(C)(c1cc(-c2cccc(C(=O)Nc3ccccc3)c2)c2ncccc2c1)S(C)(=O)=O,IC50,10.0,nM,8.0
CHEMBL210840,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,CC(C)(c1cc(-c2cccc(C(N)=O)c2)c2ncccc2c1)S(C)(=O)=O,IC50,74.0,nM,7.130768280269024
CHEMBL208149,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-PDE4D,CC(C)(c1cc(-c2cccc(C(=O)Nc3ccc(S(C)(=O)=O)cc3)c2)c2ncccc2c1)S(C)(=O)=O,IC50,2.8,nM,8.55284196865778
CHEMBL511115,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D,COc1ccc([C@]2(C#N)CC[C@@H](C(=O)O)CC2)cc1OC1CCCC1,IC50,39.0,nM,7.4089353929735005
CHEMBL218103,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D,CCc1nn(C2CCCC2)c2c1CCn1c-2nnc1C(C)(C)C,IC50,9.0,nM,8.045757490560675
CHEMBL217899,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D,CCc1nn(C2CCCC2)c2c1CCn1c(-c3cccs3)nnc1-2,IC50,13.0,nM,7.886056647693163
CHEMBL218990,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D,CCc1nn(C2CCCC2)c2c1CCn1c(-c3cccnc3)nnc1-2,IC50,70.0,nM,7.154901959985743
CHEMBL218793,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D,CCc1nn(C2CCCC2)c2c1CCn1c(-c3cccc(OC)c3)nnc1-2,IC50,180.0,nM,6.7447274948966935
CHEMBL218653,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D,CCc1nn(C2CCCC2)c2c1CCn1c(-c3ccccc3Cl)nnc1-2,IC50,13.0,nM,7.886056647693163
CHEMBL42126,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D,COc1ccc(C(=O)Nc2c(Cl)cncc2Cl)cc1OC1CCCC1,IC50,2.0,nM,8.698970004336019
CHEMBL430893,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D,COc1ccc([C@@H]2CNC(=O)C2)cc1OC1CCCC1,IC50,622.0,nM,6.206209615309181
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,82.0,nM,7.086186147616283
CHEMBL251785,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,COc1ccc(C2=Nn3c(nnc3-c3ccccc3OC)SC2)cc1OC,IC50,18.0,nM,7.7447274948966935
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D1 in cytosolic fraction of lung,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,50.0,nM,7.301029995663981
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 in cytosolic fraction of lung,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,50.0,nM,7.301029995663981
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 in particular fraction of lung,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,320.0,nM,6.494850021680094
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 in cytosolic fraction of lung,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,140.0,nM,6.853871964321762
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D4 in cytosolic fraction of lung,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,60.0,nM,7.221848749616356
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D4 in particular fraction of lung,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,50.0,nM,7.301029995663981
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D5 in cytosolic fraction of lung,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,80.0,nM,7.096910013008056
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D5 in particular fraction of lung,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,590.0,nM,6.229147988357855
CHEMBL74078,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,O=C(O)c1ccc(-c2cc3cccnc3c(-c3cccc([N+](=O)[O-])c3)n2)cc1,IC50,1.0,nM,9.0
CHEMBL77826,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,O=C(O)c1ccc(-c2cc3cccnc3c(-c3ccc4nonc4c3)n2)cc1,IC50,1.5,nM,8.823908740944319
CHEMBL19449,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CC(C)C(=O)c1c(C(C)C)nn2ccccc12,IC50,166.0,nM,6.779891911959945
CHEMBL313041,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 by rapid fluorescence based assay,COc1ccc(C2=NNC(=O)C3CC=CCC23)cc1OC,IC50,213.0,nM,6.671620396561263
CHEMBL480988,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 by rapid fluorescence based assay,COc1ccc(C2=NN(CCCCCBr)C(=O)C3CC=CCC23)cc1OC,IC50,2.3,nM,8.638272163982407
CHEMBL454507,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 by rapid fluorescence based assay,COc1ccc(C2=NN(CCCCCNCC[C@H](Oc3ccc(C(F)(F)F)cc3)c3ccccc3)C(=O)C3CC=CCC23)cc1OC,IC50,253.0,nM,6.596879478824182
CHEMBL499461,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 by rapid fluorescence based assay,COc1ccc(C2=NN(CCCCCNCC[C@@H](Oc3ccc(C(F)(F)F)cc3)c3ccccc3)C(=O)C3CC=CCC23)cc1OC,IC50,106.0,nM,6.97469413473523
CHEMBL226630,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,NC(=O)c1noc([C@H](CCCC2CCCCC2)CC(=O)NO)n1,IC50,900.0,nM,6.045757490560675
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,550.0,nM,6.259637310505756
CHEMBL462518,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCCC(O)c1ccc(OC)c(OC2CCOC2)c1,IC50,10000.0,nM,5.0
CHEMBL514277,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCC(O)(c1ccc(Oc2ccccn2)c(OC)c1)c1cnc2ccccc2c1,IC50,6000.0,nM,5.221848749616356
CHEMBL455962,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCCC(=O)c1ccc(OC2CCN(C(=O)OC(C)(C)C)CC2)c(OC)c1,IC50,93000.0,nM,4.031517051446065
CHEMBL456170,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCC(=O)c1ccc(OC2CCN(C(=O)OC(C)(C)C)CC2)c(OC)c1,IC50,29000.0,nM,4.537602002101044
CHEMBL509969,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCC(=O)c1ccc(OC2CCOCC2)c(OC)c1,IC50,60000.0,nM,4.221848749616356
CHEMBL447757,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCCC(=O)c1ccc(OC2CCOCC2)c(OC)c1,IC50,71000.0,nM,4.1487416512809245
CHEMBL445832,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCC(=O)c1ccc(OC2CCOC2)c(OC)c1,IC50,24000.0,nM,4.619788758288394
CHEMBL456366,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCCC(=O)c1ccc(OC2CCOC2)c(OC)c1,IC50,100000.0,nM,4.0
CHEMBL456367,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C(=O)c2cnc3ccccc3c2)cc1OC1CCOCC1,IC50,45000.0,nM,4.346787486224656
CHEMBL456368,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCC(=O)c1ccc(OC)c(OC2CCOCC2)c1,IC50,3500.0,nM,5.455931955649724
CHEMBL443679,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCCC(=O)c1ccc(OC)c(OC2CCOCC2)c1,IC50,720.0,nM,6.142667503568731
CHEMBL456573,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCCC(=O)c1ccc(OC)c(OC2CCOC2)c1,IC50,220.0,nM,6.657577319177793
CHEMBL456574,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCC(=O)c1ccc(OC)c(OC2CCOC2)c1,IC50,430.0,nM,6.366531544420413
CHEMBL456327,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C(=O)CCC2CCCCC2)cc1OC1CCOC1,IC50,1900.0,nM,5.721246399047171
CHEMBL513099,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C(=O)CCc2ccccc2)cc1OC1CCOC1,IC50,2600.0,nM,5.585026652029182
CHEMBL460188,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C(=O)CC2CCCCC2)cc1OC1CCOC1,IC50,2600.0,nM,5.585026652029182
CHEMBL460189,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCCC(=O)c1ccc(OC)c(OC2CCNCC2)c1,IC50,102000.0,nM,3.991399828238082
CHEMBL458296,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCC(=O)c1ccc(OC(F)F)c(Oc2ccccn2)c1,IC50,40000.0,nM,4.3979400086720375
CHEMBL458297,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCC(=O)c1ccc(OC(F)F)c(OC2CCOCC2)c1,IC50,350.0,nM,6.455931955649724
CHEMBL458298,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CC(C)CC(=O)c1ccc(OC(F)F)c(OC2CCOC2)c1,IC50,26.0,nM,7.585026652029182
CHEMBL457662,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,O=C(CCC1CCCCC1)c1ccc(OC(F)F)c(OC2CCOC2)c1,IC50,1100.0,nM,5.958607314841775
CHEMBL457663,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,O=C(CCc1ccccc1)c1ccc(OC(F)F)c(OC2CCOC2)c1,IC50,180.0,nM,6.7447274948966935
CHEMBL508134,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCCC(=O)c1ccc(OC(F)F)c(OC2CCOC2)c1,IC50,61.0,nM,7.214670164989233
CHEMBL456617,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,O=C(CCc1ccccc1)c1ccc(OC(F)F)c(OC(F)F)c1,IC50,820.0,nM,6.086186147616283
CHEMBL456618,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,O=C(CC1CCCCC1)c1ccc(OC(F)F)c(OC(F)F)c1,IC50,5200.0,nM,5.2839966563652006
CHEMBL456826,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,O=C(CCCc1ccccc1)c1ccc(OC(F)F)c(OC(F)F)c1,IC50,44000.0,nM,4.356547323513812
CHEMBL511686,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CC(C)CC(=O)c1ccc(OC(F)F)c(OC2CCCC2)c1,IC50,28.0,nM,7.552841968657781
CHEMBL458931,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCCC(=O)c1ccc(OC(F)F)c(OC2CCN(C(=O)OC(C)(C)C)CC2)c1,IC50,2200.0,nM,5.657577319177793
CHEMBL458932,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,O=C(CC1CCCCC1)c1ccc(OC(F)F)c(OC2CCOC2)c1,IC50,667.0,nM,6.175874166083451
CHEMBL458933,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,O=C(CCCc1ccccc1)c1ccc(OC(F)F)c(OC2CCOC2)c1,IC50,636.0,nM,6.196542884351587
CHEMBL456590,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CC(C)(C)C(=O)c1ccc(OC(F)F)c(OC2CCOC2)c1,IC50,410.0,nM,6.3872161432802645
CHEMBL456591,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C(=O)CC(C)C)cc1OC1CCOC1,IC50,190.0,nM,6.721246399047171
CHEMBL457215,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C(=O)CCC(C)C)cc1OC1CCOC1,IC50,380.0,nM,6.42021640338319
CHEMBL457216,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1cc(C(CC(C)=O)c2cnc3ccccc3c2)ccc1Oc1ccccn1,IC50,6000.0,nM,5.221848749616356
CHEMBL457217,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1cc(C(CC(C)=O)c2cccnc2)ccc1O,IC50,80000.0,nM,4.096910013008056
CHEMBL457431,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCCC(c1cccnc1)c1ccc(Oc2ccccn2)c(OC)c1,IC50,10000.0,nM,5.0
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,549.54,nM,6.260000690598032
CHEMBL446547,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCC(O)c1ccc(OC2CCOCC2)c(OC)c1,IC50,1513561.25,nM,2.8199999995512925
CHEMBL507064,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCCC(O)c1ccc(OC2CCOCC2)c(OC)c1,IC50,537031.8,nM,3.2699999970646445
CHEMBL462517,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCC(O)c1ccc(OC2CCOC2)c(OC)c1,IC50,524807.46,nM,3.2800000002066945
CHEMBL462448,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCCC(O)c1ccc(OC2CCOC2)c(OC)c1,IC50,398107.17,nM,3.400000000603809
CHEMBL462518,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCCC(O)c1ccc(OC)c(OC2CCOC2)c1,IC50,10000.0,nM,5.0
CHEMBL455962,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCCC(=O)c1ccc(OC2CCN(C(=O)OC(C)(C)C)CC2)c(OC)c1,IC50,93325.43,nM,4.030000000370884
CHEMBL456170,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCC(=O)c1ccc(OC2CCN(C(=O)OC(C)(C)C)CC2)c(OC)c1,IC50,28840.32,nM,4.539999925177879
CHEMBL509969,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCC(=O)c1ccc(OC2CCOCC2)c(OC)c1,IC50,60255.96,nM,4.219999989963101
CHEMBL447757,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCCC(=O)c1ccc(OC2CCOCC2)c(OC)c1,IC50,70794.58,nM,4.149999990420336
CHEMBL445832,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCC(=O)c1ccc(OC2CCOC2)c(OC)c1,IC50,23988.33,nM,4.619999985338959
CHEMBL456367,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C(=O)c2cnc3ccccc3c2)cc1OC1CCOCC1,IC50,44668.36,nM,4.349999992368662
CHEMBL456368,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCC(=O)c1ccc(OC)c(OC2CCOCC2)c1,IC50,3467.37,nM,5.459999812689
CHEMBL443679,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCCC(=O)c1ccc(OC)c(OC2CCOCC2)c1,IC50,724.44,nM,6.139997578098902
CHEMBL456573,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCCC(=O)c1ccc(OC)c(OC2CCOC2)c1,IC50,199.53,nM,6.699991797446187
CHEMBL456574,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCC(=O)c1ccc(OC)c(OC2CCOC2)c1,IC50,398.11,nM,6.399996913372259
CHEMBL516301,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C(=O)CCCc2ccccc2)cc1OC1CCOC1,IC50,2290.87,nM,5.639999555020352
CHEMBL456327,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C(=O)CCC2CCCCC2)cc1OC1CCOC1,IC50,1905.46,nM,5.720000163638921
CHEMBL513099,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C(=O)CCc2ccccc2)cc1OC1CCOC1,IC50,2570.4,nM,5.589999287456538
CHEMBL460188,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C(=O)CC2CCCCC2)cc1OC1CCOC1,IC50,2570.4,nM,5.589999287456538
CHEMBL460189,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCCC(=O)c1ccc(OC)c(OC2CCNCC2)c1,IC50,102329.3,nM,3.989999996723885
CHEMBL458296,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCC(=O)c1ccc(OC(F)F)c(Oc2ccccn2)c1,IC50,39810.72,nM,4.399999967876858
CHEMBL458297,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCC(=O)c1ccc(OC(F)F)c(OC2CCOCC2)c1,IC50,346.74,nM,6.459996055149974
CHEMBL458298,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CC(C)CC(=O)c1ccc(OC(F)F)c(OC2CCOC2)c1,IC50,18.2,nM,7.739928612014925
CHEMBL457662,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,O=C(CCC1CCCCC1)c1ccc(OC(F)F)c(OC2CCOC2)c1,IC50,1096.48,nM,5.95999928552668
CHEMBL457663,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,O=C(CCc1ccccc1)c1ccc(OC(F)F)c(OC2CCOC2)c1,IC50,181.97,nM,6.740000204918113
CHEMBL508134,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCCC(=O)c1ccc(OC(F)F)c(OC2CCOC2)c1,IC50,61.66,nM,7.209996479609511
CHEMBL456617,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,O=C(CCc1ccccc1)c1ccc(OC(F)F)c(OC(F)F)c1,IC50,501.19,nM,6.299997602857746
CHEMBL456618,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,O=C(CC1CCCCC1)c1ccc(OC(F)F)c(OC(F)F)c1,IC50,5248.07,nM,5.280000380871156
CHEMBL456826,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,O=C(CCCc1ccccc1)c1ccc(OC(F)F)c(OC(F)F)c1,IC50,43651.58,nM,4.360000032076103
CHEMBL511686,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CC(C)CC(=O)c1ccc(OC(F)F)c(OC2CCCC2)c1,IC50,21.88,nM,7.659952682338607
CHEMBL458931,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCCC(=O)c1ccc(OC(F)F)c(OC2CCN(C(=O)OC(C)(C)C)CC2)c1,IC50,2187.76,nM,5.660000322371772
CHEMBL458932,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,O=C(CC1CCCCC1)c1ccc(OC(F)F)c(OC2CCOC2)c1,IC50,660.69,nM,6.180002266489224
CHEMBL458933,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,O=C(CCCc1ccccc1)c1ccc(OC(F)F)c(OC2CCOC2)c1,IC50,630.96,nM,6.199998172182031
CHEMBL456590,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CC(C)(C)C(=O)c1ccc(OC(F)F)c(OC2CCOC2)c1,IC50,407.38,nM,6.390000296157769
CHEMBL456591,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C(=O)CC(C)C)cc1OC1CCOC1,IC50,177.83,nM,6.749994971513104
CHEMBL457215,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C(=O)CCC(C)C)cc1OC1CCOC1,IC50,380.19,nM,6.41999931041096
CHEMBL457216,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1cc(C(CC(C)=O)c2cnc3ccccc3c2)ccc1Oc1ccccn1,IC50,6025.6,nM,5.219999701663429
CHEMBL457217,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1cc(C(CC(C)=O)c2cccnc2)ccc1O,IC50,79432.82,nM,4.100000018985305
CHEMBL457431,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCCC(c1cccnc1)c1ccc(Oc2ccccn2)c(OC)c1,IC50,10000.0,nM,5.0
CHEMBL47683,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C(=O)Nc2ccccc2F)cc1OC1CCCC1,IC50,10715.19,nM,4.970000123715015
CHEMBL44109,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C(=O)Nc2ccccc2C(F)(F)F)cc1OC1CCCC1,IC50,3090.3,nM,5.509999358109048
CHEMBL45834,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C(=O)Nc2c(Cl)cccc2Cl)cc1OC1CCCC1,IC50,28.18,nM,7.550059011226662
CHEMBL451369,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C(=O)Nc2c(F)cccc2F)cc1O,IC50,37153.52,nM,4.430000034012231
CHEMBL45055,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C(=O)Nc2c(F)cccc2F)cc1OC1CCCCC1,IC50,398.11,nM,6.399996913372259
CHEMBL47113,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C(=O)Nc2c(F)cccc2F)cc1OC1CCCC1,IC50,70.79,nM,7.15002808767115
CHEMBL45854,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C(=O)Nc2ccccc2Cl)cc1OC,IC50,645.65,nM,6.190002844637807
CHEMBL298000,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,CCCOc1cc(C(=O)Nc2c(F)cccc2F)ccc1OC,IC50,1584.89,nM,5.800000874803203
CHEMBL517124,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 expressed in Escherichia coli BL21 by liquid scintillation counting,COc1ccc(C(=S)Nc2c(Cl)cccc2Cl)cc1OC1CCCC1,IC50,199.53,nM,6.699991797446187
CHEMBL549560,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2,COc1ccc(OC)c(-c2nnc3ccc(-c4ccc(OC)c(O[C@@H]5CCOC5)c4)nn23)c1,IC50,2.1,nM,8.67778070526608
CHEMBL564209,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2,COc1ccc(OC)c(-c2nnc3n2N=C(c2ccc(OC)c(O[C@@H]4CCOC4)c2)CS3)c1,IC50,1.9,nM,8.721246399047171
CHEMBL252387,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2,COc1ccc(OC)c(-c2nnc3n2N=C(c2ccc(OC)c(OC)c2)CS3)c1,IC50,49.2,nM,7.308034897232639
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,403.0,nM,6.39469495385889
CHEMBL570803,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 expressed in baculovirus system by IMAP assay,COc1ccc(/C=N/OCC(=O)N2CC(C)OC(C)C2)cc1OC1CCCC1,IC50,1910.0,nM,5.718966632752272
CHEMBL570803,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D expressed in Sf9 cells,COc1ccc(/C=N/OCC(=O)N2CC(C)OC(C)C2)cc1OC1CCCC1,IC50,670.0,nM,6.173925197299173
CHEMBL572539,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D expressed in Sf9 cells,COc1ccc(/C=N/OCC(=O)N2CCOCC2)cc1OC1CCCC1,IC50,3480.0,nM,5.458420756053419
CHEMBL570355,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 expressed in baculovirus system by IMAP assay,COc1ccc(/C=N/OCC(Cl)CN2CC(C)OC(C)C2)cc1OC1CCCC1,IC50,4270.0,nM,5.369572124974976
CHEMBL570355,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D expressed in Sf9 cells,COc1ccc(/C=N/OCC(Cl)CN2CC(C)OC(C)C2)cc1OC1CCCC1,IC50,3420.0,nM,5.465973893943865
CHEMBL572161,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D expressed in Sf9 cells,COc1ccc(/C=N/OCC(Cl)CN2CCOCC2)cc1OC1CCCC1,IC50,5910.0,nM,5.228412519118745
CHEMBL569624,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 expressed in baculovirus system by radiometric assay,COc1ccc(/C=N/OCC(O)CN2CC(C)OC(C)C2)cc1OC1CCCC1,IC50,2860.0,nM,5.543633966870956
CHEMBL569624,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D1 expressed in baculovirus system by radiometric assay,COc1ccc(/C=N/OCC(O)CN2CC(C)OC(C)C2)cc1OC1CCCC1,IC50,7090.0,nM,5.149353764816933
CHEMBL569624,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 expressed in baculovirus system by IMAP assay,COc1ccc(/C=N/OCC(O)CN2CC(C)OC(C)C2)cc1OC1CCCC1,IC50,3460.0,nM,5.460923901207224
CHEMBL569624,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 expressed in baculovirus system by radiometric assay,COc1ccc(/C=N/OCC(O)CN2CC(C)OC(C)C2)cc1OC1CCCC1,IC50,7340.0,nM,5.13430394008393
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 expressed in baculovirus system by IMAP assay,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,400.0,nM,6.3979400086720375
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D1 expressed in baculovirus system by radiometric assay,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,910.0,nM,6.040958607678906
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 expressed in baculovirus system by radiometric assay,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,1170.0,nM,5.931814138253838
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 expressed in baculovirus system by radiometric assay,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,550.0,nM,6.259637310505756
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D expressed in Sf9 cells,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,92.0,nM,7.036212172654444
CHEMBL576656,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D by luciferase-coupled assay,CC(C)(C)C1CCc2c(sc(NC(=O)c3ccncc3)c2C(N)=O)C1,IC50,316.23,nM,6.499996931948306
CHEMBL568465,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D by luciferase-coupled assay,CC1CCc2c(sc(NC(=O)c3ccccc3[N+](=O)[O-])c2C(N)=O)C1,IC50,501.19,nM,6.299997602857746
CHEMBL565565,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D by luciferase-coupled assay,NC(=O)c1c(NC(=O)c2ccccc2[N+](=O)[O-])sc2c1CCCC2,IC50,6309.57,nM,5.200000237109354
CHEMBL578985,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D by luciferase-coupled assay,CC1CCCc2sc(NC(=O)c3ccccc3[N+](=O)[O-])c(C(N)=O)c21,IC50,31622.78,nM,4.499999953328896
CHEMBL579190,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D by luciferase-coupled assay,Cc1cccc(C)c1C1CCCc2sc(NC(=O)c3ccccc3[N+](=O)[O-])c(C(N)=O)c21,IC50,2511.89,nM,5.59999938302362
CHEMBL576436,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D by luciferase-coupled assay,CC1CCc2sc(NC(=O)c3ccccc3[N+](=O)[O-])c(C(N)=O)c2C1,IC50,6309.57,nM,5.200000237109354
CHEMBL568003,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D by luciferase-coupled assay,CC(C)(C)C1CCc2sc(NC(=O)c3ccccc3[N+](=O)[O-])c(C(N)=O)c2C1,IC50,6309.57,nM,5.200000237109354
CHEMBL568004,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D by luciferase-coupled assay,CCC1CCc2c(sc(NC(=O)c3ccccc3[N+](=O)[O-])c2C(N)=O)C1,IC50,125.89,nM,6.900008766455316
CHEMBL583841,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D by luciferase-coupled assay,CC(C)(C)C1CCc2c(sc(NC(=O)c3ccccc3[N+](=O)[O-])c2C(N)=O)C1,IC50,125.89,nM,6.900008766455316
CHEMBL584684,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D by luciferase-coupled assay,CC1(C)CCc2c(sc(NC(=O)c3ccccc3[N+](=O)[O-])c2C(N)=O)C1,IC50,398.11,nM,6.399996913372259
CHEMBL565768,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D by luciferase-coupled assay,CCCCCC1CCc2c(sc(NC(=O)c3ccccc3[N+](=O)[O-])c2C(N)=O)C1,IC50,2511.89,nM,5.59999938302362
CHEMBL584893,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D by luciferase-coupled assay,NC(=O)c1c(NC(=O)c2ccccc2[N+](=O)[O-])sc2c1CCC(c1ccccc1)C2,IC50,1584.89,nM,5.800000874803203
CHEMBL567470,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,CCCOCCn1c(=O)c(N[C@H]2CC[C@H](O)CC2)nc2cnc(-c3ccc(OC)nc3)cc21,IC50,1210.0,nM,5.917214629683549
CHEMBL440878,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D catalytic domain cloned from human HL60 cells assessed as inhibition of cAMP hydrolysis,COc1ccc(C2=NNC(=O)[C@@H]3CC=CC[C@H]23)cc1OC,IC50,85.0,nM,7.070581074285707
CHEMBL605935,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D catalytic domain cloned from human HL60 cells assessed as inhibition of cAMP hydrolysis,COc1ccc(C2=NN(CC(=O)NCCCn3ccnc3)C(=O)[C@@H]3CC=CC[C@H]23)cc1OC,IC50,14.3,nM,7.844663962534938
CHEMBL595959,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D catalytic domain cloned from human HL60 cells assessed as inhibition of cAMP hydrolysis,COc1ccc(C2=NN(CCOCCn3ccnc3)C(=O)[C@@H]3CC=CC[C@H]23)cc1OC,IC50,5.2,nM,8.2839966563652
CHEMBL594108,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D catalytic domain cloned from human HL60 cells assessed as inhibition of cAMP hydrolysis,COc1ccc(C2=NN(C/C=C/Cn3ccnc3)C(=O)[C@@H]3CC=CC[C@H]23)cc1OC,IC50,0.4,nM,9.397940008672037
CHEMBL594109,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D catalytic domain cloned from human HL60 cells assessed as inhibition of cAMP hydrolysis,COc1ccc(C2=NN(Cc3ccc(Cn4ccnc4)cc3)C(=O)[C@@H]3CC=CC[C@H]23)cc1OC,IC50,0.7,nM,9.154901959985743
CHEMBL595064,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D catalytic domain cloned from human HL60 cells assessed as inhibition of cAMP hydrolysis,COc1ccc(C2=NN(Cc3ccc(CN4CCC(=O)CC4)cc3)C(=O)[C@@H]3CC=CC[C@H]23)cc1OC,IC50,0.9,nM,9.045757490560675
CHEMBL596447,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D catalytic domain cloned from human HL60 cells assessed as inhibition of cAMP hydrolysis,COc1ccc(C2=NN(Cc3ccc(CN4CCC5(CC4)OCCO5)cc3)C(=O)[C@@H]3CC=CC[C@H]23)cc1OC,IC50,1.3,nM,8.886056647693163
CHEMBL603626,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D catalytic domain cloned from human HL60 cells assessed as inhibition of cAMP hydrolysis,COc1ccc(C2=NN(Cc3ccc(CN4CCCCC4)cc3)C(=O)[C@@H]3CC=CC[C@H]23)cc1OC,IC50,8.2,nM,8.086186147616283
CHEMBL595038,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D catalytic domain cloned from human HL60 cells assessed as inhibition of cAMP hydrolysis,COc1ccc(C2=NN(Cc3ccc(CN4CCN(C)CC4)cc3)C(=O)[C@@H]3CC=CC[C@H]23)cc1OC,IC50,2.0,nM,8.698970004336019
CHEMBL595039,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D catalytic domain cloned from human HL60 cells assessed as inhibition of cAMP hydrolysis,COc1ccc(C2=NN(Cc3ccc(CN(C)C)cc3)C(=O)[C@@H]3CC=CC[C@H]23)cc1OC,IC50,9.7,nM,8.013228265733755
CHEMBL593877,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D catalytic domain cloned from human HL60 cells assessed as inhibition of cAMP hydrolysis,COc1ccc(C2=NN(Cc3ccc(CN4CCOCC4)cc3)C(=O)[C@@H]3CC=CC[C@H]23)cc1OC,IC50,0.9,nM,9.045757490560675
CHEMBL596394,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D catalytic domain cloned from human HL60 cells assessed as inhibition of cAMP hydrolysis,COc1ccc(C2=NN(Cc3cccc(CN4CCOCC4)c3)C(=O)[C@@H]3CC=CC[C@H]23)cc1OC,IC50,1.4,nM,8.853871964321762
CHEMBL592931,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D catalytic domain cloned from human HL60 cells assessed as inhibition of cAMP hydrolysis,COc1ccc(C2=NN(Cc3ccccc3CN3CCOCC3)C(=O)[C@@H]3CC=CC[C@H]23)cc1OC,IC50,1.3,nM,8.886056647693163
CHEMBL592942,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D catalytic domain cloned from human HL60 cells assessed as inhibition of cAMP hydrolysis,COc1ccc(C2=NN(Cc3ccc(CN4CCOCC4)cc3)C(=O)CC2)cc1OC,IC50,45.9,nM,7.338187314462739
CHEMBL603194,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D catalytic domain cloned from human HL60 cells assessed as inhibition of cAMP hydrolysis,COc1ccc(C2=NN(Cc3ccc(CN4CCOCC4)cc3)C(=O)[C@@H]3C[C@H]23)cc1OC,IC50,16.4,nM,7.785156151952302
CHEMBL605096,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D catalytic domain cloned from human HL60 cells assessed as inhibition of cAMP hydrolysis,COc1ccc(C2=NN(Cc3ccc(CN4CCOCC4)cc3)C(=O)[C@@H]3CC[C@H]23)cc1OC,IC50,4.3,nM,8.366531544420413
CHEMBL595272,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D catalytic domain cloned from human HL60 cells assessed as inhibition of cAMP hydrolysis,COc1ccc(C2=NN(Cc3ccccc3CN3CCOCC3)C(=O)[C@@H]3CCCC[C@H]23)cc1OC,IC50,1.0,nM,9.0
CHEMBL593656,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D catalytic domain cloned from human HL60 cells assessed as inhibition of cAMP hydrolysis,COc1ccc(C2=NN(Cc3ccc(CN4CCOCC4)cc3)C(=O)[C@@H]3CC=CC[C@H]23)cc1OC.Cl,IC50,0.3,nM,9.522878745280337
CHEMBL593877,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D catalytic domain cloned from human HL60 cells assessed as inhibition of cAMP hydrolysis,COc1ccc(C2=NN(Cc3ccc(CN4CCOCC4)cc3)C(=O)[C@@H]3CC=CC[C@H]23)cc1OC,IC50,8.8,nM,8.05551732784983
CHEMBL596175,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 assessed as cAMP hydrolysis,COc1ccc(C2=NN(CCCCCNCC[C@@H](Oc3cccc4ccccc34)c3cccs3)C(=O)[C@@H]3CC=CC[C@H]23)cc1OC,IC50,45.0,nM,7.346787486224656
CHEMBL596185,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 assessed as cAMP hydrolysis,COc1ccc(C2=NN(CCCCCNCC[C@H](Oc3cccc4ccccc34)c3cccs3)C(=O)[C@@H]3CC=CC[C@H]23)cc1OC,IC50,23.0,nM,7.638272163982407
CHEMBL440878,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 assessed as cAMP hydrolysis,COc1ccc(C2=NNC(=O)[C@@H]3CC=CC[C@H]23)cc1OC,IC50,213.0,nM,6.671620396561263
CHEMBL463431,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 assessed as cAMP hydrolysis,COc1ccc(C2=NN(CCCCCBr)C(=O)[C@@H]3CC=CC[C@H]23)cc1OC,IC50,2.0,nM,8.698970004336019
CHEMBL597718,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1ccc(-c2ccnc3cc(-c4ccccc4)nn23)cc1OC1CCCC1,IC50,70.0,nM,7.154901959985743
CHEMBL606171,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1ccc(-c2ccnc3cc(-c4ccccc4Br)nn23)cc1OC1CCCC1,IC50,140.0,nM,6.853871964321762
CHEMBL606386,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1ccc(-c2ccnc3cc(-c4ccccc4OC)nn23)cc1OC1CCCC1,IC50,70.0,nM,7.154901959985743
CHEMBL602046,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1ccc(-c2ccnc3cc(-c4ccc(Cl)cc4)nn23)cc1OC1CCCC1,IC50,90.0,nM,7.045757490560675
CHEMBL600791,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1ccc(-c2ccnc3cc(-c4ccc(Br)cc4)nn23)cc1OC1CCCC1,IC50,130.0,nM,6.886056647693163
CHEMBL600989,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1ccc(-c2cc3nccc(-c4ccc(OC)c(OC5CCCC5)c4)n3n2)cc1,IC50,60.0,nM,7.221848749616356
CHEMBL600990,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1ccc(-c2ccnc3cc(-c4cccc(Cl)c4)nn23)cc1OC1CCCC1,IC50,20.0,nM,7.698970004336019
CHEMBL605362,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1ccc(-c2ccnc3cc(-c4cccc(Br)c4)nn23)cc1OC1CCCC1,IC50,30.0,nM,7.522878745280337
CHEMBL603070,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1cccc(-c2cc3nccc(-c4ccc(OC)c(OC5CCCC5)c4)n3n2)c1,IC50,40.0,nM,7.3979400086720375
CHEMBL606214,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1ccc(-c2ccnc3cc(-c4cc(Cl)ccc4Cl)nn23)cc1OC1CCCC1,IC50,30.0,nM,7.522878745280337
CHEMBL603071,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,FC(F)Oc1ccc(-c2ccnc3cc(-c4cccc(Br)c4)nn23)cc1OCC1CC1,IC50,13.0,nM,7.886056647693163
CHEMBL602666,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,FC(F)Oc1ccc(-c2ccnc3cc(-c4cccc(I)c4)nn23)cc1OCC1CC1,IC50,6.0,nM,8.221848749616356
CHEMBL589514,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,30.0,nM,7.522878745280337
CHEMBL598719,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COC(=O)c1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,37.0,nM,7.431798275933005
CHEMBL604519,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,FC(F)Oc1ccc(-c2ccnc3cc(-c4cccnc4)nn23)cc1OCC1CC1,IC50,27.0,nM,7.568636235841012
CHEMBL599326,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,[O-][n+]1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,42.0,nM,7.376750709602099
CHEMBL604940,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,FC(F)Oc1ccc(-c2ccnc3cc(-c4ccccc4)nn23)cc1OCC1CC1,IC50,130.0,nM,6.886056647693163
CHEMBL599327,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,Fc1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,100.0,nM,7.0
CHEMBL605355,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,FC(F)Oc1ccc(-c2ccnc3cc(-c4cccc(Cl)c4)nn23)cc1OCC1CC1,IC50,36.0,nM,7.443697499232712
CHEMBL598116,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CCOc1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,48.0,nM,7.318758762624412
CHEMBL605340,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CC(C)Oc1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,46.0,nM,7.337242168318426
CHEMBL605146,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,C=CCOc1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,32.0,nM,7.494850021680094
CHEMBL598318,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,FC(F)Oc1ccc(-c2ccnc3cc(-c4cccc(C(F)(F)F)c4)nn23)cc1OCC1CC1,IC50,190.0,nM,6.721246399047171
CHEMBL598670,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,Oc1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,21.0,nM,7.6777807052660805
CHEMBL604107,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CC(=O)Oc1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,18.0,nM,7.7447274948966935
CHEMBL598671,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,Nc1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,46.0,nM,7.337242168318426
CHEMBL598049,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CNc1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,40.0,nM,7.3979400086720375
CHEMBL603230,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CS(=O)(=O)CNc1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,32.0,nM,7.494850021680094
CHEMBL597071,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,N#CNc1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,40.0,nM,7.3979400086720375
CHEMBL597072,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CN(C)c1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,120.0,nM,6.920818753952375
CHEMBL597078,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CN(CCN)c1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,47.0,nM,7.327902142064282
CHEMBL598085,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,N#CCCNc1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,83.0,nM,7.080921907623926
CHEMBL604721,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,NC(=O)Nc1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,150.0,nM,6.823908740944319
CHEMBL598086,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,O=C(O)c1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,9.0,nM,8.045757490560675
CHEMBL598500,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CC(C)OC(=O)c1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,40.0,nM,7.3979400086720375
CHEMBL598906,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COCCOC(=O)c1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,160.0,nM,6.795880017344075
CHEMBL598907,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CCNC(=O)c1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,28.0,nM,7.552841968657781
CHEMBL608268,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CC(C)(C)NC(=O)c1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,44.0,nM,7.356547323513812
CHEMBL598909,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CN(C)C(=O)c1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,23.0,nM,7.638272163982407
CHEMBL599109,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,FC(F)Oc1ccc(-c2ccnc3cc(-c4cccc(C(F)F)c4)nn23)cc1OCC1CC1,IC50,39.0,nM,7.4089353929735005
CHEMBL596696,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,FC(F)Oc1ccc(-c2ccnc3cc(-c4cc(Cl)ccc4Cl)nn23)cc1OCC1CC1,IC50,200.0,nM,6.698970004336019
CHEMBL598654,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,FC(F)Oc1ccc(-c2ccnc3cc(-c4cc(Cl)cc(Cl)c4)nn23)cc1OCC1CC1,IC50,100.0,nM,7.0
CHEMBL603892,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1ccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)cc1OC,IC50,25.0,nM,7.6020599913279625
CHEMBL604930,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1cc(OC)cc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,29.0,nM,7.537602002101044
CHEMBL598745,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1ccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)cc1O,IC50,32.0,nM,7.494850021680094
CHEMBL598946,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,FC(F)Oc1ccc(-c2ccnc3cc(-c4cccc(N5CCCCC5)c4)nn23)cc1OCC1CC1,IC50,100.0,nM,7.0
CHEMBL600468,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CC(C)(C)OC(=O)N1CCN(c2cccc(-c3cc4nccc(-c5ccc(OC(F)F)c(OCC6CC6)c5)n4n3)c2)CC1,IC50,54.0,nM,7.267606240177031
CHEMBL604731,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,O=C(c1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1)N1CCCCC1,IC50,65.0,nM,7.187086643357144
CHEMBL599525,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CCN(CC)C(=O)c1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,IC50,67.0,nM,7.173925197299173
CHEMBL599526,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,FC(F)Oc1ccc(-c2ccnc3cc(-c4cccc(-n5cnnn5)c4)nn23)cc1OCC1CC1,IC50,44.0,nM,7.356547323513812
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,550.0,nM,6.259637310505756
CHEMBL511115,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1ccc([C@]2(C#N)CC[C@@H](C(=O)O)CC2)cc1OC1CCCC1,IC50,11.0,nM,7.958607314841775
CHEMBL42126,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1ccc(C(=O)Nc2c(Cl)cncc2Cl)cc1OC1CCCC1,IC50,0.021,nM,10.67778070526608
CHEMBL313842,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1cc(-c2ccc(=O)[nH]n2)ccc1OC(F)F,IC50,390.0,nM,6.4089353929735005
CHEMBL192,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12,IC50,20000.0,nM,4.698970004336019
CHEMBL1090373,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D4 expressed in CHO cells assessed as isoproterenol-induced [125I]cAMP accumulation after 15 mins by scintillation counting,O=C(c1cnccn1)N1CCN(CCCNc2nnc(-c3cccc([N+](=O)[O-])c3)c3c2cc2ccccn23)CC1,IC50,4900.0,nM,5.309803919971486
CHEMBL198432,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1cccc(-c2cc(Cc3ccncc3)cc3cccnc23)c1,IC50,2.5,nM,8.602059991327963
CHEMBL372575,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,Cc1noc(/C(=C/c2cccc(-c3cc(C(C)(C)S(C)(=O)=O)cc4cccnc34)c2)c2ccc(S(C)(=O)=O)cc2)n1,IC50,1.2,nM,8.920818753952375
CHEMBL1224653,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1cccc(-c2cc(C(C)(C)S(C)(=O)=O)cc3cccnc23)c1,IC50,9.3,nM,8.031517051446064
CHEMBL1224717,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COC(=O)Cc1ccc(OCc2cc(-c3cccc(OC)c3)c3ncccc3c2)cc1,IC50,0.4,nM,9.397940008672037
CHEMBL1224718,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1cccc(-c2cc(COc3ccccc3Cl)cc3cccnc23)c1,IC50,5.0,nM,8.301029995663981
CHEMBL1224719,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1cccc(-c2cc(COc3cccc(Cl)c3)cc3cccnc23)c1,IC50,12.1,nM,7.91721462968355
CHEMBL1224720,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1cccc(-c2cc(COc3ccc(C(F)(F)F)cc3)cc3cccnc23)c1,IC50,48.7,nM,7.3124710387853655
CHEMBL1224721,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1cccc(-c2cc(COc3ccc(CCC#N)cc3)cc3cccnc23)c1,IC50,2.0,nM,8.698970004336019
CHEMBL1223618,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,N#CCCc1ccc(OCc2cc(-c3ccccc3)c3ncccc3c2)cc1,IC50,22.2,nM,7.653647025549361
CHEMBL1223619,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,N#CCCc1ccc(OCc2cc(-c3cccc(OC(F)(F)F)c3)c3ncccc3c2)cc1,IC50,17.0,nM,7.769551078621726
CHEMBL1223620,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,N#CCCc1ccc(OCc2cc(-c3cccc(F)c3)c3ncccc3c2)cc1,IC50,10.5,nM,7.978810700930062
CHEMBL1223621,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CCOc1cccc(-c2cc(COc3ccc(CCC#N)cc3)cc3cccnc23)c1,IC50,4.5,nM,8.346787486224656
CHEMBL1223684,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,Cc1cccc(-c2cc(COc3ccc(CCC#N)cc3)cc3cccnc23)c1,IC50,18.3,nM,7.73754891026957
CHEMBL1223685,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,N#CCCc1ccc(OCc2cc(-c3cccc(OC(F)F)c3)c3ncccc3c2)cc1,IC50,0.9,nM,9.045757490560675
CHEMBL1223686,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CS(=O)(=O)c1ccc(OCc2cc(-c3cccc(OC(F)F)c3)c3ncccc3c2)cc1,IC50,0.8,nM,9.096910013008056
CHEMBL1223687,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,O=C(O)Cc1ccc(OCc2cc(-c3cccc(OC(F)F)c3)c3ncccc3c2)cc1,IC50,0.2,nM,9.698970004336019
CHEMBL1221434,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CC(C)(O)CCc1ccc(OCc2cc(-c3cccc(OC(F)F)c3)c3ncccc3c2)cc1,IC50,0.6,nM,9.221848749616356
CHEMBL1255597,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 expressed in yeast,CC1(C)CCc2c(N3CCOCC3)nc3sc4c(N(CCO)CCN5CCOCC5)ncnc4c3c2C1,IC50,1.8,nM,8.744727494896694
CHEMBL1257189,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 expressed in yeast,CC1(C)CCc2c(-c3ccoc3)nc3sc4c(NCCN5CCOCC5)ncnc4c3c2C1,IC50,3.1,nM,8.508638306165727
CHEMBL1258806,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 expressed in yeast,CNc1nc2sc3c(NCCN4CCOCC4)ncnc3c2c2c1CCC(C)(C)C2,IC50,4.2,nM,8.3767507096021
CHEMBL1258124,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 expressed in yeast,CC1(C)CCc2c(N3CCOCC3)nc3sc4c(NCCN5CCOCC5)ncnc4c3c2C1,IC50,4.6,nM,8.337242168318426
CHEMBL1257188,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 expressed in yeast,CC1(C)CCc2c(-c3ccco3)nc3sc4c(NCCN5CCOCC5)ncnc4c3c2C1,IC50,7.9,nM,8.102372908709558
CHEMBL1258470,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 expressed in yeast,CC1(C)CCc2c(N3CCCC3)nc3sc4c(NCCN5CCOCC5)ncnc4c3c2C1,IC50,11.0,nM,7.958607314841775
CHEMBL1257654,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 expressed in yeast,CC1(C)CCc2c(N3CCOCC3)nc3sc4c(NCc5ccncc5)ncnc4c3c2C1,IC50,13.0,nM,7.886056647693163
CHEMBL1255772,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 expressed in yeast,CC1(C)Cc2c(c(N3CCOCC3)nc3sc4c(N(CCN5CCOCC5)Cc5cccnc5)ncnc4c23)CO1,IC50,19.0,nM,7.721246399047171
CHEMBL1258807,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 expressed in yeast,CN(C)c1nc2sc3c(NCCN4CCOCC4)ncnc3c2c2c1COC(C)(C)C2,IC50,25.0,nM,7.6020599913279625
CHEMBL1257536,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 expressed in yeast,CC1(C)CCc2c(N3CCOCC3)nc3sc4c(NCc5cccnc5)ncnc4c3c2C1,IC50,32.0,nM,7.494850021680094
CHEMBL1258921,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 expressed in yeast,Cc1nc2sc3c(NCCN4CCOCC4)ncnc3c2c2c1CCC(C)(C)C2,IC50,34.0,nM,7.468521082957745
CHEMBL1258922,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 expressed in yeast,CC(C)Cc1nc2sc3c(NCCN4CCOCC4)ncnc3c2c2c1CCC(C)(C)C2,IC50,39.0,nM,7.4089353929735005
CHEMBL1257778,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 expressed in yeast,CC1(C)Cc2c(c(N3CCOCC3)nc3sc4c(N(CCO)CCN5CCOCC5)ncnc4c23)CO1,IC50,39.0,nM,7.4089353929735005
CHEMBL1257422,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 expressed in yeast,CC1(C)Cc2c(c(N3CCOCC3)nc3sc4c(NCc5cccnc5)ncnc4c23)CO1,IC50,52.0,nM,7.2839966563652006
CHEMBL1257421,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 expressed in yeast,CC1(C)CCc2c(N3CCOCC3)nc3sc4c(NCCCN5CCCC5=O)ncnc4c3c2C1,IC50,61.0,nM,7.214670164989233
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 expressed in yeast,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,70.0,nM,7.154901959985743
CHEMBL1257655,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 expressed in yeast,COc1ccccc1CNc1ncnc2c1sc1nc(N3CCOCC3)c3c(c12)CC(C)(C)OC3,IC50,119.0,nM,6.924453038607469
CHEMBL1257537,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 expressed in yeast,CC1(C)Cc2c(c(N3CCOCC3)nc3sc4c(NCc5ccncc5)ncnc4c23)CO1,IC50,128.0,nM,6.892790030352131
CHEMBL1258123,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 expressed in yeast,CC1(C)Cc2c(c(N3CCOCC3)nc3sc4c(NCCN5CCOCC5)ncnc4c23)CO1,IC50,604.0,nM,6.218963061378869
CHEMBL1641615,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D6,Cc1nc2c3ccccc3nc(SCc3nc4ccccc4[nH]3)n2n1,IC50,10000.0,nM,5.0
CHEMBL1642568,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D6,Cc1ccc2nc(CCc3nc(-c4ccccc4)cn3C)n3nc(C)cc3c2c1,IC50,10000.0,nM,5.0
CHEMBL1779382,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4d6,Cc1nc2c3cc(Br)ccc3nc(SCC#N)n2n1,IC50,2200.0,nM,5.657577319177793
CHEMBL511115,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,COc1ccc([C@]2(C#N)CC[C@@H](C(=O)O)CC2)cc1OC1CCCC1,IC50,27.0,nM,7.568636235841012
CHEMBL1784107,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,C=CCc1c(C)nc(-c2ccccc2)nc1Nc1ccc(C(=O)O)cc1,IC50,1900.0,nM,5.721246399047171
CHEMBL1784108,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,Cc1nc(-c2ccccc2)nc(Nc2ccc(C(=O)O)cc2)c1C,IC50,3400.0,nM,5.468521082957745
CHEMBL1784109,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,CCc1c(C)nc(-c2ccccc2)nc1Nc1ccc(C(=O)O)cc1,IC50,2100.0,nM,5.6777807052660805
CHEMBL1784110,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,CCCc1c(C)nc(-c2ccccc2)nc1Nc1ccc(C(=O)O)cc1,IC50,7600.0,nM,5.119186407719209
CHEMBL1784114,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,Cc1nc(-c2ccccc2)nc(Nc2ccc(C(=O)O)cc2)c1C#N,IC50,1500.0,nM,5.823908740944319
CHEMBL1784116,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,Cc1nc(-c2ccccc2)nc(Nc2ccc(C(=O)O)cc2)c1C=O,IC50,1500.0,nM,5.823908740944319
CHEMBL1784117,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,Cc1nc(-c2ccccc2)nc(Nc2ccc(C(=O)O)cc2)c1CO,IC50,8000.0,nM,5.096910013008056
CHEMBL1784118,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,C=CCc1c(CC)nc(-c2ccccc2)nc1Nc1ccc(C(=O)O)cc1,IC50,82.0,nM,7.086186147616283
CHEMBL1782288,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,C=CCc1c(CCC)nc(-c2ccccc2)nc1Nc1ccc(C(=O)O)cc1,IC50,2400.0,nM,5.619788758288394
CHEMBL1782289,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,C=CCc1c(C)nc(-c2cccs2)nc1Nc1ccc(C(=O)O)cc1,IC50,1300.0,nM,5.886056647693163
CHEMBL1782290,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,C=CCc1c(C)nc(-c2ccsc2)nc1Nc1ccc(C(=O)O)cc1,IC50,990.0,nM,6.00436480540245
CHEMBL1782291,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,C=CCc1c(C)nc(-c2csc(C)n2)nc1Nc1ccc(C(=O)O)cc1,IC50,12000.0,nM,4.920818753952375
CHEMBL1782292,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,C=CCc1c(C)nc(-c2ccccn2)nc1Nc1ccc(C(=O)O)cc1,IC50,15000.0,nM,4.823908740944319
CHEMBL1782293,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,C=CCc1c(C)nc(-c2cnccn2)nc1Nc1ccc(C(=O)O)cc1,IC50,3000.0,nM,5.522878745280337
CHEMBL1782294,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,C=CCc1c(C)nc(-c2ccc(C)cc2)nc1Nc1ccc(C(=O)O)cc1,IC50,2800.0,nM,5.552841968657781
CHEMBL1782295,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,C=CCc1c(C)nc(-c2cccc(C)c2)nc1Nc1ccc(C(=O)O)cc1,IC50,1500.0,nM,5.823908740944319
CHEMBL1782296,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,C=CCc1c(C)nc(-c2ccc(OC)cc2)nc1Nc1ccc(C(=O)O)cc1,IC50,2000.0,nM,5.698970004336019
CHEMBL1782297,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,C=CCc1c(C)nc(-c2ccc(C)s2)nc1Nc1ccc(C(=O)O)cc1,IC50,1300.0,nM,5.886056647693163
CHEMBL1782298,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,C=CCc1c(C)nc(-c2ccc(OC)s2)nc1Nc1ccc(C(=O)O)cc1,IC50,760.0,nM,6.119186407719209
CHEMBL1782300,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,C=CCc1c(C)nc(-c2ccc(C)cc2)nc1Nc1ccc(CC(=O)O)cc1,IC50,11000.0,nM,4.958607314841775
CHEMBL1782301,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,C=CCc1c(C)nc(-c2cccc(C)c2)nc1Nc1ccc(CC(=O)O)cc1,IC50,9900.0,nM,5.00436480540245
CHEMBL1782302,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,C=CCc1c(C)nc(-c2ccc(OC)cc2)nc1Nc1ccc(CC(=O)O)cc1,IC50,4800.0,nM,5.318758762624412
CHEMBL1782286,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,C=CCc1c(C)nc(-c2ccc(C)s2)nc1Nc1ccc(CC(=O)O)cc1,IC50,8800.0,nM,5.055517327849831
CHEMBL1782303,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,C=CCc1c(C)nc(-c2ccc(OC)s2)nc1Nc1ccc(CC(=O)O)cc1,IC50,5300.0,nM,5.275724130399211
CHEMBL1782304,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,CCc1c(C)nc(-c2ccc(SC)s2)nc1Nc1ccc(CC(=O)O)cc1,IC50,1500.0,nM,5.823908740944319
CHEMBL1782305,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,CCc1c(C)nc(-c2ccc(Br)s2)nc1Nc1ccc(CC(=O)O)cc1,IC50,1600.0,nM,5.795880017344075
CHEMBL1782306,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,CCc1c(C)nc(-c2ccc(Cl)s2)nc1Nc1ccc(CC(=O)O)cc1,IC50,1700.0,nM,5.769551078621726
CHEMBL1782307,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,CCc1c(C)nc(-c2cc(Br)c(C)s2)nc1Nc1ccc(CC(=O)O)cc1,IC50,2900.0,nM,5.537602002101044
CHEMBL1782308,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 incubated for 10 mins using cAMP and [3H]cAMP substrates,CCc1c(C)nc(-c2ccc(F)s2)nc1Nc1ccc(CC(=O)O)cc1F,IC50,3100.0,nM,5.508638306165727
CHEMBL372575,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,Cc1noc(/C(=C/c2cccc(-c3cc(C(C)(C)S(C)(=O)=O)cc4cccnc34)c2)c2ccc(S(C)(=O)=O)cc2)n1,IC50,1.0,nM,9.0
CHEMBL485629,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,O=C(NC1CC1)c1cn(-c2cccc(C#Cc3ccc[n+]([O-])c3)c2)c2ncccc2c1=O,IC50,5.1,nM,8.292429823902063
CHEMBL253083,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,CC(C)(c1cc(-c2cccc(-c3ccc(C4CC4C(=O)O)cc3)c2)c2ncccc2c1)S(C)(=O)=O,IC50,0.54,nM,9.267606240177031
CHEMBL253083,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,CC(C)(c1cc(-c2cccc(-c3ccc(C4CC4C(=O)O)cc3)c2)c2ncccc2c1)S(C)(=O)=O,IC50,0.32,nM,9.494850021680094
CHEMBL1801067,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,O=C(NC1CC1)c1cn(-c2cccc(-c3ccc(C4CC4C(=O)O)cc3)c2)c2ncccc2c1=O,IC50,0.57,nM,9.244125144327509
CHEMBL1801068,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,O=C(NC1CC1)c1cn(-c2cccc(-c3cccc(C4CC4C(=O)O)c3)c2)c2ncccc2c1=O,IC50,0.54,nM,9.267606240177031
CHEMBL1801069,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,O=C(NC1CC1)c1cn(-c2cccc(-c3ccccc3C3CC3C(=O)O)c2)c2ncccc2c1=O,IC50,4.6,nM,8.337242168318426
CHEMBL1801070,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,CC(C)(Cc1ccc(-c2cccc(-n3cc(C(=O)NC4CC4)c(=O)c4cccnc43)c2)cc1)C(=O)O,IC50,0.88,nM,9.05551732784983
CHEMBL1801071,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,CC(C)(CC(=O)O)c1ccc(-c2cccc(-n3cc(C(=O)NC4CC4)c(=O)c4cccnc43)c2)cc1,IC50,0.85,nM,9.070581074285707
CHEMBL1801067,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,O=C(NC1CC1)c1cn(-c2cccc(-c3ccc(C4CC4C(=O)O)cc3)c2)c2ncccc2c1=O,IC50,1.6,nM,8.795880017344075
CHEMBL1801151,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,O=C(NC1CC1)c1cn(-c2cccc(-c3ccc(C4CC4c4nnn[nH]4)cc3)c2)c2ncccc2c1=O,IC50,0.55,nM,9.259637310505756
CHEMBL1801152,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,CC(C)(C)NC(=O)c1cn(-c2cccc(-c3ccc(C4CC4C(=O)O)cc3)c2)c2ncccc2c1=O,IC50,32.0,nM,7.494850021680094
CHEMBL1801153,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,O=C(NC1(O)CC1)c1cn(-c2cccc(-c3ccc(C4CC4C(=O)O)cc3)c2)c2ncccc2c1=O,IC50,17.0,nM,7.769551078621726
CHEMBL1801154,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,CC1(NC(=O)c2cn(-c3cccc(-c4ccc(C5CC5C(=O)O)cc4)c3)c3ncccc3c2=O)CC1,IC50,0.58,nM,9.236572006437063
CHEMBL1801155,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,O=C(NCC(F)(F)F)c1cn(-c2cccc(-c3ccc(C4CC4C(=O)O)cc3)c2)c2ncccc2c1=O,IC50,0.51,nM,9.292429823902063
CHEMBL1801156,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,O=C(NCC1CC1)c1cn(-c2cccc(-c3ccc(C4CC4C(=O)O)cc3)c2)c2ncccc2c1=O,IC50,0.35,nM,9.455931955649724
CHEMBL1801157,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,O=C(NC1CCC1)c1cn(-c2cccc(-c3ccc(C4CC4C(=O)O)cc3)c2)c2ncccc2c1=O,IC50,0.52,nM,9.2839966563652
CHEMBL1801158,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,O=C(NC1CC1)c1cn(-c2cccc(-c3ccc([C@@H]4C[C@H]4C(=O)O)cc3)c2)c2ncccc2c1=O,IC50,1.0,nM,9.0
CHEMBL1801159,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,O=C(NC1CC1)c1cn(-c2cccc(-c3ccc([C@H]4C[C@@H]4C(=O)O)cc3)c2)c2ncccc2c1=O,IC50,0.66,nM,9.18045606445813
CHEMBL1801160,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,O=C(NC1CC1)c1cn(-c2cccc(-c3ccc([C@@H]4C[C@H]4C(=O)O)c(F)c3)c2)c2ncccc2c1=O,IC50,0.53,nM,9.275724130399212
CHEMBL1801161,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,O=C(NC1CC1)c1cn(-c2cccc(-c3ccc([C@H]4C[C@@H]4C(=O)O)c(F)c3)c2)c2ncccc2c1=O,IC50,0.46,nM,9.337242168318426
CHEMBL1830635,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 assessed as inhibition of [3H]cAMP hydrolysis to [3H]AMP after 15 mins by scintillation proximity assay,CC1(C)CCc2c(N3CCOCC3)nc3oc4c(NCc5cccnc5)ncnc4c3c2C1,IC50,13.0,nM,7.886056647693163
CHEMBL1830636,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 assessed as inhibition of [3H]cAMP hydrolysis to [3H]AMP after 15 mins by scintillation proximity assay,CC1(C)CCc2c(N3CCOCC3)nc3oc4c(NCCN5CCOCC5)ncnc4c3c2C1,IC50,9.4,nM,8.0268721464003
CHEMBL1830638,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 assessed as inhibition of [3H]cAMP hydrolysis to [3H]AMP after 15 mins by scintillation proximity assay,CC1(C)CCc2c(N3CCOCC3)nc3oc4c(N(CCO)CCN5CCOCC5)ncnc4c3c2C1,IC50,2.3,nM,8.638272163982407
CHEMBL1830640,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 assessed as inhibition of [3H]cAMP hydrolysis to [3H]AMP after 15 mins by scintillation proximity assay,CC1(C)CCc2c(NCCO)nc3oc4c(NCc5cccnc5)ncnc4c3c2C1,IC50,13.5,nM,7.8696662315049934
CHEMBL1830641,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 assessed as inhibition of [3H]cAMP hydrolysis to [3H]AMP after 15 mins by scintillation proximity assay,CCNc1nc2oc3c(NCCN4CCOCC4)ncnc3c2c2c1CCC(C)(C)C2,IC50,2.7,nM,8.568636235841012
CHEMBL1830642,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 assessed as inhibition of [3H]cAMP hydrolysis to [3H]AMP after 15 mins by scintillation proximity assay,CCN(C)c1nc2oc3c(NCCN4CCOCC4)ncnc3c2c2c1CCC(C)(C)C2,IC50,14.0,nM,7.853871964321762
CHEMBL1830643,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 assessed as inhibition of [3H]cAMP hydrolysis to [3H]AMP after 15 mins by scintillation proximity assay,CC(C)Nc1nc2oc3c(NCCN4CCOCC4)ncnc3c2c2c1CCC(C)(C)C2,IC50,0.4,nM,9.397940008672037
CHEMBL1830644,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 assessed as inhibition of [3H]cAMP hydrolysis to [3H]AMP after 15 mins by scintillation proximity assay,CCNc1nc2oc3c(NCCCN4CCCC4=O)ncnc3c2c2c1CCC(C)(C)C2,IC50,1.5,nM,8.823908740944319
CHEMBL1830645,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 assessed as inhibition of [3H]cAMP hydrolysis to [3H]AMP after 15 mins by scintillation proximity assay,CCN(C)c1nc2oc3c(NCCCN4CCCC4=O)ncnc3c2c2c1CCC(C)(C)C2,IC50,17.0,nM,7.769551078621726
CHEMBL1830646,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 assessed as inhibition of [3H]cAMP hydrolysis to [3H]AMP after 15 mins by scintillation proximity assay,CC(C)Nc1nc2oc3c(NCCCN4CCCC4=O)ncnc3c2c2c1CCC(C)(C)C2,IC50,0.1,nM,10.0
CHEMBL1830647,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 assessed as inhibition of [3H]cAMP hydrolysis to [3H]AMP after 15 mins by scintillation proximity assay,CCN(C)c1nc2oc3c(NCc4cccnc4)ncnc3c2c2c1CCC(C)(C)C2,IC50,240.0,nM,6.619788758288394
CHEMBL1830790,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 assessed as inhibition of [3H]cAMP hydrolysis to [3H]AMP after 15 mins by scintillation proximity assay,CCNc1nc2oc3c(NCc4cccnc4)ncnc3c2c2c1CCC(C)(C)C2,IC50,1.3,nM,8.886056647693163
CHEMBL1828652,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 assessed as inhibition of [3H]cAMP hydrolysis to [3H]AMP after 15 mins by scintillation proximity assay,CC(C)Nc1nc2oc3c(NCc4cccnc4)ncnc3c2c2c1CCC(C)(C)C2,IC50,0.5,nM,9.301029995663981
CHEMBL193240,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 assessed as inhibition of [3H]cAMP hydrolysis to [3H]AMP after 15 mins by scintillation proximity assay,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,IC50,0.27,nM,9.568636235841012
CHEMBL1922942,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 overexpressed in Escherichia coli after 15 mins using [3H]cAMP by scintillation proximity assay,CCOC(=O)c1c(NC(=O)Cc2ccccc2)sc2c1CCCC2,IC50,1500.0,nM,5.823908740944319
CHEMBL114535,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 overexpressed in Escherichia coli after 15 mins using [3H]cAMP by scintillation proximity assay,CCOC(=O)c1c(NC(=O)Cc2ccccc2)sc2c1CCN(C(=O)OCC)C2,IC50,100.0,nM,7.0
CHEMBL1922946,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 overexpressed in Escherichia coli after 15 mins using [3H]cAMP by scintillation proximity assay,CCOC(=O)c1c(NC(=O)Cc2cccs2)sc2c1CCN(C(=O)OCC)C2,IC50,22.0,nM,7.657577319177793
CHEMBL1923060,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 overexpressed in Escherichia coli after 15 mins using [3H]cAMP by scintillation proximity assay,CCOC(=O)N1CCc2c(sc(NC(=O)Cc3cccs3)c2C(=O)OC2CCCC2)C1,IC50,290.0,nM,6.537602002101044
CHEMBL1923066,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 overexpressed in Escherichia coli after 15 mins using [3H]cAMP by scintillation proximity assay,CCNC(=O)N1CCc2c(sc(NC(=O)Cc3ccccc3)c2C(=O)OCC)C1,IC50,27.0,nM,7.568636235841012
CHEMBL2012219,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,COc1ccc(-c2nc(C(=O)NCc3ccc(F)cc3F)c(CN)o2)c2ccc(C(F)(F)F)nc12,IC50,0.7,nM,9.154901959985743
CHEMBL512578,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413) expressed in Escherichia coli BL21 using [3H]-cAMP/[3H]-cGMP after 15 mins by liquid scintillation counting,Oc1cc(O)cc(-c2cc3ccc(O)cc3o2)c1,IC50,2900.0,nM,5.537602002101044
CHEMBL2018876,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413) expressed in Escherichia coli BL21 using [3H]-cAMP/[3H]-cGMP after 15 mins by liquid scintillation counting,CC(C)=CCc1c(O)cc(-c2cc3ccc(O)cc3o2)cc1O,IC50,26000.0,nM,4.585026652029182
CHEMBL193240,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413) expressed in Escherichia coli BL21 using [3H]-cAMP/[3H]-cGMP after 15 mins by liquid scintillation counting,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,IC50,460.0,nM,6.337242168318426
CHEMBL2041596,CHEMBL288,Phosphodiesterase 4D,"Inhibition of human recombinant PDE4D3 using fluorescein 3',5'-cyclic phosphate after 60 mins by IMAP fluorescence polarization assay",COc1cc(COC(=O)c2ccc(-c3ccccc3)o2)cc(OC)c1OC,IC50,66300.0,nM,4.178486471595227
CHEMBL2171423,CHEMBL288,Phosphodiesterase 4D,Inhibition of cloned human recombinant PDE4D assessed as [3H]cAMP hydrolysis by radiometric assay,COc1cc(N2CCCNCC2)ccc1-c1nc2c(C)nn(C3CCCCC3)c(=O)c2[nH]1,IC50,2900.0,nM,5.537602002101044
CHEMBL2171421,CHEMBL288,Phosphodiesterase 4D,Inhibition of cloned human recombinant PDE4D assessed as [3H]cAMP hydrolysis by radiometric assay,COc1cc(N)ccc1-c1nc2c(C)nn(C3CCCCC3)c(=O)c2[nH]1,IC50,6550.0,nM,5.183758700008217
CHEMBL2171452,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 expressed in Sf21 insect cells assessed as reduction of [3H]-cAMP hydrolysis by scintillation proximity assay,COc1ccc(C2=NN(C3CCCCCC3)C(=O)C2(C)C)cc1OCCCCOc1ccc(-c2nn[nH]n2)cc1,IC50,1.2,nM,8.920818753952375
CHEMBL77826,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,O=C(O)c1ccc(-c2cc3cccnc3c(-c3ccc4nonc4c3)n2)cc1,IC50,1.5,nM,8.823908740944319
CHEMBL2172366,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D-mediated [3H]CAMP hydrolysis after 30 to 60 mins by scintillation proximity assay,COc1cccc(-c2nc(N3CCC(C(=O)O)CC3)cc3cccnc23)c1,IC50,45.0,nM,7.346787486224656
CHEMBL2172367,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D-mediated [3H]CAMP hydrolysis after 30 to 60 mins by scintillation proximity assay,O=C(O)C1CCN(c2cc3cccnc3c(-c3cccc(OC(F)(F)F)c3)n2)CC1,IC50,30.0,nM,7.522878745280337
CHEMBL2172368,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D-mediated [3H]CAMP hydrolysis after 30 to 60 mins by scintillation proximity assay,O=C(O)C1CCN(c2cc3cccnc3c(-c3cccc(F)c3)n2)CC1,IC50,51.0,nM,7.292429823902063
CHEMBL2172369,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D-mediated [3H]CAMP hydrolysis after 30 to 60 mins by scintillation proximity assay,O=C(O)C1CCN(c2cc3cccnc3c(-c3cccc(Cl)c3)n2)CC1,IC50,30.0,nM,7.522878745280337
CHEMBL2172370,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D-mediated [3H]CAMP hydrolysis after 30 to 60 mins by scintillation proximity assay,N#Cc1cccc(-c2nc(N3CCC(C(=O)O)CC3)cc3cccnc23)c1,IC50,19.0,nM,7.721246399047171
CHEMBL2172371,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D-mediated [3H]CAMP hydrolysis after 30 to 60 mins by scintillation proximity assay,CSc1cccc(-c2nc(N3CCC(C(=O)O)CC3)cc3cccnc23)c1,IC50,51.0,nM,7.292429823902063
CHEMBL2172372,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D-mediated [3H]CAMP hydrolysis after 30 to 60 mins by scintillation proximity assay,COc1cccc(-c2nc([C@H]3CC[C@H](C(=O)O)CC3)cc3cccnc23)c1,IC50,64.0,nM,7.1938200260161125
CHEMBL2172373,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D-mediated [3H]CAMP hydrolysis after 30 to 60 mins by scintillation proximity assay,O=C(O)[C@H]1CC[C@H](c2cc3cccnc3c(-c3cccc(OC(F)(F)F)c3)n2)CC1,IC50,24.0,nM,7.619788758288394
CHEMBL2172374,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D-mediated [3H]CAMP hydrolysis after 30 to 60 mins by scintillation proximity assay,O=C(O)[C@H]1CC[C@H](c2cc3cccnc3c(-c3cccc(F)c3)n2)CC1,IC50,32.0,nM,7.494850021680094
CHEMBL2172375,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D-mediated [3H]CAMP hydrolysis after 30 to 60 mins by scintillation proximity assay,N#Cc1cccc(-c2nc([C@H]3CC[C@H](C(=O)O)CC3)cc3cccnc23)c1,IC50,41.0,nM,7.3872161432802645
CHEMBL2172376,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D-mediated [3H]CAMP hydrolysis after 30 to 60 mins by scintillation proximity assay,CSc1cccc(-c2nc([C@H]3CC[C@H](C(=O)O)CC3)cc3cccnc23)c1,IC50,6.0,nM,8.221848749616356
CHEMBL313842,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D,COc1cc(-c2ccc(=O)[nH]n2)ccc1OC(F)F,IC50,800.0,nM,6.096910013008056
CHEMBL2172731,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D,COc1ccc(/C=N/N(C)C(=O)c2ccccc2)cc1OC,IC50,140.0,nM,6.853871964321762
CHEMBL2172710,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D,COc1ccc(/C=N/N(C)C(=O)c2ccc(O)cc2)cc1OC,IC50,31.0,nM,7.508638306165727
CHEMBL2172734,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D,COc1ccc(C(=O)N(C)/N=C/c2ccc(OC)c(OC)c2)cc1,IC50,74.0,nM,7.130768280269024
CHEMBL2172707,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D,Clc1ncnc2ccccc12,IC50,622.0,nM,6.206209615309181
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,622.0,nM,6.206209615309181
CHEMBL2178115,CHEMBL288,Phosphodiesterase 4D,Binding affinity to PDE4D2 catalytic domain (86 to 413 amino acid residues) expressed in Escherichia coli BL21 using [3H]cGMP as substrate after 15 mins by liquid scintillation counter,COc1ccc(NC(=O)C(C)Nc2nc3c(cnn3-c3ccccc3Cl)c(=O)[nH]2)cc1,IC50,15700.0,nM,4.804100347590766
CHEMBL2206220,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D,OCC1CCN(c2nccnc2Oc2ccc(Nc3nc4ccccc4o3)cc2)CC1,IC50,7400.0,nM,5.130768280269024
CHEMBL2315896,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant PDE4D2 (unknown origin) expressed in Sf9 cells pre-incubated with compound for 15 mins before incubation with cAMP substrate for 1 hr,CCOC(=O)C1=CN(Cc2ccc(OC)c(OC)c2)C=C(C(=O)OCC)C1c1cccc([N+](=O)[O-])c1,IC50,2890.0,nM,5.539102157243452
CHEMBL2315889,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant PDE4D2 (unknown origin) expressed in Sf9 cells pre-incubated with compound for 15 mins before incubation with cAMP substrate for 1 hr,CCOC(=O)C1=CN(Cc2ccc(OC)c(OC)c2)C=C(C(=O)OCC)C1c1c[nH]c2ccccc12,IC50,650.0,nM,6.187086643357144
CHEMBL2315591,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant PDE4D2 (unknown origin) expressed in Sf9 cells pre-incubated with compound for 15 mins before incubation with cAMP substrate for 1 hr,CCOC(=O)C1=CN(Cc2ccc(OC)c(OO)c2)C=C(C(=O)OCC)C1c1cccc(F)c1,IC50,3330.0,nM,5.47755576649368
CHEMBL2315588,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant PDE4D2 (unknown origin) expressed in Sf9 cells pre-incubated with compound for 15 mins before incubation with cAMP substrate for 1 hr,CCOC(=O)C1=CN(Cc2ccc(OC)c(OC)c2)C=C(C(=O)OCC)C1c1ccc(Cl)cc1,IC50,2780.0,nM,5.555955204081924
CHEMBL2431819,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),C[C@@H](c1ccc2ncccc2c1)c1nnc2ccc(-c3cnn(C)c3)nn12,IC50,9610.0,nM,5.017276612331455
CHEMBL2431835,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),C[C@@H](c1ccc2ncccc2c1)n1nnc2ncc(-c3cnn(CCO)c3)nc21,IC50,2120.0,nM,5.673664139071249
CHEMBL2431834,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),C[C@@H](c1ccc2ncccc2c1)n1nnc2ncc(-c3cnn(C)c3)nc21,IC50,2500.0,nM,5.6020599913279625
CHEMBL2431826,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),C[C@@H](c1ccc2ncccc2c1)c1nnc2ccc(-c3cccc(C#N)c3)nn12,IC50,2060.0,nM,5.686132779630847
CHEMBL2431822,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),C[C@@H](c1ccc2ncccc2c1)c1nnc2ccc(-c3ccc(F)c(F)c3)nn12,IC50,2230.0,nM,5.651695136951839
CHEMBL2385756,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (78 to 508),CCCCNC(=O)Cc1ccc(Nc2nc(-c3ccccc3)nc3c2S(=O)(=O)CCC3)cc1,IC50,260.0,nM,6.585026652029182
CHEMBL2385573,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (78 to 508),O=C(O)Cc1ccc(Nc2nc(-c3ccccc3)nc3c2SCCC3)cc1,IC50,1300.0,nM,5.886056647693163
CHEMBL2385749,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (78 to 508),O=C(O)Cc1ccc(Nc2nc(-c3ccccc3)nc3c2S(=O)(=O)CCC3)cc1,IC50,2800.0,nM,5.552841968657781
CHEMBL3114958,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,O=C(O)Cc1ccc(Nc2nc(-c3cc4ccccc4s3)nc3c2S(=O)(=O)CCC3)cc1F,IC50,600.0,nM,6.221848749616356
CHEMBL3114957,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,O=C(O)Cc1ccc(Nc2nc(-c3ccc4ccccc4c3)nc3c2S(=O)(=O)CCC3)cc1F,IC50,810.0,nM,6.0915149811213505
CHEMBL3114956,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,COc1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)c(F)c4)n2)S(=O)(=O)CCC3)cc1Cl,IC50,1300.0,nM,5.886056647693163
CHEMBL3114955,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,COc1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)c(F)c4)n2)S(=O)(=O)CCC3)c(F)c1F,IC50,1400.0,nM,5.853871964321762
CHEMBL3114954,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,COc1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)c(F)c4)n2)S(=O)(=O)CCC3)cc1,IC50,1300.0,nM,5.886056647693163
CHEMBL3114953,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,COc1ccc(-c2nc3c(c(Nc4cc(F)c(CC(=O)O)cc4Cl)n2)S(=O)(=O)CCC3)cc1F,IC50,560.0,nM,6.251811972993799
CHEMBL3114952,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,COc1ccc(-c2nc3c(c(Nc4cc(Cl)c(CC(=O)O)cc4Cl)n2)S(=O)(=O)CCC3)cc1F,IC50,600.0,nM,6.221848749616356
CHEMBL3114951,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,COc1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)c(Cl)c4)n2)S(=O)(=O)CCC3)cc1F,IC50,1300.0,nM,5.886056647693163
CHEMBL3114950,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,COc1ccc(-c2nc3c(c(Nc4cc(F)c(CC(=O)O)c(F)c4)n2)S(=O)(=O)CCC3)cc1F,IC50,580.0,nM,6.236572006437063
CHEMBL3114949,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,COc1ccc(-c2nc3c(c(Nc4cc(F)c(CC(=O)O)cc4F)n2)S(=O)(=O)CCC3)cc1F,IC50,1300.0,nM,5.886056647693163
CHEMBL3114948,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,COc1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)c(F)c4)n2)S(=O)(=O)CCC3)cc1F,IC50,620.0,nM,6.207608310501746
CHEMBL3114947,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,COc1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)cc4)n2)S(=O)(=O)CCC3)cc1F,IC50,1000.0,nM,6.0
CHEMBL3114946,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,O=C(O)Cc1ccc(Nc2nc(-c3cc4ccccc4o3)nc3c2S(=O)(=O)CCC3)cc1,IC50,1100.0,nM,5.958607314841775
CHEMBL3114945,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,O=C(O)Cc1ccc(Nc2nc(-c3cc4ccccc4s3)nc3c2S(=O)(=O)CCC3)cc1,IC50,400.0,nM,6.3979400086720375
CHEMBL3114944,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,O=C(O)Cc1ccc(Nc2nc(-c3ccc4c(F)cccc4c3)nc3c2S(=O)(=O)CCC3)cc1,IC50,440.0,nM,6.356547323513812
CHEMBL3114943,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,COc1cccc2cc(-c3nc4c(c(Nc5ccc(CC(=O)O)cc5)n3)S(=O)(=O)CCC4)ccc12,IC50,290.0,nM,6.537602002101044
CHEMBL3114942,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,O=C(O)Cc1ccc(Nc2nc(-c3ccc(-c4ccccc4)cc3)nc3c2S(=O)(=O)CCC3)cc1,IC50,790.0,nM,6.102372908709558
CHEMBL3114941,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,O=C(O)Cc1ccc(Nc2nc(-c3ccc4ccccc4c3)nc3c2S(=O)(=O)CCC3)cc1,IC50,520.0,nM,6.2839966563652006
CHEMBL3114940,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,COc1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)cc4)n2)S(=O)(=O)CCC3)cc1Cl,IC50,1300.0,nM,5.886056647693163
CHEMBL3114939,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,COc1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)cc4)n2)S(=O)(=O)CCC3)c(F)c1F,IC50,3400.0,nM,5.468521082957745
CHEMBL3114938,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,CN(C)c1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)cc4)n2)S(=O)(=O)CCC3)cn1,IC50,1200.0,nM,5.920818753952375
CHEMBL3114937,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,COc1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)cc4)n2)S(=O)(=O)CCC3)cn1,IC50,3800.0,nM,5.42021640338319
CHEMBL3114936,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,CC(=O)c1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)cc4)n2)S(=O)(=O)CCC3)cc1,IC50,860.0,nM,6.065501548756432
CHEMBL3114935,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,CN(C)c1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)cc4)n2)S(=O)(=O)CCC3)cc1,IC50,2100.0,nM,5.6777807052660805
CHEMBL3114934,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,COc1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)cc4)n2)S(=O)(=O)CCC3)cc1,IC50,1500.0,nM,5.823908740944319
CHEMBL3114933,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,COc1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)cc4)n2)SCCC3)cc1Cl,IC50,430.0,nM,6.366531544420413
CHEMBL3114932,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,COc1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)cc4)n2)SCCC3)c(F)c1F,IC50,2200.0,nM,5.657577319177793
CHEMBL3114931,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,CN(C)c1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)cc4)n2)SCCC3)cn1,IC50,1600.0,nM,5.795880017344075
CHEMBL3114930,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,COc1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)cc4)n2)SCCC3)cn1,IC50,7400.0,nM,5.130768280269024
CHEMBL3114929,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,CC(=O)c1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)cc4)n2)SCCC3)cc1,IC50,1000.0,nM,6.0
CHEMBL3114928,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,CN(C)c1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)cc4)n2)SCCC3)cc1,IC50,790.0,nM,6.102372908709558
CHEMBL3114927,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,COc1cccc(-c2nc3c(c(Nc4ccc(CC(=O)O)cc4)n2)SCCC3)c1,IC50,1800.0,nM,5.7447274948966935
CHEMBL3112613,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,COc1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)cc4)n2)SCCC3)cc1,IC50,280.0,nM,6.552841968657781
CHEMBL3114926,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,N#Cc1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)cc4)n2)SCCC3)cc1,IC50,290.0,nM,6.537602002101044
CHEMBL3114925,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,O=C(O)Cc1ccc(Nc2nc(-c3ccc(Cl)cc3)nc3c2SCCC3)cc1,IC50,420.0,nM,6.376750709602099
CHEMBL3114924,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,O=C(O)Cc1ccc(Nc2nc(-c3ccc(F)cc3)nc3c2SCCC3)cc1,IC50,1000.0,nM,6.0
CHEMBL3114923,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,O=C(O)Cc1ccc(Nc2nc(-c3cccc(F)c3)nc3c2SCCC3)cc1,IC50,680.0,nM,6.167491087293763
CHEMBL3114922,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,O=C(O)Cc1ccc(Nc2nc(-c3ccccc3F)nc3c2SCCC3)cc1,IC50,3400.0,nM,5.468521082957745
CHEMBL3114921,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,COc1ccc(-c2nc3c(c(Nc4ccc(CC(=O)NCC(C)(C)C)cc4)n2)S(=O)(=O)CCC3)cc1F,IC50,300.0,nM,6.522878745280337
CHEMBL2385756,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,CCCCNC(=O)Cc1ccc(Nc2nc(-c3ccccc3)nc3c2S(=O)(=O)CCC3)cc1,IC50,180.0,nM,6.7447274948966935
CHEMBL2385573,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,O=C(O)Cc1ccc(Nc2nc(-c3ccccc3)nc3c2SCCC3)cc1,IC50,1300.0,nM,5.886056647693163
CHEMBL2385749,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length human PDE4D2 assessed as cAMP hydrolysis preincubated for 20 mins followed by cAMP addition measured after 30 mins,O=C(O)Cc1ccc(Nc2nc(-c3ccccc3)nc3c2S(=O)(=O)CCC3)cc1,IC50,550.0,nM,6.259637310505756
CHEMBL3221631,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 using cAMP substrate preincubated for 15 mins followed by substrate addition measured after 1 hr by luminescence assay,NC(=O)c1cccc(-c2c(-c3ccccc3)oc(=O)c3c2nn2c(-c4ccccc4)ccnc32)c1,IC50,2840.0,nM,5.546681659952963
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 using cAMP substrate preincubated for 15 mins followed by substrate addition measured after 1 hr by luminescence assay,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,880.0,nM,6.055517327849831
CHEMBL3235990,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413aa) expressed in Escherichia coli strain BL21 after 15 mins by liquid scintillation counting in presence of [3H]-cAMP,COc1cc2oc(=O)ccc2c(OC)c1C[C@H](OC(=O)[C@]1(O)C[C@@H](O)[C@@H](O)[C@H](OC(=O)/C=C/c2ccc(O)c(O)c2)C1)C(C)(C)O,IC50,16650.0,nM,4.778585762157661
CHEMBL3235991,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413aa) expressed in Escherichia coli strain BL21 after 15 mins by liquid scintillation counting in presence of [3H]-cAMP,COc1cc(O)c(/C=C/C(=O)O[C@@H](Cc2c(OC)cc3oc(=O)ccc3c2OC)C(C)(C)O)c(OC)c1CC=C(C)C,IC50,7810.0,nM,5.1073489661227
CHEMBL3235992,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413aa) expressed in Escherichia coli strain BL21 after 15 mins by liquid scintillation counting in presence of [3H]-cAMP,COc1cc(OC)c2ccc(=O)oc2c1/C=C/[C@H]1C[C@@H](C=C(C)C)c2c(c3ccccc3n(C)c2=O)O1,IC50,140.0,nM,6.853871964321762
CHEMBL479894,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413aa) expressed in Escherichia coli strain BL21 after 15 mins by liquid scintillation counting in presence of [3H]-cAMP,COc1cc2c(c3oc(=O)ccc13)C=CC(C)(C)O2,IC50,1870.0,nM,5.7281583934635005
CHEMBL3235993,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413aa) expressed in Escherichia coli strain BL21 after 15 mins by liquid scintillation counting in presence of [3H]-cAMP,COc1cc2c(c3oc(=O)ccc13)CCC(C)(C)O2,IC50,2200.0,nM,5.657577319177793
CHEMBL529210,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413aa) expressed in Escherichia coli strain BL21 after 15 mins by liquid scintillation counting in presence of [3H]-cAMP,COc1cc2ccc(=O)oc2c2c1OC(C)(C)C=C2,IC50,960.0,nM,6.017728766960431
CHEMBL3235994,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413aa) expressed in Escherichia coli strain BL21 after 15 mins by liquid scintillation counting in presence of [3H]-cAMP,COc1cc2ccc(=O)oc2c2c1OC(C)(C)CC2,IC50,1530.0,nM,5.815308569182401
CHEMBL3235995,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413aa) expressed in Escherichia coli strain BL21 after 15 mins by liquid scintillation counting in presence of [3H]-cAMP,CC1(C)C=Cc2c(c(O)cc3ccc(=O)oc23)O1,IC50,2380.0,nM,5.623423042943488
CHEMBL3235996,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413aa) expressed in Escherichia coli strain BL21 after 15 mins by liquid scintillation counting in presence of [3H]-cAMP,COc1cc2oc(=O)ccc2c(OC)c1CC=C(C)C,IC50,9980.0,nM,5.000869458712629
CHEMBL3235997,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413aa) expressed in Escherichia coli strain BL21 after 15 mins by liquid scintillation counting in presence of [3H]-cAMP,COc1cc2oc(=O)ccc2c(OC)c1CCC(C)C,IC50,11490.0,nM,4.9396799713117145
CHEMBL3235998,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413aa) expressed in Escherichia coli strain BL21 after 15 mins by liquid scintillation counting in presence of [3H]-cAMP,COc1cc(OC)c2ccc(=O)oc2c1CC=C(C)C,IC50,6820.0,nM,5.166215625343521
CHEMBL3235999,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413aa) expressed in Escherichia coli strain BL21 after 15 mins by liquid scintillation counting in presence of [3H]-cAMP,COc1cc(OC)c2ccc(=O)oc2c1CCC(C)C,IC50,10220.0,nM,4.990549104201306
CHEMBL3236000,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413aa) expressed in Escherichia coli strain BL21 after 15 mins by liquid scintillation counting in presence of [3H]-cAMP,COC1=CC(=O)c2cc(C)cc(-c3c(OC)cc(OC)c4ccc(=O)oc34)c2C1=O,IC50,5510.0,nM,5.2588484011482155
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413aa) expressed in Escherichia coli strain BL21 after 15 mins by liquid scintillation counting in presence of [3H]-cAMP,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,590.0,nM,6.229147988357855
CHEMBL3288029,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D using [3H]cAMP by packard topcount scintillation counting analysis,Cc1csc(C(=O)N[C@H]2CC[C@@H](NC(=O)c3cc(F)cnc3Oc3cccc(-c4ccc(CN5C[C@@H](C)N[C@@H](C)C5)cc4CN4CCOCC4)c3)CC2)n1,IC50,0.01995,nM,10.700057099977233
CHEMBL3288030,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D using [3H]cAMP by packard topcount scintillation counting analysis,Cc1ccc(O)c(C(=O)N[C@H]2CC[C@@H](NC(=O)c3cc(F)cnc3Oc3cccc(-c4ccc(CN5C[C@@H](C)N[C@@H](C)C5)cc4CN4CCOCC4)c3)CC2)c1,IC50,0.01995,nM,10.700057099977233
CHEMBL2180767,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 using FAM-cAMP substrate by TR-FRET progressive binding assay,OCC1CCN(c2nccnc2OC2CN(c3ccc4ccccc4n3)C2)CC1,IC50,10800.0,nM,4.966576244513051
CHEMBL3356649,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 using FAM-cAMP substrate by TR-FRET progressive binding assay,OCC1CCN(c2nccnc2OC2CCN(c3ccc4ccccc4n3)CC2)CC1,IC50,4690.0,nM,5.328827157284916
CHEMBL3356652,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 using FAM-cAMP substrate by TR-FRET progressive binding assay,OCC1CCN(c2nc3ccccc3nc2OC2CN(c3ccc4ccccc4n3)C2)CC1,IC50,20500.0,nM,4.688246138944246
CHEMBL3356680,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 using FAM-cAMP substrate by TR-FRET progressive binding assay,Nc1ncc2cc(-c3nccnc3OC3CN(c4ccc5ccccc5n4)C3)ccc2n1,IC50,581.0,nM,6.235823867609669
CHEMBL3356684,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 using FAM-cAMP substrate by TR-FRET progressive binding assay,CC(=O)N1CCC(c2nc3ccccc3nc2OC2CN(c3ccc4ccccc4n3)C2)CC1,IC50,5050.0,nM,5.296708621881338
CHEMBL3326083,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D3 expressed in baculoviral system,COc1ccc(/C=N/N2CCOCC2)cc1OC1CCCC1,IC50,660.0,nM,6.180456064458131
CHEMBL3326084,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D3 expressed in baculoviral system,COc1ccc(/C=N/N2CC(C)OC(C)C2)cc1OC1CCCC1,IC50,1550.0,nM,5.809668301829708
CHEMBL3326087,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D3 expressed in baculoviral system,COc1ccc(/C=N/OCC(O)CN2CCC(O)CC2)cc1OC1CCCC1,IC50,1790.0,nM,5.747146969020107
CHEMBL3326089,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D3 expressed in baculoviral system,COc1ccc(/C=N/OCC(O)CNN2CCOCC2)cc1OC1CCCC1,IC50,1260.0,nM,5.899629454882437
CHEMBL3326090,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D3 expressed in baculoviral system,COc1ccc(/C=N/OCC(O)CNN2CC(C)OC(C)C2)cc1OC1CCCC1,IC50,210.0,nM,6.6777807052660805
CHEMBL569624,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D3 expressed in baculoviral system,COc1ccc(/C=N/OCC(O)CN2CC(C)OC(C)C2)cc1OC1CCCC1,IC50,3460.0,nM,5.460923901207224
CHEMBL570803,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D3 expressed in baculoviral system,COc1ccc(/C=N/OCC(=O)N2CC(C)OC(C)C2)cc1OC1CCCC1,IC50,1910.0,nM,5.718966632752272
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D3 expressed in baculoviral system,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,90.0,nM,7.045757490560675
CHEMBL3315247,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CC(C)c1nc(Nc2ccc(CC(=O)O)cc2)nc(-c2ccc(Cl)s2)n1,IC50,3580.0,nM,5.446116973356125
CHEMBL3315248,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CCc1nc(Nc2ccc(CC(=O)O)cc2)nc(-c2ccc(Cl)s2)n1,IC50,865.0,nM,6.062983892535186
CHEMBL3315250,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,O=C(O)Cc1ccc(Nc2nc(-c3ccc(Cl)s3)nc(C3CC3)n2)cc1,IC50,1489.0,nM,5.827105302247824
CHEMBL3315251,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,O=C(O)Cc1ccc(Nc2nc(-c3cccc(Cl)c3)nc(C3CC3)n2)cc1,IC50,1181.0,nM,5.927750102386485
CHEMBL3315252,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,O=C(O)Cc1ccc(Nc2nc(-c3ccc(Cl)cc3)nc(C3CC3)n2)cc1,IC50,5611.0,nM,5.250959731296543
CHEMBL3315253,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,Cc1nc(Nc2ccc(CC(=O)O)cc2)nc(-c2ccco2)n1,IC50,22260.0,nM,4.65247484000131
CHEMBL3315254,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,O=C(O)Cc1ccc(Nc2nc(-c3cccc(F)c3)nc(C3CC3)n2)cc1,IC50,2107.0,nM,5.6763354643919
CHEMBL3315255,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CCc1nc(Nc2ccc(CC(=O)O)cc2)nc(-c2ccc(F)cc2)n1,IC50,727.0,nM,6.138465589140962
CHEMBL3315257,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,O=C(O)Cc1ccc(CNc2nc(-c3ccc(Cl)cc3)nc(C3CC3)n2)cc1,IC50,859.0,nM,6.066006836168757
CHEMBL3315258,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,O=C(O)Cc1ccc(CNc2nc(-c3cccc(Cl)c3)nc(C3CC3)n2)cc1,IC50,726.0,nM,6.139063379299906
CHEMBL3315259,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,O=C(O)Cc1ccc(Oc2nc(-c3cccc(Cl)c3)nc(C3CC3)n2)cc1,IC50,2268.0,nM,5.644356949779131
CHEMBL3315261,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CCc1nc(Nc2ccc(C(=O)O)cc2)nc(-c2ccc(Cl)s2)n1,IC50,251.0,nM,6.600326278518962
CHEMBL3315262,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CCc1nc(Nc2ccc(F)cc2)nc(-c2ccc(Cl)s2)n1,IC50,207.0,nM,6.684029654543082
CHEMBL3315263,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CC(C)c1nc(Nc2ccc(C(=O)O)cc2)nc(-c2ccc(Cl)s2)n1,IC50,219.0,nM,6.6595558851598815
CHEMBL3315264,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CC(C)c1nc(Nc2ccc(F)cc2)nc(-c2ccc(Cl)s2)n1,IC50,886.0,nM,6.052566278112949
CHEMBL3315265,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,O=C(O)c1ccc(Nc2nc(-c3cccc(Cl)c3)nc(C3CC3)n2)cc1,IC50,20.0,nM,7.698970004336019
CHEMBL3315266,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,O=C(O)c1ccc(Nc2nc(-c3ccc(Cl)cc3)nc(C3CC3)n2)cc1,IC50,268.0,nM,6.571865205971211
CHEMBL3315267,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,O=C1CCC(NC2=NC(C3CC3)NC(c3cccc(Cl)c3)=N2)CN1,IC50,268.0,nM,6.571865205971211
CHEMBL3315269,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CCc1nc(Nc2ccc(CC(=O)O)cc2)nc(-c2cccc(Cl)c2)n1,IC50,681.0,nM,6.166852888087215
CHEMBL3315270,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CCc1nc(Nc2ccc(C(=O)O)cc2)nc(-c2cccc(Cl)c2)n1,IC50,213.0,nM,6.671620396561263
CHEMBL3315271,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CCc1nc(Nc2ccc(C#N)cc2)nc(-c2cccc(Cl)c2)n1,IC50,13.0,nM,7.886056647693163
CHEMBL3313945,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CCc1nc(Nc2ccc(CC#N)cc2)nc(-c2cccc(Cl)c2)n1,IC50,7.0,nM,8.154901959985743
CHEMBL3315272,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CCc1nc(Nc2ccc(-c3nnn[nH]3)cc2)nc(-c2cccc(Cl)c2)n1,IC50,132.0,nM,6.8794260687941495
CHEMBL3315273,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CCc1nc(Nc2ccc(Cc3nnn[nH]3)cc2)nc(-c2cccc(Cl)c2)n1,IC50,63.0,nM,7.200659450546418
CHEMBL3315274,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CCc1nc(Nc2ccc(NS(N)(=O)=O)cc2)nc(-c2cccc(Cl)c2)n1,IC50,160.0,nM,6.795880017344075
CHEMBL3315275,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CCc1nc(Nc2ccc(C(C)C(=O)O)cc2)nc(-c2cccc(Cl)c2)n1,IC50,96.0,nM,7.017728766960431
CHEMBL3315276,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,CCc1nc(Nc2ccc(C(C)(C)C(=O)O)cc2)nc(-c2cccc(Cl)c2)n1,IC50,600.0,nM,6.221848749616356
CHEMBL1549433,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D7,CCOc1nc(Nc2ccc(OC)cc2)nc(OCC)n1,IC50,2300.0,nM,5.638272163982407
CHEMBL1782306,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D7,CCc1c(C)nc(-c2ccc(Cl)s2)nc1Nc1ccc(CC(=O)O)cc1,IC50,1997.0,nM,5.699621935129297
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,1000.0,nM,6.0
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 amino acids) expressed in Escherichia coli strain BL21 after 15 mins using [3H]-cAMP by liquid scintillation counting,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,600.0,nM,6.221848749616356
CHEMBL3331578,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 amino acids) expressed in Escherichia coli strain BL21 after 15 mins using [3H]-cAMP by liquid scintillation counting,CCCCC[C@@H](/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)OC)[C@@H](OC(C)=O)C[C@H]1OC(C)=O)OC(C)=O,IC50,1400.0,nM,5.853871964321762
CHEMBL3331577,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 amino acids) expressed in Escherichia coli strain BL21 after 15 mins using [3H]-cAMP by liquid scintillation counting,CCCCC[C@@H](/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)OC)[C@@H](O)C[C@H]1OC(C)=O)OC(C)=O,IC50,5500.0,nM,5.259637310505756
CHEMBL3331576,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 amino acids) expressed in Escherichia coli strain BL21 after 15 mins using [3H]-cAMP by liquid scintillation counting,CCCCC[C@@H](/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)OC)[C@@H](OC(C)=O)C[C@H]1O)OC(C)=O,IC50,4700.0,nM,5.327902142064282
CHEMBL3331573,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 amino acids) expressed in Escherichia coli strain BL21 after 15 mins using [3H]-cAMP by liquid scintillation counting,CCC(CC[C@@H](/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)OC)[C@@H](OC(=O)[C@](OC)(c2ccccc2)C(F)(F)F)C[C@H]1OC(C)=O)OC(=O)[C@](OC)(c1ccccc1)C(F)(F)F)OC(C)=O,IC50,3600.0,nM,5.443697499232712
CHEMBL3331572,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 amino acids) expressed in Escherichia coli strain BL21 after 15 mins using [3H]-cAMP by liquid scintillation counting,CCC(CC[C@@H](/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)OC)[C@@H](OC(=O)[C@@](OC)(c2ccccc2)C(F)(F)F)C[C@H]1OC(C)=O)OC(=O)[C@@](OC)(c1ccccc1)C(F)(F)F)OC(C)=O,IC50,5900.0,nM,5.229147988357855
CHEMBL3331570,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 amino acids) expressed in Escherichia coli strain BL21 after 15 mins using [3H]-cAMP by liquid scintillation counting,CCCCC[C@@H](/C=C/[C@@H]1[C@@H](/C=C/CCCCC(=O)OC)[C@@H](O)C[C@H]1OC(C)=O)OC(C)=O,IC50,7200.0,nM,5.142667503568731
CHEMBL3331568,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 amino acids) expressed in Escherichia coli strain BL21 after 15 mins using [3H]-cAMP by liquid scintillation counting,CCC(=O)CC[C@@H](/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1OC(C)=O)OC(C)=O,IC50,16900.0,nM,4.772113295386326
CHEMBL3331566,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 amino acids) expressed in Escherichia coli strain BL21 after 15 mins using [3H]-cAMP by liquid scintillation counting,CCC(=O)CC[C@@H](/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)OC)[C@@H](O)C[C@H]1OC(C)=O)OC(C)=O,IC50,12100.0,nM,4.91721462968355
CHEMBL3331563,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 amino acids) expressed in Escherichia coli strain BL21 after 15 mins using [3H]-cAMP by liquid scintillation counting,CCC(=O)CC[C@@H](/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)OC)[C@@H](OC(C)=O)C[C@H]1OC(C)=O)OC(C)=O,IC50,10600.0,nM,4.97469413473523
CHEMBL3331559,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 amino acids) expressed in Escherichia coli strain BL21 after 15 mins using [3H]-cAMP by liquid scintillation counting,CCC(CC[C@@H](/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)OC)[C@@H](OC(C)=O)C[C@H]1OC(C)=O)OC(C)=O)OC(C)=O,IC50,3700.0,nM,5.431798275933005
CHEMBL48017,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMP,COc1ccc(C(=O)Nc2c(Cl)cncc2Cl)cc1OC,IC50,17.0,nM,7.769551078621726
CHEMBL3315071,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMP,COc1ccc(C(=O)Nc2c(Cl)cncc2Cl)c(OC)c1OC,IC50,3790.0,nM,5.421360790031928
CHEMBL3315072,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMP,COc1ccc(C(=O)Cc2c(Cl)cncc2Cl)cc1OC,IC50,13.0,nM,7.886056647693163
CHEMBL3315073,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMP,COc1ccc(C(=O)Cc2c(Cl)cncc2Cl)c(OC)c1OC,IC50,110.0,nM,6.958607314841775
CHEMBL3313943,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMP,CCOc1c(OC)ccc(C(=O)Cc2c(Cl)cncc2Cl)c1OC,IC50,81.0,nM,7.0915149811213505
CHEMBL3315074,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMP,COc1ccc(C(=O)Cc2c(Cl)cncc2Cl)c(OC)c1OCC1CC1,IC50,212.0,nM,6.673664139071248
CHEMBL3315075,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMP,COc1ccc(C(=O)Cc2c(Cl)cncc2Cl)c(OC)c1OC1CCCC1,IC50,2010.0,nM,5.696803942579511
CHEMBL3315076,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMP,COc1ccc(C(=O)Cc2c(Cl)cncc2Cl)c(OCc2ccccc2)c1OC,IC50,63.0,nM,7.200659450546418
CHEMBL3315077,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMP,COc1ccc(C(=O)Cc2c(Cl)cncc2Cl)c(OCCc2ccccc2)c1OC,IC50,15.0,nM,7.823908740944319
CHEMBL3315078,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMP,COc1ccc(C(=O)Cc2c(Cl)cncc2Cl)c(OCCCc2ccccc2)c1OC,IC50,45.0,nM,7.346787486224656
CHEMBL3315079,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMP,COc1ccc(C(=O)Cc2c(Cl)cncc2Cl)c(OCCc2ccc(O)cc2)c1OC,IC50,8.0,nM,8.096910013008056
CHEMBL3315080,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMP,CNC(=O)c1ccc(CCOc2c(C(=O)Cc3c(Cl)cncc3Cl)ccc(OC)c2OC)cc1,IC50,11.0,nM,7.958607314841775
CHEMBL3315081,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMP,COc1ccc(C(=O)Cc2c(Cl)cncc2Cl)c(OCCc2ccc(C(=O)O)cc2)c1OC,IC50,17.0,nM,7.769551078621726
CHEMBL3315082,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMP,COc1ccc(C(=O)Cc2c(Cl)cncc2Cl)c(OCC(=O)O)c1OC,IC50,3760.0,nM,5.424812155072339
CHEMBL3315083,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMP,COc1ccc(C(=O)Cc2c(Cl)cncc2Cl)c(OCC(=O)NCc2ccccc2)c1OC,IC50,3.0,nM,8.522878745280337
CHEMBL3315084,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMP,COc1ccc(C(=O)Cc2c(Cl)cncc2Cl)c(OCC(=O)Nc2ccccc2)c1OC,IC50,1.0,nM,9.0
CHEMBL3315085,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMP,COc1ccc(C(=O)Cc2c(Cl)cncc2Cl)c(OCC(=O)N(C)c2ccccc2)c1OC,IC50,61.0,nM,7.214670164989233
CHEMBL3315086,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMP,COc1ccc(C(=O)Cc2c(Cl)cncc2Cl)c(OCC(=O)NCCO)c1OC,IC50,17.0,nM,7.769551078621726
CHEMBL3315087,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMP,COCCNC(=O)COc1c(C(=O)Cc2c(Cl)cncc2Cl)ccc(OC)c1OC,IC50,13.0,nM,7.886056647693163
CHEMBL3315088,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMP,CCCNC(=O)COc1c(C(=O)Cc2c(Cl)cncc2Cl)ccc(OC)c1OC,IC50,5.0,nM,8.301029995663981
CHEMBL3315089,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMP,COc1ccc(C(=O)Cc2c(Cl)c[n+]([O-])cc2Cl)c(OCC(=O)NCc2ccccc2)c1OC,IC50,5.0,nM,8.301029995663981
CHEMBL3315090,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMP,COc1ccc(C(=O)Cc2c(Cl)cncc2Cl)c(OCC(N)=O)c1OC,IC50,20.0,nM,7.698970004336019
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 activity assessed as residual cAMP concentration by HTRF assay,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,130.0,nM,6.886056647693163
CHEMBL193240,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 activity assessed as residual cAMP concentration by HTRF assay,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,IC50,0.7,nM,9.154901959985743
CHEMBL3327315,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 activity assessed as residual cAMP concentration by HTRF assay,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCCCNC2CCOC2=O)c1,IC50,18.0,nM,7.7447274948966935
CHEMBL3327316,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 activity assessed as residual cAMP concentration by HTRF assay,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCCCN[C@@H]2CCOC2=O)c1,IC50,7.3,nM,8.136677139879545
CHEMBL3327317,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 activity assessed as residual cAMP concentration by HTRF assay,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCCCN[C@H]2CCOC2=O)c1,IC50,48.0,nM,7.318758762624412
CHEMBL3327318,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 activity assessed as residual cAMP concentration by HTRF assay,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCCCNC(CCO)C(=O)O)c1,IC50,2300.0,nM,5.638272163982407
CHEMBL3327319,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 activity assessed as residual cAMP concentration by HTRF assay,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCCCN[C@H](CCO)C(=O)O)c1,IC50,7200.0,nM,5.142667503568731
CHEMBL3327321,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 activity assessed as residual cAMP concentration by HTRF assay,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCCCSC2CCOC2=O)c1,IC50,5.5,nM,8.259637310505756
CHEMBL3327322,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 activity assessed as residual cAMP concentration by HTRF assay,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCCCSC(CCO)C(=O)O)c1,IC50,9.9,nM,8.00436480540245
CHEMBL3327323,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 activity assessed as residual cAMP concentration by HTRF assay,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCCCCNC2CCOC2=O)c1,IC50,6.6,nM,8.18045606445813
CHEMBL3327324,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 activity assessed as residual cAMP concentration by HTRF assay,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCCCCNC(CCO)C(=O)O)c1,IC50,150.0,nM,6.823908740944319
CHEMBL3327325,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 activity assessed as residual cAMP concentration by HTRF assay,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCCCCSC2CCOC2=O)c1,IC50,1.8,nM,8.744727494896694
CHEMBL3327326,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 activity assessed as residual cAMP concentration by HTRF assay,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCCCCSC(CCO)C(=O)O)c1,IC50,4.5,nM,8.346787486224656
CHEMBL3327327,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 activity assessed as residual cAMP concentration by HTRF assay,O=C(Nc1c(Cl)c[n+]([O-])cc1Cl)c1ccc(OC(F)F)c(OCCCNC2CCOC2=O)c1,IC50,170.0,nM,6.769551078621726
CHEMBL3327328,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 activity assessed as residual cAMP concentration by HTRF assay,COC(=O)CNCCCOc1cc(C(=O)Nc2c(Cl)cncc2Cl)ccc1OC(F)F,IC50,32.0,nM,7.494850021680094
CHEMBL3327329,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 activity assessed as residual cAMP concentration by HTRF assay,O=C(O)CNCCCOc1cc(C(=O)Nc2c(Cl)cncc2Cl)ccc1OC(F)F,IC50,1500.0,nM,5.823908740944319
CHEMBL3359633,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 assessed after 60 mins by IMAP fluorescence polarization assay,O=[N+]([O-])c1ccc(Sc2ccncc2)c(Cl)c1,IC50,7300.0,nM,5.136677139879544
CHEMBL3359635,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 assessed after 60 mins by IMAP fluorescence polarization assay,O=[N+]([O-])c1cc(Cl)ccc1Sc1ccncc1,IC50,3000.0,nM,5.522878745280337
CHEMBL484928,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 assessed after 60 mins by IMAP fluorescence polarization assay,Cc1ccc([N+](=O)[O-])cc1S(=O)(=O)N(C)C,IC50,1280.0,nM,5.892790030352131
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 assessed after 60 mins by IMAP fluorescence polarization assay,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,82.5,nM,7.0835460514500745
CHEMBL3092559,CHEMBL288,Phosphodiesterase 4D,Inhibition of 6-His-tagged human recombinant PDE4D3 expressed in Sf9 cells by scintillation proximity assay,Cc1nc2ccncc2n2c(-c3ccccc3Cl)nnc12,IC50,5890.0,nM,5.229884705212898
CHEMBL3585869,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 expressed in baculoviral system using cAMP as substrate by fluorescence polarization assay,OC(CO/N=C/c1ccc(OC(F)F)c(OC2CCCC2)c1)CN1CCOCC1,IC50,1490.0,nM,5.826813731587726
CHEMBL3585870,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 expressed in baculoviral system using cAMP as substrate by fluorescence polarization assay,CC1CN(CC(O)CO/N=C/c2ccc(OC(F)F)c(OC3CCCC3)c2)CC(C)O1,IC50,190.0,nM,6.721246399047171
CHEMBL3585871,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 expressed in baculoviral system using cAMP as substrate by fluorescence polarization assay,OC1CCN(CC(O)CO/N=C/c2ccc(OC(F)F)c(OC3CCCC3)c2)CC1,IC50,2540.0,nM,5.5951662833800615
CHEMBL3585872,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 expressed in baculoviral system using cAMP as substrate by fluorescence polarization assay,CC1CN(NCC(O)CO/N=C/c2ccc(OC(F)F)c(OC3CCCC3)c2)CC(C)O1,IC50,190.0,nM,6.721246399047171
CHEMBL3585873,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 expressed in baculoviral system using cAMP as substrate by fluorescence polarization assay,O=C(CO/N=C/c1ccc(OC(F)F)c(OC2CCCC2)c1)N1CCOCC1,IC50,1120.0,nM,5.950781977329818
CHEMBL3585874,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 expressed in baculoviral system using cAMP as substrate by fluorescence polarization assay,CC1CN(C(=O)CO/N=C/c2ccc(OC(F)F)c(OC3CCCC3)c2)CC(C)O1,IC50,4840.0,nM,5.315154638355588
CHEMBL3585875,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 expressed in baculoviral system using cAMP as substrate by fluorescence polarization assay,O=C(CO/N=C/c1ccc(OC(F)F)c(OC2CCCC2)c1)N1CCC(O)CC1,IC50,2630.0,nM,5.580044251510242
CHEMBL3585876,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 expressed in baculoviral system using cAMP as substrate by fluorescence polarization assay,CC1CN(C(=O)CCO/N=C/c2ccc(OC(F)F)c(OC3CCCC3)c2)CC(C)O1,IC50,470.0,nM,6.327902142064282
CHEMBL3601563,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3,COc1ccc2c([C@H]3CCc4ccc(Cl)cc43)nccc2c1OC,IC50,7620.0,nM,5.118045028660399
CHEMBL3605513,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,N#Cc1cccc(-c2nc(N3CCOCC3)cc3cccnc23)c1,IC50,3.0,nM,8.522878745280337
CHEMBL3605512,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,N#Cc1cccc(-c2nc(N3CCC(O)CC3)cc3cccnc23)c1,IC50,22.0,nM,7.657577319177793
CHEMBL3605511,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,N#Cc1cccc(-c2nc(N3CCC(CO)CC3)cc3cccnc23)c1,IC50,13.0,nM,7.886056647693163
CHEMBL3605510,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,N#Cc1cccc(-c2nc(N3CCC(C(N)=O)CC3)cc3cccnc23)c1,IC50,8.0,nM,8.096910013008056
CHEMBL2172372,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,COc1cccc(-c2nc([C@H]3CC[C@H](C(=O)O)CC3)cc3cccnc23)c1,IC50,64.0,nM,7.1938200260161125
CHEMBL3605509,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,O=C(O)[C@H]1CC[C@H](c2cc3cccnc3c(-c3cccc(Cl)c3)n2)CC1,IC50,30.0,nM,7.522878745280337
CHEMBL2172375,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,N#Cc1cccc(-c2nc([C@H]3CC[C@H](C(=O)O)CC3)cc3cccnc23)c1,IC50,41.0,nM,7.3872161432802645
CHEMBL2172368,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,O=C(O)C1CCN(c2cc3cccnc3c(-c3cccc(F)c3)n2)CC1,IC50,51.0,nM,7.292429823902063
CHEMBL2172370,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,N#Cc1cccc(-c2nc(N3CCC(C(=O)O)CC3)cc3cccnc23)c1,IC50,19.0,nM,7.721246399047171
CHEMBL2172374,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,O=C(O)[C@H]1CC[C@H](c2cc3cccnc3c(-c3cccc(F)c3)n2)CC1,IC50,32.0,nM,7.494850021680094
CHEMBL77826,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,O=C(O)c1ccc(-c2cc3cccnc3c(-c3ccc4nonc4c3)n2)cc1,IC50,1.5,nM,8.823908740944319
CHEMBL3628786,CHEMBL288,Phosphodiesterase 4D,"Inhibition of human full-length PDE4D7 using AM-Cyclic-3',5'-AMP after 60 mins by fluorescence polarization assay",COc1ccc(CNC(=O)c2ccc(OC(F)F)c(OCC3CC3)c2)cc1,IC50,108.0,nM,6.96657624451305
CHEMBL3628685,CHEMBL288,Phosphodiesterase 4D,"Inhibition of human full-length PDE4D7 using AM-Cyclic-3',5'-AMP after 60 mins by fluorescence polarization assay",COc1ccc(CNC(=O)c2ccc(OC(F)F)c(OC3CCCC3)c2)cc1,IC50,94.0,nM,7.026872146400302
CHEMBL3628681,CHEMBL288,Phosphodiesterase 4D,"Inhibition of human full-length PDE4D7 using AM-Cyclic-3',5'-AMP after 60 mins by fluorescence polarization assay",COc1ccc(CNC(=O)c2ccc(OC)c(OCC3CC3)c2)cc1,IC50,342.0,nM,6.465973893943865
CHEMBL3628679,CHEMBL288,Phosphodiesterase 4D,"Inhibition of human full-length PDE4D7 using AM-Cyclic-3',5'-AMP after 60 mins by fluorescence polarization assay",COc1ccc(CNC(=O)c2ccc(OC)c(OC3CCCC3)c2)cc1,IC50,284.0,nM,6.546681659952963
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,"Inhibition of human full-length PDE4D7 using AM-Cyclic-3',5'-AMP after 60 mins by fluorescence polarization assay",COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,160.0,nM,6.795880017344075
CHEMBL3644504,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Phosphodiesterase Assay: A TR-FRET-based phosphodiesterase assay kit from ""Molecular Devices"" was used to test whether these compounds were indeed direct inhibitors of the PDE4 enzyme. Using Roflumilast as a positive control, compounds of the present invention were tested against fluorescein-labeled cAMP substrate. The principle of the assay is based on the binding of a nucleotide monophosphate generated upon cAMP conversion to 5′ AMP by PDE to an ""IMAP binding reagent"", which in turn is also ligated to a separate complex carrying terbium (Tb)-donor molecule. Proximity of the fluoreceinated 5′AMP to the Tb donor generates Fluorescence Resonance Energy Transfer. A PDE inhibitor will reduce the conversion of cAMP to 5′AMP, thus reducing monophosphate that can bind to the IMAP binding reagent and reduce the resulting FRET signal.",COc1cccc2c1ncc1c(=O)n(-c3cccc(Cl)c3)c(=O)n([C@H]3CCN(S(C)(=O)=O)C3)c12,IC50,206.0,nM,6.686132779630847
CHEMBL3644506,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Phosphodiesterase Assay: A TR-FRET-based phosphodiesterase assay kit from ""Molecular Devices"" was used to test whether these compounds were indeed direct inhibitors of the PDE4 enzyme. Using Roflumilast as a positive control, compounds of the present invention were tested against fluorescein-labeled cAMP substrate. The principle of the assay is based on the binding of a nucleotide monophosphate generated upon cAMP conversion to 5′ AMP by PDE to an ""IMAP binding reagent"", which in turn is also ligated to a separate complex carrying terbium (Tb)-donor molecule. Proximity of the fluoreceinated 5′AMP to the Tb donor generates Fluorescence Resonance Energy Transfer. A PDE inhibitor will reduce the conversion of cAMP to 5′AMP, thus reducing monophosphate that can bind to the IMAP binding reagent and reduce the resulting FRET signal.",COc1cccc2c1ncc1c(=O)n(-c3cccc(Cl)c3)c(=O)n(C3CCN(S(=O)(=O)CS(C)(=O)=O)CC3)c12,IC50,80.0,nM,7.096910013008056
CHEMBL3644496,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Phosphodiesterase Assay: A TR-FRET-based phosphodiesterase assay kit from ""Molecular Devices"" was used to test whether these compounds were indeed direct inhibitors of the PDE4 enzyme. Using Roflumilast as a positive control, compounds of the present invention were tested against fluorescein-labeled cAMP substrate. The principle of the assay is based on the binding of a nucleotide monophosphate generated upon cAMP conversion to 5′ AMP by PDE to an ""IMAP binding reagent"", which in turn is also ligated to a separate complex carrying terbium (Tb)-donor molecule. Proximity of the fluoreceinated 5′AMP to the Tb donor generates Fluorescence Resonance Energy Transfer. A PDE inhibitor will reduce the conversion of cAMP to 5′AMP, thus reducing monophosphate that can bind to the IMAP binding reagent and reduce the resulting FRET signal.",CCCc1cccc2c1ncc1c(=O)n(CC)c(=O)n(C3CCCC3)c12,IC50,25000.0,nM,4.6020599913279625
CHEMBL3644499,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Phosphodiesterase Assay: A TR-FRET-based phosphodiesterase assay kit from ""Molecular Devices"" was used to test whether these compounds were indeed direct inhibitors of the PDE4 enzyme. Using Roflumilast as a positive control, compounds of the present invention were tested against fluorescein-labeled cAMP substrate. The principle of the assay is based on the binding of a nucleotide monophosphate generated upon cAMP conversion to 5′ AMP by PDE to an ""IMAP binding reagent"", which in turn is also ligated to a separate complex carrying terbium (Tb)-donor molecule. Proximity of the fluoreceinated 5′AMP to the Tb donor generates Fluorescence Resonance Energy Transfer. A PDE inhibitor will reduce the conversion of cAMP to 5′AMP, thus reducing monophosphate that can bind to the IMAP binding reagent and reduce the resulting FRET signal.",COc1cccc2c1ncc1c(=O)n(-c3cccc(C)c3)c(=O)n(C3CCCC3)c12,IC50,338.0,nM,6.471083299722345
CHEMBL3644505,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Phosphodiesterase Assay: A TR-FRET-based phosphodiesterase assay kit from ""Molecular Devices"" was used to test whether these compounds were indeed direct inhibitors of the PDE4 enzyme. Using Roflumilast as a positive control, compounds of the present invention were tested against fluorescein-labeled cAMP substrate. The principle of the assay is based on the binding of a nucleotide monophosphate generated upon cAMP conversion to 5′ AMP by PDE to an ""IMAP binding reagent"", which in turn is also ligated to a separate complex carrying terbium (Tb)-donor molecule. Proximity of the fluoreceinated 5′AMP to the Tb donor generates Fluorescence Resonance Energy Transfer. A PDE inhibitor will reduce the conversion of cAMP to 5′AMP, thus reducing monophosphate that can bind to the IMAP binding reagent and reduce the resulting FRET signal.",CCS(=O)(=O)N1CCC(n2c(=O)n(-c3cccc(Cl)c3)c(=O)c3cnc4c(OC)cccc4c32)CC1,IC50,59.0,nM,7.229147988357855
CHEMBL3644504,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Phosphodiesterase Assay: A TR-FRET-based phosphodiesterase assay kit from ""Molecular Devices"" was used to test whether these compounds were indeed direct inhibitors of the PDE4 enzyme. Using Roflumilast as a positive control, compounds of the present invention were tested against fluorescein-labeled cAMP substrate. The principle of the assay is based on the binding of a nucleotide monophosphate generated upon cAMP conversion to 5′ AMP by PDE to an ""IMAP binding reagent"", which in turn is also ligated to a separate complex carrying terbium (Tb)-donor molecule. Proximity of the fluoreceinated 5′AMP to the Tb donor generates Fluorescence Resonance Energy Transfer. A PDE inhibitor will reduce the conversion of cAMP to 5′AMP, thus reducing monophosphate that can bind to the IMAP binding reagent and reduce the resulting FRET signal.",COc1cccc2c1ncc1c(=O)n(-c3cccc(Cl)c3)c(=O)n([C@H]3CCN(S(C)(=O)=O)C3)c12,IC50,163.0,nM,6.787812395596042
CHEMBL3644495,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Phosphodiesterase Assay: A TR-FRET-based phosphodiesterase assay kit from ""Molecular Devices"" was used to test whether these compounds were indeed direct inhibitors of the PDE4 enzyme. Using Roflumilast as a positive control, compounds of the present invention were tested against fluorescein-labeled cAMP substrate. The principle of the assay is based on the binding of a nucleotide monophosphate generated upon cAMP conversion to 5′ AMP by PDE to an ""IMAP binding reagent"", which in turn is also ligated to a separate complex carrying terbium (Tb)-donor molecule. Proximity of the fluoreceinated 5′AMP to the Tb donor generates Fluorescence Resonance Energy Transfer. A PDE inhibitor will reduce the conversion of cAMP to 5′AMP, thus reducing monophosphate that can bind to the IMAP binding reagent and reduce the resulting FRET signal.",CCn1c(=O)c2cnc3c(Cl)cccc3c2n(C2CCCC2)c1=O,IC50,25000.0,nM,4.6020599913279625
CHEMBL3644497,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Phosphodiesterase Assay: A TR-FRET-based phosphodiesterase assay kit from ""Molecular Devices"" was used to test whether these compounds were indeed direct inhibitors of the PDE4 enzyme. Using Roflumilast as a positive control, compounds of the present invention were tested against fluorescein-labeled cAMP substrate. The principle of the assay is based on the binding of a nucleotide monophosphate generated upon cAMP conversion to 5′ AMP by PDE to an ""IMAP binding reagent"", which in turn is also ligated to a separate complex carrying terbium (Tb)-donor molecule. Proximity of the fluoreceinated 5′AMP to the Tb donor generates Fluorescence Resonance Energy Transfer. A PDE inhibitor will reduce the conversion of cAMP to 5′AMP, thus reducing monophosphate that can bind to the IMAP binding reagent and reduce the resulting FRET signal.",CCn1c(=O)c2cnc3c(C(C)C)cccc3c2n(C2CCCC2)c1=O,IC50,25000.0,nM,4.6020599913279625
CHEMBL3938524,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Phosphodiesterase Assay: A TR-FRET-based phosphodiesterase assay kit from ""Molecular Devices"" was used to test whether these compounds were indeed direct inhibitors of the PDE4 enzyme. Using Roflumilast as a positive control, compounds of the present invention were tested against fluorescein-labeled cAMP substrate. The principle of the assay is based on the binding of a nucleotide monophosphate generated upon cAMP conversion to 5′ AMP by PDE to an ""IMAP binding reagent"", which in turn is also ligated to a separate complex carrying terbium (Tb)-donor molecule. Proximity of the fluoreceinated 5′AMP to the Tb donor generates Fluorescence Resonance Energy Transfer. A PDE inhibitor will reduce the conversion of cAMP to 5′AMP, thus reducing monophosphate that can bind to the IMAP binding reagent and reduce the resulting FRET signal.",COc1cccc2c1ncc1c(=O)n(-c3cccc(Cl)c3)c(=O)n(C3CCC(C(=O)O)CC3)c12,IC50,55.0,nM,7.259637310505756
CHEMBL3644498,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Phosphodiesterase Assay: A TR-FRET-based phosphodiesterase assay kit from ""Molecular Devices"" was used to test whether these compounds were indeed direct inhibitors of the PDE4 enzyme. Using Roflumilast as a positive control, compounds of the present invention were tested against fluorescein-labeled cAMP substrate. The principle of the assay is based on the binding of a nucleotide monophosphate generated upon cAMP conversion to 5′ AMP by PDE to an ""IMAP binding reagent"", which in turn is also ligated to a separate complex carrying terbium (Tb)-donor molecule. Proximity of the fluoreceinated 5′AMP to the Tb donor generates Fluorescence Resonance Energy Transfer. A PDE inhibitor will reduce the conversion of cAMP to 5′AMP, thus reducing monophosphate that can bind to the IMAP binding reagent and reduce the resulting FRET signal.",COc1cccc2c1ncc1c(=O)n(-c3cc(C)cs3)c(=O)n(C3CCCC3)c12,IC50,616.0,nM,6.210419287835574
CHEMBL3644501,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Phosphodiesterase Assay: A TR-FRET-based phosphodiesterase assay kit from ""Molecular Devices"" was used to test whether these compounds were indeed direct inhibitors of the PDE4 enzyme. Using Roflumilast as a positive control, compounds of the present invention were tested against fluorescein-labeled cAMP substrate. The principle of the assay is based on the binding of a nucleotide monophosphate generated upon cAMP conversion to 5′ AMP by PDE to an ""IMAP binding reagent"", which in turn is also ligated to a separate complex carrying terbium (Tb)-donor molecule. Proximity of the fluoreceinated 5′AMP to the Tb donor generates Fluorescence Resonance Energy Transfer. A PDE inhibitor will reduce the conversion of cAMP to 5′AMP, thus reducing monophosphate that can bind to the IMAP binding reagent and reduce the resulting FRET signal.",COc1cccc2c1ncc1c(=O)n(-c3cccc(Cl)c3)c(=O)n(C3CCN(S(C)(=O)=O)CC3)c12,IC50,151.0,nM,6.821023052706831
CHEMBL3644500,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Phosphodiesterase Assay: A TR-FRET-based phosphodiesterase assay kit from ""Molecular Devices"" was used to test whether these compounds were indeed direct inhibitors of the PDE4 enzyme. Using Roflumilast as a positive control, compounds of the present invention were tested against fluorescein-labeled cAMP substrate. The principle of the assay is based on the binding of a nucleotide monophosphate generated upon cAMP conversion to 5′ AMP by PDE to an ""IMAP binding reagent"", which in turn is also ligated to a separate complex carrying terbium (Tb)-donor molecule. Proximity of the fluoreceinated 5′AMP to the Tb donor generates Fluorescence Resonance Energy Transfer. A PDE inhibitor will reduce the conversion of cAMP to 5′AMP, thus reducing monophosphate that can bind to the IMAP binding reagent and reduce the resulting FRET signal.",COc1cccc2c1ncc1c(=O)n(-c3ccc4c(c3)OCO4)c(=O)n(C3CCCC3)c12,IC50,827.0,nM,6.082494490447454
CHEMBL3945875,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Phosphodiesterase Assay: A TR-FRET-based phosphodiesterase assay kit from ""Molecular Devices"" was used to test whether these compounds were indeed direct inhibitors of the PDE4 enzyme. Using Roflumilast as a positive control, compounds of the present invention were tested against fluorescein-labeled cAMP substrate. The principle of the assay is based on the binding of a nucleotide monophosphate generated upon cAMP conversion to 5′ AMP by PDE to an ""IMAP binding reagent"", which in turn is also ligated to a separate complex carrying terbium (Tb)-donor molecule. Proximity of the fluoreceinated 5′AMP to the Tb donor generates Fluorescence Resonance Energy Transfer. A PDE inhibitor will reduce the conversion of cAMP to 5′AMP, thus reducing monophosphate that can bind to the IMAP binding reagent and reduce the resulting FRET signal.",COc1cccc2c1ncc1c(=O)n(-c3cccc(Cl)c3)c(=O)n(C3CCC(NS(C)(=O)=O)CC3)c12,IC50,73.0,nM,7.136677139879544
CHEMBL512578,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D using 3H-cAMP as substrate after 15 mins by liquid scintillation counting analysis,Oc1cc(O)cc(-c2cc3ccc(O)cc3o2)c1,IC50,2910.0,nM,5.536107011014092
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D using 3H-cAMP as substrate after 15 mins by liquid scintillation counting analysis,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,610.0,nM,6.214670164989233
CHEMBL3735540,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D using 3H-cAMP as substrate after 15 mins by liquid scintillation counting analysis,Oc1cc(O)c2cc(-c3cc(I)c(O)c4ncccc34)oc2c1,IC50,230.0,nM,6.638272163982407
CHEMBL3734974,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D using 3H-cAMP as substrate after 15 mins by liquid scintillation counting analysis,Oc1ccc2oc(-c3cc(I)c(O)c4ncccc34)cc2c1,IC50,320.0,nM,6.494850021680094
CHEMBL3735548,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D using 3H-cAMP as substrate after 15 mins by liquid scintillation counting analysis,Oc1ccc2cc(-c3cc(I)c(O)c4ncccc34)oc2c1,IC50,890.0,nM,6.050609993355087
CHEMBL3735108,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D using 3H-cAMP as substrate after 15 mins by liquid scintillation counting analysis,Cc1c(-c2cc(Cl)c(O)c3ncccc23)oc2ccc(O)cc12,IC50,2920.0,nM,5.534617148551582
CHEMBL3736201,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D using 3H-cAMP as substrate after 15 mins by liquid scintillation counting analysis,Oc1ccc2oc(-c3cc(Cl)c(O)c4ncccc34)cc2c1,IC50,960.0,nM,6.017728766960431
CHEMBL3735104,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D using 3H-cAMP as substrate after 15 mins by liquid scintillation counting analysis,Oc1ccc2cc(-c3cc(Cl)c(O)c4ncccc34)oc2c1,IC50,1070.0,nM,5.97061622231479
CHEMBL3736003,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D using 3H-cAMP as substrate after 15 mins by liquid scintillation counting analysis,Oc1c(Cl)cc(-c2cc3cccc(O)c3o2)c2cccnc12,IC50,2080.0,nM,5.681936665037238
CHEMBL3736059,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D using 3H-cAMP as substrate after 15 mins by liquid scintillation counting analysis,Oc1c(Cl)cc(-c2cc3ccccc3o2)c2cccnc12,IC50,3050.0,nM,5.515700160653214
CHEMBL3735525,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D using 3H-cAMP as substrate after 15 mins by liquid scintillation counting analysis,Oc1cc(O)c2cc(-c3ccc4cccc(O)c4n3)oc2c1,IC50,2010.0,nM,5.696803942579511
CHEMBL3734795,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D using 3H-cAMP as substrate after 15 mins by liquid scintillation counting analysis,Oc1ccc2cc(-c3ccc4cccc(O)c4n3)oc2c1,IC50,8860.0,nM,5.052566278112949
CHEMBL3735115,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D using 3H-cAMP as substrate after 15 mins by liquid scintillation counting analysis,Oc1ccc(-c2cc3cc(I)cc(I)c3o2)c2cccnc12,IC50,750.0,nM,6.1249387366083
CHEMBL3736439,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D using 3H-cAMP as substrate after 15 mins by liquid scintillation counting analysis,Cc1c(-c2ccc(O)c3ncccc23)oc2ccc(O)cc12,IC50,3670.0,nM,5.435333935747911
CHEMBL3735557,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D using 3H-cAMP as substrate after 15 mins by liquid scintillation counting analysis,Oc1cc(O)c2cc(-c3ccc(O)c4ncccc34)oc2c1,IC50,1210.0,nM,5.917214629683549
CHEMBL3736120,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D using 3H-cAMP as substrate after 15 mins by liquid scintillation counting analysis,Oc1ccc2oc(-c3ccc(O)c4ncccc34)cc2c1,IC50,2310.0,nM,5.636388020107855
CHEMBL2326941,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human recombinant PDE4D3 using [3H]-cAMP as substrate by scintillation proximity assay,COc1ccc(C2=NN(C3CCCCCC3)C(=O)[C@@H]3CC=CC[C@H]23)cc1OCCCCOc1ccc(-c2nnn[nH]2)cc1,IC50,0.631,nM,9.199970640755865
CHEMBL3769962,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 (unknown origin),COc1ccc([C@@H]2CNC(=O)[C@@H](Cc3cccc(C)c3)C2)cc1OC1CCCC1,IC50,150.0,nM,6.823908740944319
CHEMBL3785098,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin) preincubated for 5 mins followed by cAMP addition measured after 15 mins by PDE-Glo phosphodiesterase assay,C=C(C)Cn1c(SCC(=O)c2cccs2)nc2sc3c(c2c1=O)CCCC3,IC50,380.0,nM,6.42021640338319
CHEMBL3785585,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin) preincubated for 5 mins followed by cAMP addition measured after 15 mins by PDE-Glo phosphodiesterase assay,CCCn1c(SCC(=O)c2cccs2)nc2sc3c(c2c1=O)CCCC3,IC50,486.0,nM,6.313363730737707
CHEMBL1334234,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin) preincubated for 5 mins followed by cAMP addition measured after 15 mins by PDE-Glo phosphodiesterase assay,C=C(C)Cn1c(SCC(=O)c2ccccc2)nc2sc3c(c2c1=O)CCCC3,IC50,965.0,nM,6.015472686656207
CHEMBL3785925,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin) preincubated for 5 mins followed by cAMP addition measured after 15 mins by PDE-Glo phosphodiesterase assay,O=C(CSc1nc2sccc2c(=O)n1C1CC1)c1ccccc1,IC50,3100.0,nM,5.508638306165727
CHEMBL3785859,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin) preincubated for 5 mins followed by cAMP addition measured after 15 mins by PDE-Glo phosphodiesterase assay,O=c1c2ccsc2nc(SCC(O)c2ccccc2)n1C1CC1,IC50,6070.0,nM,5.2168113089247425
CHEMBL325795,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 catalytic domain (86 to 413 residues) (unknown origin),COc1ccc([C@H]2CNC(=O)C2)cc1OC1CCCC1,IC50,1000.0,nM,6.0
CHEMBL325795,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 catalytic domain (86 to 413 residues) (unknown origin) using [3H]-cAMP as substrate after 15 mins by liquid scintillation counting method,COc1ccc([C@H]2CNC(=O)C2)cc1OC1CCCC1,IC50,1062.0,nM,5.97387548325455
CHEMBL3792892,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 catalytic domain (86 to 413 residues) (unknown origin) using [3H]-cAMP as substrate after 15 mins by liquid scintillation counting method,Oc1cc(O)c2c(c1)O[C@]1(c3ccc(O)c(O)c3)O[C@@H]1[C@H]2c1c(O)cc(O)c2c1O[C@H](c1ccc(O)c(O)c1)[C@H](O)C2,IC50,13273.0,nM,4.877030905606253
CHEMBL3792576,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 catalytic domain (86 to 413 residues) (unknown origin) using [3H]-cAMP as substrate after 15 mins by liquid scintillation counting method,C[C@@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]2(C(=O)O)CCC1(C)C,IC50,6568.0,nM,5.1825668558886155
CHEMBL3793522,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 catalytic domain (86 to 413 residues) (unknown origin) using [3H]-cAMP as substrate after 15 mins by liquid scintillation counting method,C=C1CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@@H](OC(=O)/C=C\c6ccc(O)cc6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C,IC50,542.0,nM,6.266000713461613
CHEMBL3793675,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 catalytic domain (86 to 413 residues) (unknown origin) using [3H]-cAMP as substrate after 15 mins by liquid scintillation counting method,C=C1CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@@H](OC(=O)/C=C/c6ccc(O)cc6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C,IC50,245.0,nM,6.610833915635467
CHEMBL3885161,CHEMBL288,Phosphodiesterase 4D,"Inhibition of full length human PDE4D7 using FAM-3',5'-cAMP as substrate after 1 hr by fluorescence polarization assay",O=C(Nc1cccnc1)c1ccc(OC(F)F)c(OC2CCCC2)c1,IC50,68.0,nM,7.167491087293763
CHEMBL3884224,CHEMBL288,Phosphodiesterase 4D,"Inhibition of full length human PDE4D7 using FAM-3',5'-cAMP as substrate after 1 hr by fluorescence polarization assay",O=C(Nc1cccnc1)c1ccc(OC(F)F)c(OCC2CC2)c1,IC50,71.0,nM,7.1487416512809245
CHEMBL3883753,CHEMBL288,Phosphodiesterase 4D,"Inhibition of full length human PDE4D7 using FAM-3',5'-cAMP as substrate after 1 hr by fluorescence polarization assay",O=C(Nc1ccccc1Cl)c1ccc(OC(F)F)c(OC2CCCC2)c1,IC50,22.0,nM,7.657577319177793
CHEMBL3884788,CHEMBL288,Phosphodiesterase 4D,"Inhibition of full length human PDE4D7 using FAM-3',5'-cAMP as substrate after 1 hr by fluorescence polarization assay",O=C(Nc1ccccc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,IC50,39.0,nM,7.4089353929735005
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,"Inhibition of full length human PDE4D7 using FAM-3',5'-cAMP as substrate after 1 hr by fluorescence polarization assay",COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,160.0,nM,6.795880017344075
CHEMBL3938531,CHEMBL288,Phosphodiesterase 4D,"Diaxonhit Phosphodiesterase Assay: The phosphodiesterase assay was developed using the LANCE cAMP kit (PerkinElmer). The assay buffer contained HBSS with 5 mM HEPES, 0.1% BSA, and 1.5 mM MgCl2, pH 7.4. PDE10A (BPS Bioscience) was used at 200 pg/well (with a specific activity of 3200 pmole/min/ug with assay conditions: 10 mM Tris-HCl, pH 7.4, 10 mM MgCl2, 1 mM MnCl2, 200 uM cAMP, 2.5 kU 5' nucleotidase, 37° C., 20 min) and PDE4D3 (BPS Bioscience) was used at 100 pg/well (with a specific activity of 32713 pmole/min/ug with assay conditions: 10 mM Tris-HCl, pH 7.4, 10 mM MgCl2, 1 mM MnCl2, 200 uM cAMP, 2.5 kU 5' nucleotidase, 37° C., 20 min). The Biotin-cAMP tracer, supplied in 10 mmol/L Tris-HCl buffered (pH 8.0) salt solution with 1 mmol/L ethylenediaminetetraacetic acid (EDTA), 0.1% bovine serum albumin (BSA), and 0.05% sodium azide, is used at a dilution of 1/375. The assay detection mixture contained the LANCE Eu-W8044 labeled streptavidin 1/2250 (supplied in 50 mmol/L Tris-HCl buffer).",CCc1ncc(Cc2ccc3cccc(O)c3n2)c2cc(OC)c(OC)cc12,IC50,439.0,nM,6.357535479757878
CHEMBL3975984,CHEMBL288,Phosphodiesterase 4D,"Diaxonhit Phosphodiesterase Assay: The phosphodiesterase assay was developed using the LANCE cAMP kit (PerkinElmer). The assay buffer contained HBSS with 5 mM HEPES, 0.1% BSA, and 1.5 mM MgCl2, pH 7.4. PDE10A (BPS Bioscience) was used at 200 pg/well (with a specific activity of 3200 pmole/min/ug with assay conditions: 10 mM Tris-HCl, pH 7.4, 10 mM MgCl2, 1 mM MnCl2, 200 uM cAMP, 2.5 kU 5' nucleotidase, 37° C., 20 min) and PDE4D3 (BPS Bioscience) was used at 100 pg/well (with a specific activity of 32713 pmole/min/ug with assay conditions: 10 mM Tris-HCl, pH 7.4, 10 mM MgCl2, 1 mM MnCl2, 200 uM cAMP, 2.5 kU 5' nucleotidase, 37° C., 20 min). The Biotin-cAMP tracer, supplied in 10 mmol/L Tris-HCl buffered (pH 8.0) salt solution with 1 mmol/L ethylenediaminetetraacetic acid (EDTA), 0.1% bovine serum albumin (BSA), and 0.05% sodium azide, is used at a dilution of 1/375. The assay detection mixture contained the LANCE Eu-W8044 labeled streptavidin 1/2250 (supplied in 50 mmol/L Tris-HCl buffer).",CCc1ncc(Cc2ccc3cccc(NC(=O)C(N)=O)c3n2)c2cc(OC)c(OC)cc12,IC50,398.0,nM,6.400116927926312
CHEMBL3974402,CHEMBL288,Phosphodiesterase 4D,"Diaxonhit Phosphodiesterase Assay: The phosphodiesterase assay was developed using the LANCE cAMP kit (PerkinElmer). The assay buffer contained HBSS with 5 mM HEPES, 0.1% BSA, and 1.5 mM MgCl2, pH 7.4. PDE10A (BPS Bioscience) was used at 200 pg/well (with a specific activity of 3200 pmole/min/ug with assay conditions: 10 mM Tris-HCl, pH 7.4, 10 mM MgCl2, 1 mM MnCl2, 200 uM cAMP, 2.5 kU 5' nucleotidase, 37° C., 20 min) and PDE4D3 (BPS Bioscience) was used at 100 pg/well (with a specific activity of 32713 pmole/min/ug with assay conditions: 10 mM Tris-HCl, pH 7.4, 10 mM MgCl2, 1 mM MnCl2, 200 uM cAMP, 2.5 kU 5' nucleotidase, 37° C., 20 min). The Biotin-cAMP tracer, supplied in 10 mmol/L Tris-HCl buffered (pH 8.0) salt solution with 1 mmol/L ethylenediaminetetraacetic acid (EDTA), 0.1% bovine serum albumin (BSA), and 0.05% sodium azide, is used at a dilution of 1/375. The assay detection mixture contained the LANCE Eu-W8044 labeled streptavidin 1/2250 (supplied in 50 mmol/L Tris-HCl buffer).",CCCc1ncc(Cc2cnc3ccc(O)c(C(F)(F)F)c3c2)c2cc(OC)c(OC)cc12,IC50,232.0,nM,6.634512015109101
CHEMBL3907937,CHEMBL288,Phosphodiesterase 4D,"Diaxonhit Phosphodiesterase Assay: The phosphodiesterase assay was developed using the LANCE cAMP kit (PerkinElmer). The assay buffer contained HBSS with 5 mM HEPES, 0.1% BSA, and 1.5 mM MgCl2, pH 7.4. PDE10A (BPS Bioscience) was used at 200 pg/well (with a specific activity of 3200 pmole/min/ug with assay conditions: 10 mM Tris-HCl, pH 7.4, 10 mM MgCl2, 1 mM MnCl2, 200 uM cAMP, 2.5 kU 5' nucleotidase, 37° C., 20 min) and PDE4D3 (BPS Bioscience) was used at 100 pg/well (with a specific activity of 32713 pmole/min/ug with assay conditions: 10 mM Tris-HCl, pH 7.4, 10 mM MgCl2, 1 mM MnCl2, 200 uM cAMP, 2.5 kU 5' nucleotidase, 37° C., 20 min). The Biotin-cAMP tracer, supplied in 10 mmol/L Tris-HCl buffered (pH 8.0) salt solution with 1 mmol/L ethylenediaminetetraacetic acid (EDTA), 0.1% bovine serum albumin (BSA), and 0.05% sodium azide, is used at a dilution of 1/375. The assay detection mixture contained the LANCE Eu-W8044 labeled streptavidin 1/2250 (supplied in 50 mmol/L Tris-HCl buffer).",COCc1ncc(Cc2cnc3ccc(O)c(C(F)(F)F)c3c2)c2cc(OC)c(OC)cc12,IC50,194.0,nM,6.7121982700697735
CHEMBL3644495,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Assay: The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or MnCl2). In a separate 96-well polypropylene plate, compound dilutions were prepared in assay buffer. Separate microcentrifuge tubes were prepared of PDE4B and PDE4D according to assay template−in assay buffer. The tubes were kept on ice. The enzyme concentration shown on the template were diluted by 1:4. FAM-cAMP substrate solution was prepared according to assay template. 5 μl compound was transferred from polypropylene plate into black 384-well plate. This plate was centrifuged briefly to make sure all 5 μl is on the bottom. Up to 80 μl of prepared PDE4B enzyme solution was transferred into alternate wells on row 'N' of 384-well plate starting from cell N1. Up to 80 μl of prepared PDE4D enzyme solution was transferred into alternate wells on row 'O' of 384-well plate, starting from cell O2. cAMP substrate solution was transferred into bottom row of separate 96-well plate. 5 μl of enzyme solution from the ""reservoir"" row (N or O) was transferred to each of the wells containing compounds, per layout map. Next, 10 μl of cAMP substrate was transferred to these wells. The order of substrate-first or enzyme-first can be switched depending on what is optimal. The final cAMP concentration was 100 nM in the reaction. 20 μl of assay buffer was pipetted into 4 separate wells−these are the blanks. The plate was sealed with an aluminum strip and incubated at 30° C. for 90 minutes. A TR-FRET solution was prepared. 4 ml of 1×IMAP Buffer A was added to 6 ml of IMAP Buffer B. 25 μl ( 1/800 of 20 ml) of binding beads was added to this and mix by inverting. 60 μl of this mixture was pipetted into 2 of the wells containing the ""blank"" assay buffer. Next, 49.7 μl ( 1/400 of remaining volume) of Tb donor solution was added to the remaining TR-FRET solution and mixed by inverting. 60 μl of this solution was pipetted into remaining 2 ""blank"" assay buffer-containing wells. The TR-FRET solution was poured into a pipette boat and a multichannel pipette was used to drop 60 μl of solution into all assay wells. The wells were covered with a foil strip and incubated for at least 3 hours or overnight protected from light (e.g. in a drawer) at room temperature. The plate was read on the Envision Reader: Emission 1: 520/Emission 2: 486/Exc: 340. Mirror: Umbelliferone (UV).",CCn1c(=O)c2cnc3c(Cl)cccc3c2n(C2CCCC2)c1=O,IC50,25000.0,nM,4.6020599913279625
CHEMBL3644496,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Assay: The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or MnCl2). In a separate 96-well polypropylene plate, compound dilutions were prepared in assay buffer. Separate microcentrifuge tubes were prepared of PDE4B and PDE4D according to assay template−in assay buffer. The tubes were kept on ice. The enzyme concentration shown on the template were diluted by 1:4. FAM-cAMP substrate solution was prepared according to assay template. 5 μl compound was transferred from polypropylene plate into black 384-well plate. This plate was centrifuged briefly to make sure all 5 μl is on the bottom. Up to 80 μl of prepared PDE4B enzyme solution was transferred into alternate wells on row 'N' of 384-well plate starting from cell N1. Up to 80 μl of prepared PDE4D enzyme solution was transferred into alternate wells on row 'O' of 384-well plate, starting from cell O2. cAMP substrate solution was transferred into bottom row of separate 96-well plate. 5 μl of enzyme solution from the ""reservoir"" row (N or O) was transferred to each of the wells containing compounds, per layout map. Next, 10 μl of cAMP substrate was transferred to these wells. The order of substrate-first or enzyme-first can be switched depending on what is optimal. The final cAMP concentration was 100 nM in the reaction. 20 μl of assay buffer was pipetted into 4 separate wells−these are the blanks. The plate was sealed with an aluminum strip and incubated at 30° C. for 90 minutes. A TR-FRET solution was prepared. 4 ml of 1×IMAP Buffer A was added to 6 ml of IMAP Buffer B. 25 μl ( 1/800 of 20 ml) of binding beads was added to this and mix by inverting. 60 μl of this mixture was pipetted into 2 of the wells containing the ""blank"" assay buffer. Next, 49.7 μl ( 1/400 of remaining volume) of Tb donor solution was added to the remaining TR-FRET solution and mixed by inverting. 60 μl of this solution was pipetted into remaining 2 ""blank"" assay buffer-containing wells. The TR-FRET solution was poured into a pipette boat and a multichannel pipette was used to drop 60 μl of solution into all assay wells. The wells were covered with a foil strip and incubated for at least 3 hours or overnight protected from light (e.g. in a drawer) at room temperature. The plate was read on the Envision Reader: Emission 1: 520/Emission 2: 486/Exc: 340. Mirror: Umbelliferone (UV).",CCCc1cccc2c1ncc1c(=O)n(CC)c(=O)n(C3CCCC3)c12,IC50,25000.0,nM,4.6020599913279625
CHEMBL3644497,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Assay: The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or MnCl2). In a separate 96-well polypropylene plate, compound dilutions were prepared in assay buffer. Separate microcentrifuge tubes were prepared of PDE4B and PDE4D according to assay template−in assay buffer. The tubes were kept on ice. The enzyme concentration shown on the template were diluted by 1:4. FAM-cAMP substrate solution was prepared according to assay template. 5 μl compound was transferred from polypropylene plate into black 384-well plate. This plate was centrifuged briefly to make sure all 5 μl is on the bottom. Up to 80 μl of prepared PDE4B enzyme solution was transferred into alternate wells on row 'N' of 384-well plate starting from cell N1. Up to 80 μl of prepared PDE4D enzyme solution was transferred into alternate wells on row 'O' of 384-well plate, starting from cell O2. cAMP substrate solution was transferred into bottom row of separate 96-well plate. 5 μl of enzyme solution from the ""reservoir"" row (N or O) was transferred to each of the wells containing compounds, per layout map. Next, 10 μl of cAMP substrate was transferred to these wells. The order of substrate-first or enzyme-first can be switched depending on what is optimal. The final cAMP concentration was 100 nM in the reaction. 20 μl of assay buffer was pipetted into 4 separate wells−these are the blanks. The plate was sealed with an aluminum strip and incubated at 30° C. for 90 minutes. A TR-FRET solution was prepared. 4 ml of 1×IMAP Buffer A was added to 6 ml of IMAP Buffer B. 25 μl ( 1/800 of 20 ml) of binding beads was added to this and mix by inverting. 60 μl of this mixture was pipetted into 2 of the wells containing the ""blank"" assay buffer. Next, 49.7 μl ( 1/400 of remaining volume) of Tb donor solution was added to the remaining TR-FRET solution and mixed by inverting. 60 μl of this solution was pipetted into remaining 2 ""blank"" assay buffer-containing wells. The TR-FRET solution was poured into a pipette boat and a multichannel pipette was used to drop 60 μl of solution into all assay wells. The wells were covered with a foil strip and incubated for at least 3 hours or overnight protected from light (e.g. in a drawer) at room temperature. The plate was read on the Envision Reader: Emission 1: 520/Emission 2: 486/Exc: 340. Mirror: Umbelliferone (UV).",CCn1c(=O)c2cnc3c(C(C)C)cccc3c2n(C2CCCC2)c1=O,IC50,25000.0,nM,4.6020599913279625
CHEMBL3644498,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Assay: The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or MnCl2). In a separate 96-well polypropylene plate, compound dilutions were prepared in assay buffer. Separate microcentrifuge tubes were prepared of PDE4B and PDE4D according to assay template−in assay buffer. The tubes were kept on ice. The enzyme concentration shown on the template were diluted by 1:4. FAM-cAMP substrate solution was prepared according to assay template. 5 μl compound was transferred from polypropylene plate into black 384-well plate. This plate was centrifuged briefly to make sure all 5 μl is on the bottom. Up to 80 μl of prepared PDE4B enzyme solution was transferred into alternate wells on row 'N' of 384-well plate starting from cell N1. Up to 80 μl of prepared PDE4D enzyme solution was transferred into alternate wells on row 'O' of 384-well plate, starting from cell O2. cAMP substrate solution was transferred into bottom row of separate 96-well plate. 5 μl of enzyme solution from the ""reservoir"" row (N or O) was transferred to each of the wells containing compounds, per layout map. Next, 10 μl of cAMP substrate was transferred to these wells. The order of substrate-first or enzyme-first can be switched depending on what is optimal. The final cAMP concentration was 100 nM in the reaction. 20 μl of assay buffer was pipetted into 4 separate wells−these are the blanks. The plate was sealed with an aluminum strip and incubated at 30° C. for 90 minutes. A TR-FRET solution was prepared. 4 ml of 1×IMAP Buffer A was added to 6 ml of IMAP Buffer B. 25 μl ( 1/800 of 20 ml) of binding beads was added to this and mix by inverting. 60 μl of this mixture was pipetted into 2 of the wells containing the ""blank"" assay buffer. Next, 49.7 μl ( 1/400 of remaining volume) of Tb donor solution was added to the remaining TR-FRET solution and mixed by inverting. 60 μl of this solution was pipetted into remaining 2 ""blank"" assay buffer-containing wells. The TR-FRET solution was poured into a pipette boat and a multichannel pipette was used to drop 60 μl of solution into all assay wells. The wells were covered with a foil strip and incubated for at least 3 hours or overnight protected from light (e.g. in a drawer) at room temperature. The plate was read on the Envision Reader: Emission 1: 520/Emission 2: 486/Exc: 340. Mirror: Umbelliferone (UV).",COc1cccc2c1ncc1c(=O)n(-c3cc(C)cs3)c(=O)n(C3CCCC3)c12,IC50,616.0,nM,6.210419287835574
CHEMBL3644499,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Assay: The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or MnCl2). In a separate 96-well polypropylene plate, compound dilutions were prepared in assay buffer. Separate microcentrifuge tubes were prepared of PDE4B and PDE4D according to assay template−in assay buffer. The tubes were kept on ice. The enzyme concentration shown on the template were diluted by 1:4. FAM-cAMP substrate solution was prepared according to assay template. 5 μl compound was transferred from polypropylene plate into black 384-well plate. This plate was centrifuged briefly to make sure all 5 μl is on the bottom. Up to 80 μl of prepared PDE4B enzyme solution was transferred into alternate wells on row 'N' of 384-well plate starting from cell N1. Up to 80 μl of prepared PDE4D enzyme solution was transferred into alternate wells on row 'O' of 384-well plate, starting from cell O2. cAMP substrate solution was transferred into bottom row of separate 96-well plate. 5 μl of enzyme solution from the ""reservoir"" row (N or O) was transferred to each of the wells containing compounds, per layout map. Next, 10 μl of cAMP substrate was transferred to these wells. The order of substrate-first or enzyme-first can be switched depending on what is optimal. The final cAMP concentration was 100 nM in the reaction. 20 μl of assay buffer was pipetted into 4 separate wells−these are the blanks. The plate was sealed with an aluminum strip and incubated at 30° C. for 90 minutes. A TR-FRET solution was prepared. 4 ml of 1×IMAP Buffer A was added to 6 ml of IMAP Buffer B. 25 μl ( 1/800 of 20 ml) of binding beads was added to this and mix by inverting. 60 μl of this mixture was pipetted into 2 of the wells containing the ""blank"" assay buffer. Next, 49.7 μl ( 1/400 of remaining volume) of Tb donor solution was added to the remaining TR-FRET solution and mixed by inverting. 60 μl of this solution was pipetted into remaining 2 ""blank"" assay buffer-containing wells. The TR-FRET solution was poured into a pipette boat and a multichannel pipette was used to drop 60 μl of solution into all assay wells. The wells were covered with a foil strip and incubated for at least 3 hours or overnight protected from light (e.g. in a drawer) at room temperature. The plate was read on the Envision Reader: Emission 1: 520/Emission 2: 486/Exc: 340. Mirror: Umbelliferone (UV).",COc1cccc2c1ncc1c(=O)n(-c3cccc(C)c3)c(=O)n(C3CCCC3)c12,IC50,338.0,nM,6.471083299722345
CHEMBL3644500,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Assay: The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or MnCl2). In a separate 96-well polypropylene plate, compound dilutions were prepared in assay buffer. Separate microcentrifuge tubes were prepared of PDE4B and PDE4D according to assay template−in assay buffer. The tubes were kept on ice. The enzyme concentration shown on the template were diluted by 1:4. FAM-cAMP substrate solution was prepared according to assay template. 5 μl compound was transferred from polypropylene plate into black 384-well plate. This plate was centrifuged briefly to make sure all 5 μl is on the bottom. Up to 80 μl of prepared PDE4B enzyme solution was transferred into alternate wells on row 'N' of 384-well plate starting from cell N1. Up to 80 μl of prepared PDE4D enzyme solution was transferred into alternate wells on row 'O' of 384-well plate, starting from cell O2. cAMP substrate solution was transferred into bottom row of separate 96-well plate. 5 μl of enzyme solution from the ""reservoir"" row (N or O) was transferred to each of the wells containing compounds, per layout map. Next, 10 μl of cAMP substrate was transferred to these wells. The order of substrate-first or enzyme-first can be switched depending on what is optimal. The final cAMP concentration was 100 nM in the reaction. 20 μl of assay buffer was pipetted into 4 separate wells−these are the blanks. The plate was sealed with an aluminum strip and incubated at 30° C. for 90 minutes. A TR-FRET solution was prepared. 4 ml of 1×IMAP Buffer A was added to 6 ml of IMAP Buffer B. 25 μl ( 1/800 of 20 ml) of binding beads was added to this and mix by inverting. 60 μl of this mixture was pipetted into 2 of the wells containing the ""blank"" assay buffer. Next, 49.7 μl ( 1/400 of remaining volume) of Tb donor solution was added to the remaining TR-FRET solution and mixed by inverting. 60 μl of this solution was pipetted into remaining 2 ""blank"" assay buffer-containing wells. The TR-FRET solution was poured into a pipette boat and a multichannel pipette was used to drop 60 μl of solution into all assay wells. The wells were covered with a foil strip and incubated for at least 3 hours or overnight protected from light (e.g. in a drawer) at room temperature. The plate was read on the Envision Reader: Emission 1: 520/Emission 2: 486/Exc: 340. Mirror: Umbelliferone (UV).",COc1cccc2c1ncc1c(=O)n(-c3ccc4c(c3)OCO4)c(=O)n(C3CCCC3)c12,IC50,827.0,nM,6.082494490447454
CHEMBL3644501,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Assay: The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or MnCl2). In a separate 96-well polypropylene plate, compound dilutions were prepared in assay buffer. Separate microcentrifuge tubes were prepared of PDE4B and PDE4D according to assay template−in assay buffer. The tubes were kept on ice. The enzyme concentration shown on the template were diluted by 1:4. FAM-cAMP substrate solution was prepared according to assay template. 5 μl compound was transferred from polypropylene plate into black 384-well plate. This plate was centrifuged briefly to make sure all 5 μl is on the bottom. Up to 80 μl of prepared PDE4B enzyme solution was transferred into alternate wells on row 'N' of 384-well plate starting from cell N1. Up to 80 μl of prepared PDE4D enzyme solution was transferred into alternate wells on row 'O' of 384-well plate, starting from cell O2. cAMP substrate solution was transferred into bottom row of separate 96-well plate. 5 μl of enzyme solution from the ""reservoir"" row (N or O) was transferred to each of the wells containing compounds, per layout map. Next, 10 μl of cAMP substrate was transferred to these wells. The order of substrate-first or enzyme-first can be switched depending on what is optimal. The final cAMP concentration was 100 nM in the reaction. 20 μl of assay buffer was pipetted into 4 separate wells−these are the blanks. The plate was sealed with an aluminum strip and incubated at 30° C. for 90 minutes. A TR-FRET solution was prepared. 4 ml of 1×IMAP Buffer A was added to 6 ml of IMAP Buffer B. 25 μl ( 1/800 of 20 ml) of binding beads was added to this and mix by inverting. 60 μl of this mixture was pipetted into 2 of the wells containing the ""blank"" assay buffer. Next, 49.7 μl ( 1/400 of remaining volume) of Tb donor solution was added to the remaining TR-FRET solution and mixed by inverting. 60 μl of this solution was pipetted into remaining 2 ""blank"" assay buffer-containing wells. The TR-FRET solution was poured into a pipette boat and a multichannel pipette was used to drop 60 μl of solution into all assay wells. The wells were covered with a foil strip and incubated for at least 3 hours or overnight protected from light (e.g. in a drawer) at room temperature. The plate was read on the Envision Reader: Emission 1: 520/Emission 2: 486/Exc: 340. Mirror: Umbelliferone (UV).",COc1cccc2c1ncc1c(=O)n(-c3cccc(Cl)c3)c(=O)n(C3CCN(S(C)(=O)=O)CC3)c12,IC50,151.0,nM,6.821023052706831
CHEMBL3938524,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Assay: The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or MnCl2). In a separate 96-well polypropylene plate, compound dilutions were prepared in assay buffer. Separate microcentrifuge tubes were prepared of PDE4B and PDE4D according to assay template−in assay buffer. The tubes were kept on ice. The enzyme concentration shown on the template were diluted by 1:4. FAM-cAMP substrate solution was prepared according to assay template. 5 μl compound was transferred from polypropylene plate into black 384-well plate. This plate was centrifuged briefly to make sure all 5 μl is on the bottom. Up to 80 μl of prepared PDE4B enzyme solution was transferred into alternate wells on row 'N' of 384-well plate starting from cell N1. Up to 80 μl of prepared PDE4D enzyme solution was transferred into alternate wells on row 'O' of 384-well plate, starting from cell O2. cAMP substrate solution was transferred into bottom row of separate 96-well plate. 5 μl of enzyme solution from the ""reservoir"" row (N or O) was transferred to each of the wells containing compounds, per layout map. Next, 10 μl of cAMP substrate was transferred to these wells. The order of substrate-first or enzyme-first can be switched depending on what is optimal. The final cAMP concentration was 100 nM in the reaction. 20 μl of assay buffer was pipetted into 4 separate wells−these are the blanks. The plate was sealed with an aluminum strip and incubated at 30° C. for 90 minutes. A TR-FRET solution was prepared. 4 ml of 1×IMAP Buffer A was added to 6 ml of IMAP Buffer B. 25 μl ( 1/800 of 20 ml) of binding beads was added to this and mix by inverting. 60 μl of this mixture was pipetted into 2 of the wells containing the ""blank"" assay buffer. Next, 49.7 μl ( 1/400 of remaining volume) of Tb donor solution was added to the remaining TR-FRET solution and mixed by inverting. 60 μl of this solution was pipetted into remaining 2 ""blank"" assay buffer-containing wells. The TR-FRET solution was poured into a pipette boat and a multichannel pipette was used to drop 60 μl of solution into all assay wells. The wells were covered with a foil strip and incubated for at least 3 hours or overnight protected from light (e.g. in a drawer) at room temperature. The plate was read on the Envision Reader: Emission 1: 520/Emission 2: 486/Exc: 340. Mirror: Umbelliferone (UV).",COc1cccc2c1ncc1c(=O)n(-c3cccc(Cl)c3)c(=O)n(C3CCC(C(=O)O)CC3)c12,IC50,55.0,nM,7.259637310505756
CHEMBL3644503,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Assay: The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or MnCl2). In a separate 96-well polypropylene plate, compound dilutions were prepared in assay buffer. Separate microcentrifuge tubes were prepared of PDE4B and PDE4D according to assay template−in assay buffer. The tubes were kept on ice. The enzyme concentration shown on the template were diluted by 1:4. FAM-cAMP substrate solution was prepared according to assay template. 5 μl compound was transferred from polypropylene plate into black 384-well plate. This plate was centrifuged briefly to make sure all 5 μl is on the bottom. Up to 80 μl of prepared PDE4B enzyme solution was transferred into alternate wells on row 'N' of 384-well plate starting from cell N1. Up to 80 μl of prepared PDE4D enzyme solution was transferred into alternate wells on row 'O' of 384-well plate, starting from cell O2. cAMP substrate solution was transferred into bottom row of separate 96-well plate. 5 μl of enzyme solution from the ""reservoir"" row (N or O) was transferred to each of the wells containing compounds, per layout map. Next, 10 μl of cAMP substrate was transferred to these wells. The order of substrate-first or enzyme-first can be switched depending on what is optimal. The final cAMP concentration was 100 nM in the reaction. 20 μl of assay buffer was pipetted into 4 separate wells−these are the blanks. The plate was sealed with an aluminum strip and incubated at 30° C. for 90 minutes. A TR-FRET solution was prepared. 4 ml of 1×IMAP Buffer A was added to 6 ml of IMAP Buffer B. 25 μl ( 1/800 of 20 ml) of binding beads was added to this and mix by inverting. 60 μl of this mixture was pipetted into 2 of the wells containing the ""blank"" assay buffer. Next, 49.7 μl ( 1/400 of remaining volume) of Tb donor solution was added to the remaining TR-FRET solution and mixed by inverting. 60 μl of this solution was pipetted into remaining 2 ""blank"" assay buffer-containing wells. The TR-FRET solution was poured into a pipette boat and a multichannel pipette was used to drop 60 μl of solution into all assay wells. The wells were covered with a foil strip and incubated for at least 3 hours or overnight protected from light (e.g. in a drawer) at room temperature. The plate was read on the Envision Reader: Emission 1: 520/Emission 2: 486/Exc: 340. Mirror: Umbelliferone (UV).",COc1cccc2c1ncc1c(=O)n(-c3cccc(Cl)c3)c(=O)n([C@@H]3CCN(S(C)(=O)=O)C3)c12,IC50,163.0,nM,6.787812395596042
CHEMBL3644504,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Assay: The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or MnCl2). In a separate 96-well polypropylene plate, compound dilutions were prepared in assay buffer. Separate microcentrifuge tubes were prepared of PDE4B and PDE4D according to assay template−in assay buffer. The tubes were kept on ice. The enzyme concentration shown on the template were diluted by 1:4. FAM-cAMP substrate solution was prepared according to assay template. 5 μl compound was transferred from polypropylene plate into black 384-well plate. This plate was centrifuged briefly to make sure all 5 μl is on the bottom. Up to 80 μl of prepared PDE4B enzyme solution was transferred into alternate wells on row 'N' of 384-well plate starting from cell N1. Up to 80 μl of prepared PDE4D enzyme solution was transferred into alternate wells on row 'O' of 384-well plate, starting from cell O2. cAMP substrate solution was transferred into bottom row of separate 96-well plate. 5 μl of enzyme solution from the ""reservoir"" row (N or O) was transferred to each of the wells containing compounds, per layout map. Next, 10 μl of cAMP substrate was transferred to these wells. The order of substrate-first or enzyme-first can be switched depending on what is optimal. The final cAMP concentration was 100 nM in the reaction. 20 μl of assay buffer was pipetted into 4 separate wells−these are the blanks. The plate was sealed with an aluminum strip and incubated at 30° C. for 90 minutes. A TR-FRET solution was prepared. 4 ml of 1×IMAP Buffer A was added to 6 ml of IMAP Buffer B. 25 μl ( 1/800 of 20 ml) of binding beads was added to this and mix by inverting. 60 μl of this mixture was pipetted into 2 of the wells containing the ""blank"" assay buffer. Next, 49.7 μl ( 1/400 of remaining volume) of Tb donor solution was added to the remaining TR-FRET solution and mixed by inverting. 60 μl of this solution was pipetted into remaining 2 ""blank"" assay buffer-containing wells. The TR-FRET solution was poured into a pipette boat and a multichannel pipette was used to drop 60 μl of solution into all assay wells. The wells were covered with a foil strip and incubated for at least 3 hours or overnight protected from light (e.g. in a drawer) at room temperature. The plate was read on the Envision Reader: Emission 1: 520/Emission 2: 486/Exc: 340. Mirror: Umbelliferone (UV).",COc1cccc2c1ncc1c(=O)n(-c3cccc(Cl)c3)c(=O)n([C@H]3CCN(S(C)(=O)=O)C3)c12,IC50,206.0,nM,6.686132779630847
CHEMBL3644505,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Assay: The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or MnCl2). In a separate 96-well polypropylene plate, compound dilutions were prepared in assay buffer. Separate microcentrifuge tubes were prepared of PDE4B and PDE4D according to assay template−in assay buffer. The tubes were kept on ice. The enzyme concentration shown on the template were diluted by 1:4. FAM-cAMP substrate solution was prepared according to assay template. 5 μl compound was transferred from polypropylene plate into black 384-well plate. This plate was centrifuged briefly to make sure all 5 μl is on the bottom. Up to 80 μl of prepared PDE4B enzyme solution was transferred into alternate wells on row 'N' of 384-well plate starting from cell N1. Up to 80 μl of prepared PDE4D enzyme solution was transferred into alternate wells on row 'O' of 384-well plate, starting from cell O2. cAMP substrate solution was transferred into bottom row of separate 96-well plate. 5 μl of enzyme solution from the ""reservoir"" row (N or O) was transferred to each of the wells containing compounds, per layout map. Next, 10 μl of cAMP substrate was transferred to these wells. The order of substrate-first or enzyme-first can be switched depending on what is optimal. The final cAMP concentration was 100 nM in the reaction. 20 μl of assay buffer was pipetted into 4 separate wells−these are the blanks. The plate was sealed with an aluminum strip and incubated at 30° C. for 90 minutes. A TR-FRET solution was prepared. 4 ml of 1×IMAP Buffer A was added to 6 ml of IMAP Buffer B. 25 μl ( 1/800 of 20 ml) of binding beads was added to this and mix by inverting. 60 μl of this mixture was pipetted into 2 of the wells containing the ""blank"" assay buffer. Next, 49.7 μl ( 1/400 of remaining volume) of Tb donor solution was added to the remaining TR-FRET solution and mixed by inverting. 60 μl of this solution was pipetted into remaining 2 ""blank"" assay buffer-containing wells. The TR-FRET solution was poured into a pipette boat and a multichannel pipette was used to drop 60 μl of solution into all assay wells. The wells were covered with a foil strip and incubated for at least 3 hours or overnight protected from light (e.g. in a drawer) at room temperature. The plate was read on the Envision Reader: Emission 1: 520/Emission 2: 486/Exc: 340. Mirror: Umbelliferone (UV).",CCS(=O)(=O)N1CCC(n2c(=O)n(-c3cccc(Cl)c3)c(=O)c3cnc4c(OC)cccc4c32)CC1,IC50,59.0,nM,7.229147988357855
CHEMBL3644506,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Assay: The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or MnCl2). In a separate 96-well polypropylene plate, compound dilutions were prepared in assay buffer. Separate microcentrifuge tubes were prepared of PDE4B and PDE4D according to assay template−in assay buffer. The tubes were kept on ice. The enzyme concentration shown on the template were diluted by 1:4. FAM-cAMP substrate solution was prepared according to assay template. 5 μl compound was transferred from polypropylene plate into black 384-well plate. This plate was centrifuged briefly to make sure all 5 μl is on the bottom. Up to 80 μl of prepared PDE4B enzyme solution was transferred into alternate wells on row 'N' of 384-well plate starting from cell N1. Up to 80 μl of prepared PDE4D enzyme solution was transferred into alternate wells on row 'O' of 384-well plate, starting from cell O2. cAMP substrate solution was transferred into bottom row of separate 96-well plate. 5 μl of enzyme solution from the ""reservoir"" row (N or O) was transferred to each of the wells containing compounds, per layout map. Next, 10 μl of cAMP substrate was transferred to these wells. The order of substrate-first or enzyme-first can be switched depending on what is optimal. The final cAMP concentration was 100 nM in the reaction. 20 μl of assay buffer was pipetted into 4 separate wells−these are the blanks. The plate was sealed with an aluminum strip and incubated at 30° C. for 90 minutes. A TR-FRET solution was prepared. 4 ml of 1×IMAP Buffer A was added to 6 ml of IMAP Buffer B. 25 μl ( 1/800 of 20 ml) of binding beads was added to this and mix by inverting. 60 μl of this mixture was pipetted into 2 of the wells containing the ""blank"" assay buffer. Next, 49.7 μl ( 1/400 of remaining volume) of Tb donor solution was added to the remaining TR-FRET solution and mixed by inverting. 60 μl of this solution was pipetted into remaining 2 ""blank"" assay buffer-containing wells. The TR-FRET solution was poured into a pipette boat and a multichannel pipette was used to drop 60 μl of solution into all assay wells. The wells were covered with a foil strip and incubated for at least 3 hours or overnight protected from light (e.g. in a drawer) at room temperature. The plate was read on the Envision Reader: Emission 1: 520/Emission 2: 486/Exc: 340. Mirror: Umbelliferone (UV).",COc1cccc2c1ncc1c(=O)n(-c3cccc(Cl)c3)c(=O)n(C3CCN(S(=O)(=O)CS(C)(=O)=O)CC3)c12,IC50,80.0,nM,7.096910013008056
CHEMBL3945875,CHEMBL288,Phosphodiesterase 4D,"TR-FRET-Based Assay: The assay buffer was prepared by diluting 5× supplied Tween-based buffer in 1:5 in water to make 1× buffer. Add desired additive to buffer (DTT or MnCl2). In a separate 96-well polypropylene plate, compound dilutions were prepared in assay buffer. Separate microcentrifuge tubes were prepared of PDE4B and PDE4D according to assay template−in assay buffer. The tubes were kept on ice. The enzyme concentration shown on the template were diluted by 1:4. FAM-cAMP substrate solution was prepared according to assay template. 5 μl compound was transferred from polypropylene plate into black 384-well plate. This plate was centrifuged briefly to make sure all 5 μl is on the bottom. Up to 80 μl of prepared PDE4B enzyme solution was transferred into alternate wells on row 'N' of 384-well plate starting from cell N1. Up to 80 μl of prepared PDE4D enzyme solution was transferred into alternate wells on row 'O' of 384-well plate, starting from cell O2. cAMP substrate solution was transferred into bottom row of separate 96-well plate. 5 μl of enzyme solution from the ""reservoir"" row (N or O) was transferred to each of the wells containing compounds, per layout map. Next, 10 μl of cAMP substrate was transferred to these wells. The order of substrate-first or enzyme-first can be switched depending on what is optimal. The final cAMP concentration was 100 nM in the reaction. 20 μl of assay buffer was pipetted into 4 separate wells−these are the blanks. The plate was sealed with an aluminum strip and incubated at 30° C. for 90 minutes. A TR-FRET solution was prepared. 4 ml of 1×IMAP Buffer A was added to 6 ml of IMAP Buffer B. 25 μl ( 1/800 of 20 ml) of binding beads was added to this and mix by inverting. 60 μl of this mixture was pipetted into 2 of the wells containing the ""blank"" assay buffer. Next, 49.7 μl ( 1/400 of remaining volume) of Tb donor solution was added to the remaining TR-FRET solution and mixed by inverting. 60 μl of this solution was pipetted into remaining 2 ""blank"" assay buffer-containing wells. The TR-FRET solution was poured into a pipette boat and a multichannel pipette was used to drop 60 μl of solution into all assay wells. The wells were covered with a foil strip and incubated for at least 3 hours or overnight protected from light (e.g. in a drawer) at room temperature. The plate was read on the Envision Reader: Emission 1: 520/Emission 2: 486/Exc: 340. Mirror: Umbelliferone (UV).",COc1cccc2c1ncc1c(=O)n(-c3cccc(Cl)c3)c(=O)n(C3CCC(NS(C)(=O)=O)CC3)c12,IC50,73.0,nM,7.136677139879544
CHEMBL1463540,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 (unknown origin) assessed as decrease in FAM-cAMP hydrolysis preincubated for 5 mins followed by FAM-cAMP addition measured after 30 mins by IMAP assay,O=c1n(Cc2ccc(Cl)cc2)c2sc3c(c2c2ncnn12)CCCC3,IC50,3900.0,nM,5.4089353929735005
CHEMBL4067682,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 (unknown origin) assessed as decrease in FAM-cAMP hydrolysis preincubated for 5 mins followed by FAM-cAMP addition measured after 30 mins by IMAP assay,COc1ccc(Cn2c(=O)n3ncnc3c3c4c(sc32)CN(CC2CCOCC2)CC4)c(F)c1,IC50,9300.0,nM,5.031517051446064
CHEMBL4099219,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using [3H]cAMP or [3H]cGMP as substrate after 15 mins by liquid scintillation counting method,O=c1c2ccccc2oc2c(Cc3ccc4c(c3)OCO4)[nH]c(-c3nccs3)c12,IC50,2769.0,nM,5.557677044254426
CHEMBL506972,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using [3H]-cAMP as substrate after 30 mins by scintillation counting method,CCOC(=O)c1c(C)n[nH]c1C,IC50,82000.0,nM,4.086186147616283
CHEMBL1773422,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 expressed in sf9 cells,CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S+](C)[O-])n2C)ccn1,IC50,1100.0,nM,5.958607314841775
CHEMBL1773422,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 expressed in sf9 cells,CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc([S+](C)[O-])n2C)ccn1,IC50,800.0,nM,6.096910013008056
CHEMBL4075428,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 expressed in sf9 cells,Cn1c([S+](C)[O-])nc(-c2ccc(F)cc2)c1-c1ccnc(N)c1,IC50,2400.0,nM,5.619788758288394
CHEMBL4075428,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3 expressed in sf9 cells,Cn1c([S+](C)[O-])nc(-c2ccc(F)cc2)c1-c1ccnc(N)c1,IC50,700.0,nM,6.154901959985743
CHEMBL4060569,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human N-terminal GST-tagged PDE4D2 (2 to 507 residues) expressed in baculovirus infected fall armyworm Sf9 cells using [3H]cAMP as substrate preincubated for 30 mins followed by substrate addition measured after 60 mins by scintillation counting,COC[C@@H](NC(=O)N1CC(=O)Nc2cc(OC)cnc21)c1ccc(OC(F)(F)F)c(F)c1,IC50,14882.0,nM,4.8273386997984655
CHEMBL4097537,CHEMBL288,Phosphodiesterase 4D,Inhibition of phosphodiesterase 4D (unknown origin),COc1nn(-c2ccccn2)c2cc(-c3ccc([C@H]4C[C@@H]4C(=O)O)cc3)ccc12,IC50,1600.0,nM,5.795880017344075
CHEMBL4128481,CHEMBL288,Phosphodiesterase 4D,"Inhibition of full length recombinant human PDE4D3 using 3',5'-[3H]cAMP as substrate after 30 mins by scintillation proximity assay",COc1ccc2c(N[C@@H](C)Cc3cc(C)[nH]n3)ncnc2c1OC,IC50,26.3,nM,7.580044251510242
CHEMBL3643413,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D,CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1,IC50,4700.0,nM,5.327902142064282
CHEMBL4176593,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D3,Cc1cc(C#N)c(F)cc1-c1c(C(=O)NC2CC2)nn2c1OCC(F)C2,IC50,558.0,nM,6.253365801062421
CHEMBL4164367,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D3,Cc1cc(Cl)ccc1-c1c(C(=O)NC2CC2)nn2c1OCC(F)C2,IC50,6420.0,nM,5.192464971931146
CHEMBL4168265,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D3,O=C(NC1CC1)c1nn2c(c1-c1cc(F)c(Cl)cc1F)OC[C@@H](F)C2,IC50,306.0,nM,6.514278573518419
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,620.0,nM,6.207608310501746
CHEMBL4170139,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,C/C(C=O)=C\Cc1c(-c2ccc(O)cc2O)oc2c3c(cc(O)c2c1=O)OC(C)(C)C=C3,IC50,9210.0,nM,5.03574036980315
CHEMBL4159517,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,CC(C)C[C@@H]1Oc2cc(O)ccc2-c2oc3c4c(cc(O)c3c(=O)c21)OC(C)(C)CC4,IC50,7500.0,nM,5.1249387366083
CHEMBL4176273,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,CC(C)C[C@H]1Oc2cc(O)ccc2-c2oc3c4c(cc(O)c3c(=O)c21)OC(C)(C)CC4,IC50,4350.0,nM,5.361510743045363
CHEMBL4168408,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,COc1ccc2c(c1)O[C@@H](C=C(C)C)c1c-2oc2c3c(cc(O)c2c1=O)OC(C)(C)C=C3,IC50,8600.0,nM,5.065501548756432
CHEMBL4170952,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,CC(=O)Oc1ccc2c(c1)O[C@H](C=C(C)C)c1c-2oc2c3c(cc(O)c2c1=O)OC(C)(C)C=C3,IC50,4890.0,nM,5.310691140876379
CHEMBL4163032,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,COc1ccc2c(c1)O[C@H](C=C(C)C)c1c-2oc2c3c(cc(O)c2c1=O)OC(C)(C)C=C3,IC50,5180.0,nM,5.285670240254767
CHEMBL4174381,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,C=CC(C)(C)c1cc(-c2cc(=O)c3c(O)cc(O)cc3o2)c(O)cc1O,IC50,1880.0,nM,5.72584215073632
CHEMBL485777,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,CC(C)=CCc1c(O)cc2oc(-c3ccc(O)cc3O)c(CC=C(C)C)c(=O)c2c1O,IC50,260.0,nM,6.585026652029182
CHEMBL518543,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,CC(C)=CCc1c(-c2ccc(O)cc2O)oc2c(CC=C(C)C)c(O)cc(O)c2c1=O,IC50,310.0,nM,6.508638306165727
CHEMBL4169898,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,CC(C)=CCc1cc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)c(O)c(CC=C(C)C)c1O,IC50,9900.0,nM,5.00436480540245
CHEMBL4162628,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,CC(C)=CCC/C(C)=C/Cc1c(O)c(CC=C(C)C)cc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)c1O,IC50,2190.0,nM,5.6595558851598815
CHEMBL4173326,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,CC(C)=CCC/C(C)=C/Cc1cc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)c(O)cc1O,IC50,1260.0,nM,5.899629454882437
CHEMBL4168945,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,CC(C)=CCC/C(C)=C/Cc1c(O)ccc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)c1O,IC50,2330.0,nM,5.632644078973981
CHEMBL464006,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,CC(C)=CCc1c(-c2ccc(O)cc2O)oc2c3c(cc(O)c2c1=O)OC(C)(C)C=C3,IC50,900.0,nM,6.045757490560675
CHEMBL4167451,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,CC(C)=CCCC1(C)C=Cc2c(ccc(-c3oc4cc(O)cc(O)c4c(=O)c3CC=C(C)C)c2O)O1,IC50,270.0,nM,6.568636235841012
CHEMBL371562,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,CC(C)=CCc1c(O)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,IC50,630.0,nM,6.200659450546418
CHEMBL4170837,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,CC1(C)C=Cc2c(ccc(-c3cc(=O)c4c(O)cc5c(c4o3)C=CC(C)(C)O5)c2O)O1,IC50,30.0,nM,7.522878745280337
CHEMBL4160223,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,CC(C)=CCCC1(C)C=Cc2cc(C3CC(=O)c4c(O)cc(O)cc4O3)c(O)cc2O1,IC50,3590.0,nM,5.444905551421681
CHEMBL4160605,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,CC1(C)C=Cc2c(c3c(c4c(=O)cc(-c5ccc(O)cc5O)oc24)OC(C)(C)CC3)O1,IC50,870.0,nM,6.060480747381382
CHEMBL4168522,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,CC(C)=CCc1c(O)cc(O)c2c(=O)c3c(oc12)-c1ccc(O)cc1OC3C=C(C)C,IC50,40.0,nM,7.3979400086720375
CHEMBL4164003,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,CC(C)=CC1Oc2cc(O)ccc2-c2oc3cc(O)cc(O)c3c(=O)c21,IC50,400.0,nM,6.3979400086720375
CHEMBL4171877,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,COC1CC(C)(C)Oc2cc(O)c3c(=O)c(CC=C(C)C)c(-c4ccc(O)cc4O)oc3c21,IC50,20.0,nM,7.698970004336019
CHEMBL4176617,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,CC(C)=C[C@@H]1Oc2cc(O)ccc2-c2oc3c4c(cc(O)c3c(=O)c21)OC(C)(C)C=C4,IC50,250.0,nM,6.6020599913279625
CHEMBL4168752,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,CC(C)=C[C@H]1Oc2cc(O)ccc2-c2oc3c4c(cc(O)c3c(=O)c21)OC(C)(C)C=C4,IC50,5.4,nM,8.267606240177031
CHEMBL4160950,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D expressed in Escherichia coli assessed as increase in cAMP levels after 60 mins by BIOMOLGREEN dye-based assay,CC1=NNC(=O)C(c2c[nH]c3ccccc23)C1,IC50,32000.0,nM,4.494850021680094
CHEMBL4164353,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D expressed in Escherichia coli assessed as increase in cAMP levels after 60 mins by BIOMOLGREEN dye-based assay,COc1ccc2[nH]cc(C3CC(C)=NNC3=O)c2c1,IC50,23000.0,nM,4.638272163982407
CHEMBL4173360,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D expressed in Escherichia coli assessed as increase in cAMP levels after 60 mins by BIOMOLGREEN dye-based assay,CC1=NN(C)C(=O)C(N2CCOCC2)C1,IC50,35000.0,nM,4.455931955649724
CHEMBL313842,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D expressed in Escherichia coli assessed as increase in cAMP levels after 60 mins by BIOMOLGREEN dye-based assay,COc1cc(-c2ccc(=O)[nH]n2)ccc1OC(F)F,IC50,2000.0,nM,5.698970004336019
CHEMBL275084,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D expressed in Escherichia coli assessed as increase in cAMP levels after 60 mins by BIOMOLGREEN dye-based assay,CC(C)Cn1c(=O)n(C)c(=O)c2nc[nH]c21,IC50,38000.0,nM,4.42021640338319
CHEMBL4217492,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,COc1cc2c(cc1OC1CCCC1)CN(C(=O)c1ccc(O)cc1)CC2,IC50,16320.0,nM,4.787279845582158
CHEMBL4208161,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,COc1ccc(C(=O)N2CCc3cc(OC)c(OC4CCCC4)cc3C2)cc1,IC50,13260.0,nM,4.877456475931246
CHEMBL4213076,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,COc1cc2c(cc1OC1CCCC1)CN(C(=O)c1ccc(OC(F)(F)F)cc1)CC2,IC50,6500.0,nM,5.187086643357144
CHEMBL4204765,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,COc1cc2c(cc1OC1CCCC1)CN(C(=O)c1ccc(Cl)cc1)CC2,IC50,92580.0,nM,4.033482823553208
CHEMBL4205250,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,COc1ccc(C(=O)N2CCc3cc(OC)c(OC4CCCC4)cc3C2)cc1O,IC50,18620.0,nM,4.730020323354676
CHEMBL4211564,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,COc1ccc(C(=O)N2CCc3cc(OC)c(OC4CCCC4)cc3C2)cc1OC,IC50,18270.0,nM,4.738261452647462
CHEMBL4216542,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,COc1ccc(S(=O)(=O)N2CCc3cc(OC)c(OC4CCCC4)cc3C2)cc1,IC50,43620.0,nM,4.360314338757319
CHEMBL4206447,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,COc1cc2c(cc1OC1CCCC1)CN(S(=O)(=O)c1ccc(Cl)cc1)CC2,IC50,133560.0,nM,3.874323589617667
CHEMBL4206423,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,COc1cc2c(cc1OC1CCCC1)CN(S(=O)(=O)c1ccc(NC(C)=O)cc1)CC2,IC50,11650.0,nM,4.933674074637962
CHEMBL4215772,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,COC(=O)C1Cc2cc(OC)c(OC3CCCC3)cc2CN1C(=O)c1ccc(OC(F)(F)F)cc1,IC50,18400.0,nM,4.735182176990463
CHEMBL4215240,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,CCOC(=O)C1Cc2cc(OC)c(OC3CCCC3)cc2CN1C(=O)c1ccc(OC(F)(F)F)cc1,IC50,32680.0,nM,4.485717952139622
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,1430.0,nM,5.844663962534938
CHEMBL193240,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,IC50,1.1,nM,8.958607314841775
CHEMBL4209111,CHEMBL288,Phosphodiesterase 4D,Allosteric modulation of human PDE4D,NC(=O)Cc1ccc(Nc2cc(C(F)(F)F)nc(-c3cccc(Cl)c3)n2)cc1,IC50,8.0,nM,8.096910013008056
CHEMBL3184687,CHEMBL288,Phosphodiesterase 4D,Allosteric modulation of recombinant human PDE4D expressed in HEK293 cells by cAMP assay,COc1ccc(Cc2ccc(NC(N)=O)cc2)cc1-c1cccc(Cl)c1,IC50,27.0,nM,7.568636235841012
CHEMBL4213295,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 (unknown origin) using [3H]cAMP as substrate preincubated for 5 mins followed by substrate addition and measured after 15 mins by scintillation proximity assay,COc1ccc(C2=NN(C3CCCC3)C(=O)C3CC=CCC23)cc1Cl,IC50,0.78,nM,9.10790539730952
CHEMBL4218772,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 catalytic domain (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using 3H-cAMP as substrate after 15 mins by liquid scintillation counting,COCCNc1cc(O)c2c(=O)c3c(-c4nccs4)[nH]c(Cc4ccc5c(c4)OCO5)c3oc2c1,IC50,43.0,nM,7.366531544420413
CHEMBL4279157,CHEMBL288,Phosphodiesterase 4D,Displacement of [3H]-c-AMP from His-Tb-tagged human PDE4D2 (86 to 413 residues) preincubated for 10 mins followed by [3H]-c-AMP addition measured after 1 hr by scintillation proximity assay,CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(N)=O)cnc12,IC50,62.0,nM,7.207608310501746
CHEMBL4293907,CHEMBL288,Phosphodiesterase 4D,Displacement of [3H]-c-AMP from His-Tb-tagged human PDE4D2 (86 to 413 residues) preincubated for 10 mins followed by [3H]-c-AMP addition measured after 1 hr by scintillation proximity assay,CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(=O)NC3CC3)cnc12,IC50,6.0,nM,8.221848749616356
CHEMBL4289426,CHEMBL288,Phosphodiesterase 4D,Displacement of [3H]-c-AMP from His-Tb-tagged human PDE4D2 (86 to 413 residues) preincubated for 10 mins followed by [3H]-c-AMP addition measured after 1 hr by scintillation proximity assay,CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(=O)NCC(C)(C)CO)cnc12,IC50,15.0,nM,7.823908740944319
CHEMBL4278757,CHEMBL288,Phosphodiesterase 4D,Displacement of [3H]-c-AMP from His-Tb-tagged human PDE4D2 (86 to 413 residues) preincubated for 10 mins followed by [3H]-c-AMP addition measured after 1 hr by scintillation proximity assay,CNc1cc(Nc2cc(C)cc(C)c2)nn2c(C(=O)NCC(C)(CO)CO)cnc12,IC50,18.0,nM,7.7447274948966935
CHEMBL4285841,CHEMBL288,Phosphodiesterase 4D,Displacement of [3H]-c-AMP from His-Tb-tagged human PDE4D2 (86 to 413 residues) preincubated for 10 mins followed by [3H]-c-AMP addition measured after 1 hr by scintillation proximity assay,CNc1cc(Nc2cccc3c2OCCO3)nn2c(C(=O)NC3CC3)cnc12,IC50,24.0,nM,7.619788758288394
CHEMBL4295039,CHEMBL288,Phosphodiesterase 4D,Displacement of [3H]-c-AMP from His-Tb-tagged human PDE4D2 (86 to 413 residues) preincubated for 10 mins followed by [3H]-c-AMP addition measured after 1 hr by scintillation proximity assay,CNc1cc(Nc2ccccc2OC)nn2c(C(=O)NCC(C)(C)CO)cnc12,IC50,88.0,nM,7.055517327849831
CHEMBL4287761,CHEMBL288,Phosphodiesterase 4D,Displacement of [3H]-c-AMP from His-Tb-tagged human PDE4D2 (86 to 413 residues) preincubated for 10 mins followed by [3H]-c-AMP addition measured after 1 hr by scintillation proximity assay,CNc1cc(Nc2cc(F)cc(F)c2OC)nn2c(C(=O)NCC(C)(C)CO)cnc12,IC50,32.0,nM,7.494850021680094
CHEMBL4279883,CHEMBL288,Phosphodiesterase 4D,Displacement of [3H]-c-AMP from His-Tb-tagged human PDE4D2 (86 to 413 residues) preincubated for 10 mins followed by [3H]-c-AMP addition measured after 1 hr by scintillation proximity assay,CNc1cc(Nc2cc(F)cc(F)c2OC)nn2c(C(=O)NC[C@](C)(O)CO)cnc12,IC50,43.0,nM,7.366531544420413
CHEMBL4291200,CHEMBL288,Phosphodiesterase 4D,Displacement of [3H]-c-AMP from His-Tb-tagged human PDE4D2 (86 to 413 residues) preincubated for 10 mins followed by [3H]-c-AMP addition measured after 1 hr by scintillation proximity assay,CNc1cc(Nc2c(F)c(F)cc(F)c2F)nn2c(C(=O)NC[C@](C)(O)CO)cnc12,IC50,13.0,nM,7.886056647693163
CHEMBL4283351,CHEMBL288,Phosphodiesterase 4D,Displacement of [3H]-c-AMP from His-Tb-tagged human PDE4D2 (86 to 413 residues) preincubated for 10 mins followed by [3H]-c-AMP addition measured after 1 hr by scintillation proximity assay,CNc1cc(Nc2cccc(C(C)(C)C)c2)nn2c(C(N)=O)cnc12,IC50,2400.0,nM,5.619788758288394
CHEMBL4291611,CHEMBL288,Phosphodiesterase 4D,Displacement of [3H]-c-AMP from His-Tb-tagged human PDE4D2 (86 to 413 residues) preincubated for 10 mins followed by [3H]-c-AMP addition measured after 1 hr by scintillation proximity assay,CNc1cc(Nc2cccc(-c3ccccc3)c2)nn2c(C(N)=O)cnc12,IC50,380.0,nM,6.42021640338319
CHEMBL4290130,CHEMBL288,Phosphodiesterase 4D,Displacement of [3H]-c-AMP from His-Tb-tagged human PDE4D2 (86 to 413 residues) preincubated for 10 mins followed by [3H]-c-AMP addition measured after 1 hr by scintillation proximity assay,C[C@](O)(CO)CNc1cc(Nc2cccc(-c3ccc(C(F)(F)F)cc3F)c2)nn2c(C(N)=O)cnc12,IC50,5600.0,nM,5.251811972993799
CHEMBL4292472,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate measured after 30 mins,COc1ccc(-c2ccc(C(=O)n3nc(C)cc3C)o2)cc1,IC50,9600.0,nM,5.017728766960431
CHEMBL4281168,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate measured after 30 mins,Cc1ccc(-c2ccc(C(=O)n3nc(C)cc3C)o2)cc1,IC50,52900.0,nM,4.276544327964814
CHEMBL4289060,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate measured after 30 mins,Cc1cc(C)n(C(=O)c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)n1,IC50,87300.0,nM,4.0589857562944305
CHEMBL4277735,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate measured after 30 mins,Cc1cc(C)n(C(=O)c2ccc(-c3ccc(F)cc3)o2)n1,IC50,49300.0,nM,4.30715308072277
CHEMBL4285675,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate measured after 30 mins,Cc1cc(C)n(C(=O)c2ccc(-c3ccc(Cl)cc3)o2)n1,IC50,26400.0,nM,4.578396073130169
CHEMBL4294394,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate measured after 30 mins,Cc1cc(C)n(C(=O)c2ccc(-c3ccc(F)cc3F)o2)n1,IC50,19600.0,nM,4.707743928643524
CHEMBL4283822,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate measured after 30 mins,Cc1cc(C)n(C(=O)c2ccc(-c3c(F)cccc3F)o2)n1,IC50,88200.0,nM,4.054531414868181
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate measured after 30 mins,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,2500.0,nM,5.6020599913279625
CHEMBL4171991,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,O=C(c1ccc(-c2ccc(Cl)cc2)o1)N1CCc2ccccc2C1,IC50,25200.0,nM,4.598599459218456
CHEMBL4170840,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,O=C(c1ccc(-c2ccc(F)cc2)o1)N1CCc2ccccc2C1,IC50,49300.0,nM,4.30715308072277
CHEMBL4174666,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,O=C(c1ccc(-c2ccc([N+](=O)[O-])cc2)o1)N1CCc2ccccc2C1,IC50,88300.0,nM,4.054039296422431
CHEMBL4164011,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,Cc1ccc(-c2ccc(C(=O)N3CCc4ccccc4C3)o2)cc1,IC50,56800.0,nM,4.245651664288981
CHEMBL4167454,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,COc1ccc(-c2ccc(C(=O)N3CCc4ccccc4C3)o2)cc1,IC50,10200.0,nM,4.991399828238082
CHEMBL4176569,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,O=C(c1ccc(-c2ccc(F)cc2F)o1)N1CCc2ccccc2C1,IC50,18100.0,nM,4.7423214251308154
CHEMBL4165955,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,O=C(c1ccc(-c2c(F)cccc2F)o1)N1CCc2ccccc2C1,IC50,89200.0,nM,4.049635145623877
CHEMBL4162324,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,O=C(c1ccc(-c2cccc(Cl)c2)o1)N1CCCc2ccccc21,IC50,96800.0,nM,4.014124642691606
CHEMBL4172687,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,O=C(c1ccc(-c2ccc(Cl)cc2)o1)N1CCCc2ccccc21,IC50,21300.0,nM,4.671620396561262
CHEMBL4168223,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,O=C(c1ccc(-c2ccc(F)cc2)o1)N1CCCc2ccccc21,IC50,40300.0,nM,4.394694953858891
CHEMBL4172684,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,O=C(c1ccc(-c2ccc([N+](=O)[O-])cc2)o1)N1CCCc2ccccc21,IC50,77200.0,nM,4.112382699664264
CHEMBL4167151,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,Cc1ccc(-c2ccc(C(=O)N3CCCc4ccccc43)o2)cc1,IC50,50100.0,nM,4.300162274132754
CHEMBL4170548,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,COc1ccc(-c2ccc(C(=O)N3CCCc4ccccc43)o2)cc1,IC50,10300.0,nM,4.987162775294828
CHEMBL4167824,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,O=C(c1ccc(-c2ccc(F)cc2F)o1)N1CCCc2ccccc21,IC50,15600.0,nM,4.806875401645539
CHEMBL4160331,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,O=C(c1ccc(-c2c(F)cccc2F)o1)N1CCCc2ccccc21,IC50,81300.0,nM,4.089909454405932
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U937 cells-derived PDE4D using [3H]-cAMP as substrate after 30 mins,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,2800.0,nM,5.552841968657781
CHEMBL484785,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D7 (unknown origin),N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1,IC50,55.0,nM,7.259637310505756
CHEMBL3394769,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,O=C1C=CC(=C(c2ccc(O)cc2)c2c(-c3ccc(O)cc3)ccc(CO)c2C#Cc2ccc(O)cc2)C=C1,IC50,1000.0,nM,6.0
CHEMBL4444637,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,OCc1ccc2c(c1C#Cc1ccc(O)cc1)C(c1ccc(O)cc1)(c1ccc(O)cc1)c1cc(O)ccc1-2,IC50,200.0,nM,6.698970004336019
CHEMBL4584384,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,Oc1ccc(C#Cc2ccc(O)c3c2C(c2ccc(O)cc2)(c2ccc(O)cc2)c2cc(O)ccc2-3)cc1,IC50,1200.0,nM,5.920818753952375
CHEMBL4460827,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,COc1ccc(C2(c3ccc(OC)cc3)c3cc(O)ccc3-c3ccc(C=O)c(C#Cc4ccc(O)cc4)c32)cc1,IC50,10.0,nM,8.0
CHEMBL4451141,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,COc1ccc(C2(c3ccc(OC)cc3)c3cc(O)ccc3-c3cccc(C#Cc4ccc(O)cc4)c32)cc1,IC50,90.0,nM,7.045757490560675
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli strain BL21 using [3H]cAMP as substrate after 15 mins by liquid scintillation counter analysis,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,500.0,nM,6.301029995663981
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (unknown origin) by preincubated for 30 mins before substrate addition and measured after 60 mins by IMAP TR-FRET phosphodiesterase evaluation assay,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,200.0,nM,6.698970004336019
CHEMBL4557935,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (unknown origin) by preincubated for 30 mins before substrate addition and measured after 60 mins by IMAP TR-FRET phosphodiesterase evaluation assay,COc1ccc(-c2c3ccc(OC)cc3c3c4c(ccc(-c5ccc(O)cc5)c24)C(=O)O[C@H]3c2ccc(O)cc2)cc1,IC50,13700.0,nM,4.863279432843593
CHEMBL4564393,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (unknown origin) by preincubated for 30 mins before substrate addition and measured after 60 mins by IMAP TR-FRET phosphodiesterase evaluation assay,COc1ccc(C2(c3ccc(OC)cc3)c3cc(O)ccc3-c3ccc(C)c(C#Cc4ccc(O)cc4)c32)cc1,IC50,24600.0,nM,4.609064892896621
CHEMBL4434820,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (unknown origin) by preincubated for 30 mins before substrate addition and measured after 60 mins by IMAP TR-FRET phosphodiesterase evaluation assay,COCc1ccc2c(c1C#Cc1ccc(O)cc1)C(c1ccc(OC)cc1)(c1ccc(OC)cc1)c1cc(O)ccc1-2,IC50,2800.0,nM,5.552841968657781
CHEMBL4455061,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (unknown origin) by preincubated for 30 mins before substrate addition and measured after 60 mins by IMAP TR-FRET phosphodiesterase evaluation assay,COc1ccc(C2(c3ccc(OC)cc3)c3cc(O)ccc3-c3ccc(CO)c(C#Cc4ccc(O)cc4)c32)cc1,IC50,5400.0,nM,5.267606240177031
CHEMBL4467092,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (unknown origin) by preincubated for 30 mins before substrate addition and measured after 60 mins by IMAP TR-FRET phosphodiesterase evaluation assay,COCc1ccc2c(c1C#Cc1ccc(O)cc1)C(c1ccc(O)cc1)(c1ccc(O)cc1)c1cc(O)ccc1-2,IC50,23200.0,nM,4.634512015109101
CHEMBL4567635,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (unknown origin) by preincubated for 30 mins before substrate addition and measured after 60 mins by IMAP TR-FRET phosphodiesterase evaluation assay,COCc1cc(O)c2c(c1C#Cc1ccc(O)cc1)C(c1ccc(O)cc1)(c1ccc(O)cc1)c1cc(O)ccc1-2,IC50,29500.0,nM,4.530177984021837
CHEMBL4529248,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (unknown origin) by preincubated for 30 mins before substrate addition and measured after 60 mins by IMAP TR-FRET phosphodiesterase evaluation assay,COc1ccc([C@@]2(c3ccc(O)cc3)c3cc(O)ccc3-c3ccc(C)c(C#Cc4ccc(O)cc4)c32)cc1,IC50,19500.0,nM,4.709965388637482
CHEMBL4443860,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (unknown origin) by preincubated for 30 mins before substrate addition and measured after 60 mins by IMAP TR-FRET phosphodiesterase evaluation assay,COc1ccc([C@@]2(c3ccc(O)cc3)c3cc(O)ccc3-c3ccc(CO)c(C#Cc4ccc(O)cc4)c32)cc1,IC50,32100.0,nM,4.493494967595128
CHEMBL4554204,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (unknown origin) by preincubated for 30 mins before substrate addition and measured after 60 mins by IMAP TR-FRET phosphodiesterase evaluation assay,COCc1ccc2c(c1C#Cc1ccc(O)cc1)[C@](c1ccc(O)cc1)(c1ccc(OC)cc1)c1cc(O)ccc1-2,IC50,33800.0,nM,4.471083299722345
CHEMBL4545044,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D2 using [3H]cAMP as substrate measured after 20 mins by scintillation counting analysis,CCn1cnc2c(-c3ccc(F)c(-c4cc5c(cc4OC)C(=O)N(C)C5)c3)cnnc21,IC50,6600.0,nM,5.180456064458131
CHEMBL4518369,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),C[C@@H]1COCCN1c1nc(N2CCOC[C@@H]2C)nc2sc(-c3cc[nH]n3)nc12,IC50,210.0,nM,6.6777807052660805
CHEMBL4538132,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli BL21 codonplus cells using [3H]cAMP as substrate preincubated for 15 mins followed by substrate addition by liquid scintillation counting method,CCn1ncc2c(NC3CCCCC3)c(C(=O)NCCNc3c4c(nc5ccccc35)CCCC4)cnc21,IC50,41.0,nM,7.3872161432802645
CHEMBL4466312,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli BL21 codonplus cells using [3H]cAMP as substrate preincubated for 15 mins followed by substrate addition by liquid scintillation counting method,CCn1ncc2c(NC3CCCCC3)c(C(=O)NCCCCNc3c4c(nc5ccccc35)CCCC4)cnc21,IC50,108.0,nM,6.96657624451305
CHEMBL4576029,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli BL21 codonplus cells using [3H]cAMP as substrate preincubated for 15 mins followed by substrate addition by liquid scintillation counting method,CCn1ncc2c(NC3CCCCC3)c(C(=O)NCCCCCNc3c4c(nc5ccccc35)CCCC4)cnc21,IC50,477.0,nM,6.3214816209598865
CHEMBL4582090,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli BL21 codonplus cells using [3H]cAMP as substrate preincubated for 15 mins followed by substrate addition by liquid scintillation counting method,CCn1ncc2c(NC3CCCCC3)c(C(=O)NCCCCCCNc3c4c(nc5ccccc35)CCCC4)cnc21,IC50,501.0,nM,6.300162274132754
CHEMBL4543665,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli BL21 codonplus cells using [3H]cAMP as substrate preincubated for 15 mins followed by substrate addition by liquid scintillation counting method,CCn1ncc2c(NC3CCCCC3)c(C(=O)NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cnc21,IC50,1071.0,nM,5.970210529168144
CHEMBL4445394,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli BL21 codonplus cells using [3H]cAMP as substrate preincubated for 15 mins followed by substrate addition by liquid scintillation counting method,CCn1ncc2c(NC3CCCCC3)c(C(=O)NCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cnc21,IC50,1307.0,nM,5.883724412419456
CHEMBL4577198,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli BL21 codonplus cells using [3H]cAMP as substrate preincubated for 15 mins followed by substrate addition by liquid scintillation counting method,CCn1ncc2c(NC3CCCCC3)c(C(=O)NCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)cnc21,IC50,25.0,nM,7.6020599913279625
CHEMBL4454965,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli BL21 codonplus cells using [3H]cAMP as substrate preincubated for 15 mins followed by substrate addition by liquid scintillation counting method,CCn1ncc2c(NC3CCCCC3)c(C(=O)NCCCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)cnc21,IC50,87.0,nM,7.060480747381382
CHEMBL4589577,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli BL21 codonplus cells using [3H]cAMP as substrate preincubated for 15 mins followed by substrate addition by liquid scintillation counting method,CCn1ncc2c(NC3CCCCC3)c(C(=O)NCCCCCNc3c4c(nc5ccc(Cl)cc35)CCCC4)cnc21,IC50,308.0,nM,6.511449283499555
CHEMBL4549577,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli BL21 codonplus cells using [3H]cAMP as substrate preincubated for 15 mins followed by substrate addition by liquid scintillation counting method,CCn1ncc2c(NC3CCCCC3)c(C(=O)NCCCCCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)cnc21,IC50,271.0,nM,6.567030709125595
CHEMBL4469202,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli BL21 codonplus cells using [3H]cAMP as substrate preincubated for 15 mins followed by substrate addition by liquid scintillation counting method,CCn1ncc2c(NC3CCCCC3)c(C(=O)NCCCCCCCNc3c4c(nc5ccc(Cl)cc35)CCCC4)cnc21,IC50,934.0,nM,6.029653123769906
CHEMBL4443780,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli BL21 codonplus cells using [3H]cAMP as substrate preincubated for 15 mins followed by substrate addition by liquid scintillation counting method,CCn1ncc2c(NC3CCCCC3)c(C(=O)NCCCCCCCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)cnc21,IC50,1077.0,nM,5.9677842967020185
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli BL21 codonplus cells using [3H]cAMP as substrate preincubated for 15 mins followed by substrate addition by liquid scintillation counting method,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,671.0,nM,6.1732774798310075
CHEMBL514800,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC,IC50,33.0,nM,7.481486060122112
CHEMBL193240,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,IC50,0.2,nM,9.698970004336019
CHEMBL4592339,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D catalytic domain using [3H]cAMP as substrate measured after 30 mins by scintillation proximity assay,COc1cc2c(cc1OC)[C@H](CCc1c[nH]c3cc(F)ccc13)N(C=O)CC2,IC50,250.0,nM,6.6020599913279625
CHEMBL4527894,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D catalytic domain using [3H]cAMP as substrate measured after 30 mins by scintillation proximity assay,COc1cc2c(cc1OC)[C@H](CCc1c[nH]c3cc(C)ccc13)N(C=O)CC2,IC50,240.0,nM,6.619788758288394
CHEMBL4532140,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D catalytic domain using [3H]cAMP as substrate measured after 30 mins by scintillation proximity assay,CCOc1cc2c(cc1OC)CCN(C=O)[C@H]2CCc1c[nH]c2cc(C)ccc12,IC50,98.0,nM,7.008773924307505
CHEMBL4443701,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D catalytic domain using [3H]cAMP as substrate measured after 30 mins by scintillation proximity assay,COc1cc2c(cc1OCC1CC1)[C@H](CCc1c[nH]c3cc(C)ccc13)N(C=O)CC2,IC50,700.0,nM,6.154901959985743
CHEMBL4543264,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D catalytic domain using [3H]cAMP as substrate measured after 30 mins by scintillation proximity assay,CCOc1cc2c(cc1OC)CCN(C=O)[C@H]2CCc1c[nH]c2ccccc12,IC50,130.0,nM,6.886056647693163
CHEMBL4536368,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D catalytic domain using [3H]cAMP as substrate measured after 30 mins by scintillation proximity assay,COc1cc2c(cc1OCC1CC1)[C@H](CCc1c[nH]c3ccccc13)N(C=O)CC2,IC50,820.0,nM,6.086186147616283
CHEMBL4556365,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D catalytic domain using [3H]cAMP as substrate measured after 30 mins by scintillation proximity assay,COc1cc2c(cc1OC)C(CCc1c[nH]c3ccccc13)N(C=O)CC2,IC50,510.0,nM,6.292429823902063
CHEMBL4520636,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D catalytic domain using [3H]cAMP as substrate measured after 30 mins by scintillation proximity assay,COc1cc2c(cc1OC)[C@H](CCc1c[nH]c3ccccc13)N(C=O)CC2,IC50,270.0,nM,6.568636235841012
CHEMBL4455732,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D catalytic domain using [3H]cAMP as substrate measured after 30 mins by scintillation proximity assay,COc1cc2c(cc1OC)CN(C=O)CC2,IC50,58500.0,nM,4.232844133917819
CHEMBL4440925,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D catalytic domain using [3H]cAMP as substrate measured after 30 mins by scintillation proximity assay,CCOc1cc2c(cc1OC)CCN(C=O)C2,IC50,20700.0,nM,4.684029654543083
CHEMBL4525913,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D catalytic domain using [3H]cAMP as substrate measured after 30 mins by scintillation proximity assay,CCOc1cc2c(cc1OC)CN(C=O)CC2,IC50,26100.0,nM,4.583359492661719
CHEMBL4466435,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D catalytic domain using [3H]cAMP as substrate measured after 30 mins by scintillation proximity assay,COc1cc2c(cc1OC)[C@H](Cc1c[nH]c3ccccc13)N(C=O)CC2,IC50,650.0,nM,6.187086643357144
CHEMBL4572934,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D catalytic domain using [3H]cAMP as substrate measured after 30 mins by scintillation proximity assay,COc1cc2c(cc1OC)[C@H](CCCc1c[nH]c3ccccc13)N(C=O)CC2,IC50,4300.0,nM,5.366531544420413
CHEMBL4445498,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D catalytic domain using [3H]cAMP as substrate measured after 30 mins by scintillation proximity assay,COc1cc2c(cc1OC)[C@@H](CCc1c[nH]c3ccccc13)N(C=O)CC2,IC50,3710.0,nM,5.430626090384954
CHEMBL514800,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin) using cAMP as substrate,CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC,IC50,74.0,nM,7.130768280269024
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin) using cAMP as substrate,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,240.0,nM,6.619788758288394
CHEMBL511115,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin) using cAMP as substrate,COc1ccc([C@]2(C#N)CC[C@@H](C(=O)O)CC2)cc1OC1CCCC1,IC50,120.0,nM,6.920818753952375
CHEMBL193240,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin) using cAMP as substrate,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,IC50,0.4,nM,9.397940008672037
CHEMBL561643,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) expressed in Escherichia coli BL21 codon-plus cells using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation counting method,COc1c(O)cc2oc3cc4c(c(O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,420.0,nM,6.376750709602099
CHEMBL514800,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (unknown origin),CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC,IC50,540.0,nM,6.267606240177031
CHEMBL193240,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (unknown origin),O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,IC50,0.4,nM,9.397940008672037
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) expressed in Escherichia coli BL21 codon-plus cells using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation counting method,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,540.0,nM,6.267606240177031
CHEMBL4434646,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) expressed in Escherichia coli BL21 codon-plus cells using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation counting method,COc1c(OCC(=O)O)cc2oc3cc4c(c(O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,480.0,nM,6.318758762624412
CHEMBL4529685,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) expressed in Escherichia coli BL21 codon-plus cells using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation counting method,COc1c(OCCCC(=O)O)cc2oc3cc4c(c(O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,44.0,nM,7.356547323513812
CHEMBL4567905,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) expressed in Escherichia coli BL21 codon-plus cells using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation counting method,COc1c(OCCCCC(=O)O)cc2oc3cc4c(c(O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,99.0,nM,7.00436480540245
CHEMBL4473291,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) expressed in Escherichia coli BL21 codon-plus cells using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation counting method,COc1c(OCCCCCC(=O)O)cc2oc3cc4c(c(O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,76.0,nM,7.119186407719209
CHEMBL4471352,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) expressed in Escherichia coli BL21 codon-plus cells using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation counting method,COc1c(OCCCCCCC(=O)O)cc2oc3cc4c(c(O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,17.0,nM,7.769551078621726
CHEMBL4453774,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) expressed in Escherichia coli BL21 codon-plus cells using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation counting method,COc1c(OCCCCCCCC(=O)O)cc2oc3cc4c(c(O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,16.0,nM,7.795880017344075
CHEMBL4435746,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) expressed in Escherichia coli BL21 codon-plus cells using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation counting method,COc1c(OCCCCCCCCC(=O)O)cc2oc3cc4c(c(O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,58.0,nM,7.236572006437063
CHEMBL4524406,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) expressed in Escherichia coli BL21 codon-plus cells using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation counting method,COc1c(OCCCCN2CCCC2)cc2oc3cc4c(c(O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,622.0,nM,6.206209615309181
CHEMBL4563050,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) expressed in Escherichia coli BL21 codon-plus cells using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation counting method,COc1c(OCCCCCN2CCCC2)cc2oc3cc4c(c(O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,200.0,nM,6.698970004336019
CHEMBL4515248,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) expressed in Escherichia coli BL21 codon-plus cells using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation counting method,COc1c(OCCCCCCN2CCCC2)cc2oc3cc4c(c(O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,99.0,nM,7.00436480540245
CHEMBL323197,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) expressed in Escherichia coli BL21 codon-plus cells using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation counting method,COc1c(O)cc2oc3cc(O)c(CC=C(C)C)c(O)c3c(=O)c2c1CC=C(C)C,IC50,1310.0,nM,5.882728704344236
CHEMBL4536071,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) expressed in Escherichia coli BL21 codon-plus cells using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation counting method,COc1c(OCCCCCCCN2CCCC2)cc2oc3cc4c(c(O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,148.0,nM,6.8297382846050425
CHEMBL4537678,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human His-Tb fused PDE4D2 (86 to 413 residues) expressed in Escherichia coli using [3H]cAMP as substrate preincubated for 10 mins followed by [3H]cAMP addition and measured after 1 hr by scintillation proximity assay,CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1C(N)=O,IC50,10400.0,nM,4.982966660701219
CHEMBL4583948,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human His-Tb fused PDE4D2 (86 to 413 residues) expressed in Escherichia coli using [3H]cAMP as substrate preincubated for 10 mins followed by [3H]cAMP addition and measured after 1 hr by scintillation proximity assay,CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1,IC50,4500.0,nM,5.346787486224656
CHEMBL4460194,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human His-Tb fused PDE4D2 (86 to 413 residues) expressed in Escherichia coli using [3H]cAMP as substrate preincubated for 10 mins followed by [3H]cAMP addition and measured after 1 hr by scintillation proximity assay,CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1OC,IC50,9200.0,nM,5.036212172654444
CHEMBL4476830,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human His-Tb fused PDE4D2 (86 to 413 residues) expressed in Escherichia coli using [3H]cAMP as substrate preincubated for 10 mins followed by [3H]cAMP addition and measured after 1 hr by scintillation proximity assay,CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccc(F)c(F)c1OC,IC50,7400.0,nM,5.130768280269024
CHEMBL4526283,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human His-Tb fused PDE4D2 (86 to 413 residues) expressed in Escherichia coli using [3H]cAMP as substrate preincubated for 10 mins followed by [3H]cAMP addition and measured after 1 hr by scintillation proximity assay,CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1S(C)(=O)=O,IC50,4200.0,nM,5.376750709602099
CHEMBL4453827,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human His-Tb fused PDE4D2 (86 to 413 residues) expressed in Escherichia coli using [3H]cAMP as substrate preincubated for 10 mins followed by [3H]cAMP addition and measured after 1 hr by scintillation proximity assay,CCS(=O)(=O)c1ccccc1Nc1cc(Nc2ccc(F)cn2)ncc1C(=O)NC,IC50,4600.0,nM,5.337242168318426
CHEMBL4469812,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human His-Tb fused PDE4D2 (86 to 413 residues) expressed in Escherichia coli using [3H]cAMP as substrate preincubated for 10 mins followed by [3H]cAMP addition and measured after 1 hr by scintillation proximity assay,CNC(=O)c1cnc(Nc2ccc(F)cn2)cc1Nc1ccccc1SC,IC50,4400.0,nM,5.356547323513812
CHEMBL511115,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using [3H]-cAMP or [3H]-cGMP incubated for 30 mins by scintillation counting method,COc1ccc([C@]2(C#N)CC[C@@H](C(=O)O)CC2)cc1OC1CCCC1,IC50,11.0,nM,7.958607314841775
CHEMBL404216,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using [3H]-cAMP or [3H]-cGMP incubated for 30 mins by scintillation counting method,CCC1C(C)=NN=C(c2ccc(OC)c(OC)c2)c2cc(OC)c(OC)cc21,IC50,900.0,nM,6.045757490560675
CHEMBL4568146,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using [3H]-cAMP or [3H]-cGMP incubated for 30 mins by scintillation counting method,O=C(Nc1c(Cl)cncc1Cl)C(=O)c1cn(Cc2ccc(F)cc2)c2ncccc12,IC50,3.5,nM,8.455931955649724
CHEMBL323312,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using [3H]-cAMP or [3H]-cGMP incubated for 30 mins by scintillation counting method,Cc1c[n+]([O-])ccc1CC(c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1)c1ccc(OC(F)F)c(OC(F)F)c1,IC50,2.4,nM,8.619788758288394
CHEMBL332750,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using [3H]-cAMP or [3H]-cGMP incubated for 30 mins by scintillation counting method,CCOc1ccc(-c2nc(-c3cccc(C(=O)O)n3)cs2)cc1OCC,IC50,70.0,nM,7.154901959985743
CHEMBL4474098,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using [3H]-cAMP or [3H]-cGMP incubated for 30 mins by scintillation counting method,COc1ccc([C@H](Cc2ccncc2)c2ccccc2)cc1OC1CCCC1.Cl,IC50,2.1,nM,8.67778070526608
CHEMBL313842,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using [3H]-cAMP or [3H]-cGMP incubated for 30 mins by scintillation counting method,COc1cc(-c2ccc(=O)[nH]n2)ccc1OC(F)F,IC50,390.0,nM,6.4089353929735005
CHEMBL2104505,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using [3H]-cAMP or [3H]-cGMP incubated for 30 mins by scintillation counting method,COc1cc2c(cc1OC)[C@@H]1CN(C)CC[C@@H]1N=C2c1ccc(NS(=O)(=O)c2ccc(C)cc2)cc1,IC50,30.0,nM,7.522878745280337
CHEMBL4297527,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using [3H]-cAMP or [3H]-cGMP incubated for 30 mins by scintillation counting method,O=C(Nc1c(Cl)c[n+]([O-])cc1Cl)c1ccc(OC(F)F)c2oc3ccncc3c12,IC50,2.7,nM,8.568636235841012
CHEMBL4297520,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using [3H]-cAMP or [3H]-cGMP incubated for 30 mins by scintillation counting method,CS(=O)(=O)Nc1ccc2oc3c(OC(F)F)ccc(C(=O)Nc4c(Cl)cncc4Cl)c3c2c1,IC50,166.0,nM,6.779891911959945
CHEMBL603830,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using [3H]-cAMP or [3H]-cGMP incubated for 30 mins by scintillation counting method,CCCOc1cc([C@]2(C)CNC(=O)O2)ccc1OC,IC50,1100.0,nM,5.958607314841775
CHEMBL362652,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using [3H]-cAMP or [3H]-cGMP incubated for 30 mins by scintillation counting method,CCNc1ncn(Cc2ccc(OC)c(OC3CCCC3)c2)c2nc(C(C)C)nc1-2,IC50,200.0,nM,6.698970004336019
CHEMBL42126,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using [3H]-cAMP or [3H]-cGMP incubated for 30 mins by scintillation counting method,COc1ccc(C(=O)Nc2c(Cl)cncc2Cl)cc1OC1CCCC1,IC50,0.02,nM,10.698970004336019
CHEMBL590754,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using [3H]-cAMP or [3H]-cGMP incubated for 30 mins by scintillation counting method,COc1ccc(/C(C)=N/OC(N)=O)cc1OC1CCCC1,IC50,1000.0,nM,6.0
CHEMBL193240,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using [3H]-cAMP or [3H]-cGMP incubated for 30 mins by scintillation counting method,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,IC50,0.68,nM,9.167491087293763
CHEMBL193240,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) catalytic domain using [3H]-cAMP as substrate after 15 mins by liquid scintillation counting method,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,IC50,480.0,nM,6.318758762624412
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) catalytic domain using [3H]-cAMP as substrate after 15 mins by liquid scintillation counting method,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,621.0,nM,6.20690839982342
CHEMBL4588860,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) catalytic domain using [3H]-cAMP as substrate after 15 mins by liquid scintillation counting method,O=C(Nc1ccc2cccc(O)c2n1)c1ccc(OC(F)F)c(OCC2CC2)c1,IC50,4060.0,nM,5.391473966422806
CHEMBL4440713,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) catalytic domain using [3H]-cAMP as substrate after 15 mins by liquid scintillation counting method,COc1ccc(C(=O)Nc2ccc3cccc(O)c3n2)cc1OC1CCCC1,IC50,4640.0,nM,5.333482019445119
CHEMBL4593431,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) catalytic domain using [3H]-cAMP as substrate after 15 mins by liquid scintillation counting method,COc1ccc(NC(=O)c2ccc3c(Cl)cc(Cl)c(O)c3n2)cc1OC1CCCC1,IC50,6780.0,nM,5.168770306132936
CHEMBL4475112,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) catalytic domain using [3H]-cAMP as substrate after 15 mins by liquid scintillation counting method,COc1ccc(NC(=O)c2ccc3cccc(O)c3n2)cc1OC1CCCC1,IC50,4150.0,nM,5.3819519032879075
CHEMBL4460271,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) catalytic domain using [3H]-cAMP as substrate after 15 mins by liquid scintillation counting method,COc1ccc(NC(=O)c2ccc3c(Cl)cc(Cl)c(O)c3n2)cc1OC,IC50,8070.0,nM,5.09312646527793
CHEMBL4568492,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) catalytic domain using [3H]-cAMP as substrate after 15 mins by liquid scintillation counting method,COc1ccc(NC(=O)c2ccc3cccc(O)c3n2)cc1OC,IC50,4320.0,nM,5.364516253185088
CHEMBL4434751,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) catalytic domain using [3H]-cAMP as substrate after 15 mins by liquid scintillation counting method,Cl.O=C(Nc1cc(I)c(O)c2ncccc12)c1ccc(OC(F)F)c(OCC2CC2)c1,IC50,426.0,nM,6.370590400897282
CHEMBL4464327,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) catalytic domain using [3H]-cAMP as substrate after 15 mins by liquid scintillation counting method,Cl.O=C(Nc1cc(Cl)c(O)c2ncccc12)c1ccc(OC(F)F)c(OCC2CC2)c1,IC50,3830.0,nM,5.416801226031377
CHEMBL4447509,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) catalytic domain using [3H]-cAMP as substrate after 15 mins by liquid scintillation counting method,Cl.O=C(Nc1ccc(O)c2ncccc12)c1ccc(OC(F)F)c(OCC2CC2)c1,IC50,399.0,nM,6.399027104313252
CHEMBL4445263,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) catalytic domain using [3H]-cAMP as substrate after 15 mins by liquid scintillation counting method,COc1ccc(C(=O)Nc2cc(I)c(O)c3ncccc23)cc1OC1CCCC1.Cl,IC50,597.0,nM,6.224025668870631
CHEMBL4556461,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) catalytic domain using [3H]-cAMP as substrate after 15 mins by liquid scintillation counting method,COc1ccc(C(=O)Nc2cc(Cl)c(O)c3ncccc23)cc1OC1CCCC1.Cl,IC50,3130.0,nM,5.504455662453552
CHEMBL4586148,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) catalytic domain using [3H]-cAMP as substrate after 15 mins by liquid scintillation counting method,COc1ccc(C(=O)Nc2ccc(O)c3ncccc23)cc1OC1CCCC1.Cl,IC50,492.0,nM,6.308034897232639
CHEMBL4456168,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) catalytic domain using [3H]-cAMP as substrate after 15 mins by liquid scintillation counting method,COc1ccc(C(=O)Nc2cc(I)c(O)c3ncccc23)cc1OC.Cl,IC50,7360.0,nM,5.133122185662501
CHEMBL4455866,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 (86 to 413 residues) catalytic domain using [3H]-cAMP as substrate after 15 mins by liquid scintillation counting method,COc1ccc(C(=O)Nc2ccc(O)c3ncccc23)cc1OC.Cl,IC50,7630.0,nM,5.117475462045119
CHEMBL19224,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC,IC50,1400.0,nM,5.853871964321762
CHEMBL4534321,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),CC(=O)Nc1cccc(-c2ccn(C(Cc3cc[n+]([O-])cc3)c3ccc(OC(F)F)c(OCC4CC4)c3)n2)c1,IC50,0.5,nM,9.301029995663981
CHEMBL275084,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),CC(C)Cn1c(=O)n(C)c(=O)c2nc[nH]c21,IC50,31000.0,nM,4.508638306165727
CHEMBL313842,CHEMBL288,Phosphodiesterase 4D,Inhibition of human GST-tagged PDE4D catalytic domain (183T to 510S residues) expressed in Escherichia coli cells,COc1cc(-c2ccc(=O)[nH]n2)ccc1OC(F)F,IC50,160.0,nM,6.795880017344075
CHEMBL430893,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (79 to 438 residues) Escherichia coli BL21-CodonPlus(DE3) cells,COc1ccc([C@@H]2CNC(=O)C2)cc1OC1CCCC1,IC50,231.0,nM,6.636388020107855
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (79 to 438 residues) Escherichia coli BL21-CodonPlus(DE3) cells,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,550.0,nM,6.259637310505756
CHEMBL1229585,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (79 to 438 residues) Escherichia coli BL21-CodonPlus(DE3) cells,CCCCOc1cc(C[C@@H]2CNC(=O)N2)ccc1OC,IC50,631.0,nM,6.199970640755866
CHEMBL1230397,CHEMBL288,Phosphodiesterase 4D,Inhibition of human His-tagged PDE4D catalytic domain expressed in Escherichia coli BL21-CodonPlus(DE3) cells using [3H]cAMP or [3H]cGMP as substrate incubated for 30 mins by scintillation counting method,CCOC(=O)c1c(C)nn(-c2ccc(N)cc2)c1C,IC50,160.0,nM,6.795880017344075
CHEMBL1230268,CHEMBL288,Phosphodiesterase 4D,Inhibition of human His-tagged PDE4D catalytic domain expressed in Escherichia coli BL21-CodonPlus(DE3) cells using [3H]cAMP or [3H]cGMP as substrate incubated for 30 mins by scintillation counting method,CCOC(=O)c1c(C)nn(-c2ccc(OC)cc2)c1C,IC50,2000.0,nM,5.698970004336019
CHEMBL1794670,CHEMBL288,Phosphodiesterase 4D,Inhibition of human His-tagged PDE4D catalytic domain expressed in Escherichia coli BL21-CodonPlus(DE3) cells using [3H]cAMP or [3H]cGMP as substrate incubated for 30 mins by scintillation counting method,CCOC(=O)c1c(C)nn(-c2ccccc2)c1C,IC50,270.0,nM,6.568636235841012
CHEMBL506972,CHEMBL288,Phosphodiesterase 4D,Inhibition of human His-tagged PDE4D catalytic domain expressed in Escherichia coli BL21-CodonPlus(DE3) cells using [3H]cAMP or [3H]cGMP as substrate incubated for 30 mins by scintillation counting method,CCOC(=O)c1c(C)n[nH]c1C,IC50,82000.0,nM,4.086186147616283
CHEMBL313842,CHEMBL288,Phosphodiesterase 4D,Inhibition of human His-tagged PDE4D catalytic domain expressed in Escherichia coli BL21-CodonPlus(DE3) cells using [3H]cAMP or [3H]cGMP as substrate incubated for 30 mins by scintillation counting method,COc1cc(-c2ccc(=O)[nH]n2)ccc1OC(F)F,IC50,390.0,nM,6.4089353929735005
CHEMBL1230564,CHEMBL288,Phosphodiesterase 4D,Inhibition of human His-tagged PDE4D catalytic domain expressed in Escherichia coli BL21-CodonPlus(DE3) cells using [3H]cAMP or [3H]cGMP as substrate incubated for 30 mins by scintillation counting method,CCOC(=O)c1c(C)nn(-c2cccc([N+](=O)[O-])c2)c1C,IC50,21.0,nM,7.6777807052660805
CHEMBL193240,CHEMBL288,Phosphodiesterase 4D,Inhibition of human His-tagged PDE4D catalytic domain expressed in Escherichia coli BL21-CodonPlus(DE3) cells using [3H]cAMP or [3H]cGMP as substrate incubated for 30 mins by scintillation counting method,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,IC50,0.68,nM,9.167491087293763
CHEMBL42126,CHEMBL288,Phosphodiesterase 4D,Inhibition of human His-tagged PDE4D catalytic domain expressed in Escherichia coli BL21-CodonPlus(DE3) cells using [3H]cAMP or [3H]cGMP as substrate incubated for 30 mins by scintillation counting method,COc1ccc(C(=O)Nc2c(Cl)cncc2Cl)cc1OC1CCCC1,IC50,0.021,nM,10.67778070526608
CHEMBL511115,CHEMBL288,Phosphodiesterase 4D,Inhibition of human His-tagged PDE4D catalytic domain expressed in Escherichia coli BL21-CodonPlus(DE3) cells using [3H]cAMP or [3H]cGMP as substrate incubated for 30 mins by scintillation counting method,COc1ccc([C@]2(C#N)CC[C@@H](C(=O)O)CC2)cc1OC1CCCC1,IC50,11.0,nM,7.958607314841775
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human His-tagged PDE4D catalytic domain expressed in Escherichia coli BL21-CodonPlus(DE3) cells using [3H]cAMP or [3H]cGMP as substrate incubated for 30 mins by scintillation counting method,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,550.0,nM,6.259637310505756
CHEMBL74078,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli BL21-CodonPlus(DE3) cells using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation counting method,O=C(O)c1ccc(-c2cc3cccnc3c(-c3cccc([N+](=O)[O-])c3)n2)cc1,IC50,570.0,nM,6.2441251443275085
CHEMBL3919436,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,O=C(O)c1ccc(-c2c(/C=C/c3ccc4ccccc4n3)nc3c(N4CCOCC4)ccnn23)cc1,IC50,4000.0,nM,5.3979400086720375
CHEMBL4647105,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain (86 to 413 residues) expressed in Escherichia coli BL21 (DE3) cells using [3H]cAMP as substrate measured after 30 mins by scintillation proximity assay,CC(C)C1=CC[C@H]2C(=CC[C@@H]3[C@]2(C)CCC[C@@]3(C)C(=O)O)C1=O,IC50,2800.0,nM,5.552841968657781
CHEMBL3590338,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain (86 to 413 residues) expressed in Escherichia coli BL21 (DE3) cells using [3H]cAMP as substrate measured after 30 mins by scintillation proximity assay,C=C(C)c1ccc2c(c1)CC[C@H]1[C@](C)(C(=O)O)CCC[C@]21C,IC50,3300.0,nM,5.481486060122112
CHEMBL514800,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain (86 to 413 residues) expressed in Escherichia coli BL21 (DE3) cells using [3H]cAMP as substrate measured after 30 mins by scintillation proximity assay,CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC,IC50,47.6,nM,7.3223930472795065
CHEMBL4644729,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) using [3H]-cAMP substrate incubated for 15 mins by liquid scintillation counting method relative to control,C[C@@H](Nc1nc2c(cnn2C(C)(C)C)c(=O)n1Cc1ccc(F)cc1)c1ccc(Cl)cc1,IC50,699.0,nM,6.1555228242543185
CHEMBL4643449,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),CC(C)c1cc(COc2ccccc2CC(=O)O)cc(-c2ccc3c(c2)[C@H](N)CO3)c1,IC50,7200.0,nM,5.142667503568731
CHEMBL4637027,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),CC(C)c1cc(-c2ccc3c(c2)[C@H](N)CO3)cc([C@H](O)Cn2ccc3cccc(C(=O)O)c32)c1,IC50,2400.0,nM,5.619788758288394
CHEMBL4755779,CHEMBL288,Phosphodiesterase 4D,Inhibition of 6xHis-tagged human recombinant PDE4D3 expressed in Sf9 cells by scintillation counting method,O=C(c1cc2c(s1)CCCC2)N1CCCC(c2cc(C(F)F)nc3ncnn23)C1,IC50,6460.0,nM,5.189767482004916
CHEMBL4792140,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc(C(=O)O)c(CO)c2)n2nc(C3(C(=O)NCC(C)C)CC3)nc12,IC50,9.0,nM,8.045757490560675
CHEMBL4743334,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc(C(=O)O)c(CO)c2)n2nc(C3CC3)nc12,IC50,340.0,nM,6.468521082957745
CHEMBL4744621,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc(C(=O)O)cc2)n2nc(C3(C(=O)NCC(C)C)CC3)nc12,IC50,7.0,nM,8.154901959985743
CHEMBL4760414,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc(C(=O)O)cc2)n2nc(C3CC3)nc12,IC50,100.0,nM,7.0
CHEMBL4797163,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2cccc(C(=O)O)c2CO)n2nc(C3CC3)nc12,IC50,7100.0,nM,5.1487416512809245
CHEMBL4789407,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2cccc(C(=O)O)c2)n2nc(C3(C(=O)NCC(C)C)CC3)nc12,IC50,100.0,nM,7.0
CHEMBL4748344,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2cccc(C(=O)O)c2)n2nc(C3CC3)nc12,IC50,600.0,nM,6.221848749616356
CHEMBL4789429,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc(C(=O)O)c(CO)c2)n2nc(C3(C(=O)O)CC3)nc12,IC50,9000.0,nM,5.045757490560675
CHEMBL4794426,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)O)CC3)nc12,IC50,21000.0,nM,4.6777807052660805
CHEMBL4750770,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc(C(=O)O)c(CO)c2)n2nc(C3(C(=O)OCC(C)C)CC3)nc12,IC50,150.0,nM,6.823908740944319
CHEMBL4791500,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OC[C@@H](C)CO)CC3)nc12,IC50,17.0,nM,7.769551078621726
CHEMBL4792758,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OC[C@H](C)CO)CC3)nc12,IC50,18.0,nM,7.7447274948966935
CHEMBL4760404,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OCC(C)(C)O)CC3)nc12,IC50,15.0,nM,7.823908740944319
CHEMBL4757090,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OC4CCOCC4)CC3)nc12,IC50,12.0,nM,7.920818753952375
CHEMBL4782606,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)O[C@H]4CCOC4)CC3)nc12,IC50,12.0,nM,7.920818753952375
CHEMBL4745639,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)O[C@@H]4CCOC4)CC3)nc12,IC50,18.0,nM,7.7447274948966935
CHEMBL4753567,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OC4COC4)CC3)nc12,IC50,37.0,nM,7.431798275933005
CHEMBL4750576,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OC4CCCCCC4)CC3)nc12,IC50,2.5,nM,8.602059991327963
CHEMBL4740828,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OC4CCCCC4)CC3)nc12,IC50,2.0,nM,8.698970004336019
CHEMBL4740242,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OC4CCCC4)CC3)nc12,IC50,2.5,nM,8.602059991327963
CHEMBL4745874,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OC4CCC4)CC3)nc12,IC50,8.0,nM,8.096910013008056
CHEMBL4753953,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,CCCCOC(=O)C1(c2nc3c(OC)ccc(-c4ccc5c(c4)COC5=O)n3n2)CC1,IC50,9.0,nM,8.045757490560675
CHEMBL4747201,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OCC(C)C)CC3)nc12,IC50,3.8,nM,8.42021640338319
CHEMBL4764289,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,CC[C@H](C)OC(=O)C1(c2nc3c(OC)ccc(-c4ccc5c(c4)COC5=O)n3n2)CC1,IC50,5.7,nM,8.244125144327509
CHEMBL4739987,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,CC[C@@H](C)OC(=O)C1(c2nc3c(OC)ccc(-c4ccc5c(c4)COC5=O)n3n2)CC1,IC50,4.5,nM,8.346787486224656
CHEMBL4761069,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OC(C)(C)C)CC3)nc12,IC50,8.0,nM,8.096910013008056
CHEMBL4753380,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OC(C)C)CC3)nc12,IC50,14.0,nM,7.853871964321762
CHEMBL4759431,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,CCCOC(=O)C1(c2nc3c(OC)ccc(-c4ccc5c(c4)COC5=O)n3n2)CC1,IC50,13.0,nM,7.886056647693163
CHEMBL4746850,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,CCOC(=O)C1(c2nc3c(OC)ccc(-c4ccc5c(c4)COC5=O)n3n2)CC1,IC50,70.0,nM,7.154901959985743
CHEMBL4741618,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COC(=O)C1(c2nc3c(OC)ccc(-c4ccc5c(c4)COC5=O)n3n2)CC1,IC50,170.0,nM,6.769551078621726
CHEMBL4742661,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2cccc(C#N)c2)n2nc(C3(C(=O)OCC(C)C)CC3)nc12,IC50,17.0,nM,7.769551078621726
CHEMBL4753710,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2cccc(C#N)c2)n2nc(C3(CCC(=O)O)CC3)nc12,IC50,80.0,nM,7.096910013008056
CHEMBL4795307,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2cccc(C#N)c2)n2nc(C3(CC(=O)O)CC3)nc12,IC50,2000.0,nM,5.698970004336019
CHEMBL4791018,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2cccc(C#N)c2)n2nc(C3(C(=O)O)CC3)nc12,IC50,22000.0,nM,4.657577319177793
CHEMBL4741065,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2cccc(C#N)c2)n2nc(C3(COC(=O)C(C)C)CC3)nc12,IC50,5.1,nM,8.292429823902063
CHEMBL4754336,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2cccc(C#N)c2)n2nc(C3(CCCO)CC3)nc12,IC50,42.0,nM,7.376750709602099
CHEMBL4756569,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2cccc(C#N)c2)n2nc(C3(CCO)CC3)nc12,IC50,100.0,nM,7.0
CHEMBL4791895,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2cccc(C#N)c2)n2nc(C3(CO)CC3)nc12,IC50,130.0,nM,6.886056647693163
CHEMBL4784121,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)NCC(C)C)CC3)nc12,IC50,0.8,nM,9.096910013008056
CHEMBL4748609,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3CC3)nc12,IC50,15.0,nM,7.823908740944319
CHEMBL4760926,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COC(=O)c1ccc(-c2ccc(OC)c3nc(C4(C(=O)NCC(C)C)CC4)nn23)cc1,IC50,130.0,nM,6.886056647693163
CHEMBL4791384,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COC(=O)c1ccc(-c2ccc(OC)c3nc(C4CC4)nn23)cc1,IC50,2100.0,nM,5.6777807052660805
CHEMBL4739866,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2cccc3c2COC3=O)n2nc(C3(C(=O)NCC(C)C)CC3)nc12,IC50,210.0,nM,6.6777807052660805
CHEMBL4793156,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2cccc3c2COC3=O)n2nc(C3CC3)nc12,IC50,200.0,nM,6.698970004336019
CHEMBL4795054,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COC(=O)c1cccc(-c2ccc(OC)c3nc(C4(C(=O)NCC(C)C)CC4)nn23)c1,IC50,7.4,nM,8.130768280269024
CHEMBL4755604,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COC(=O)c1cccc(-c2ccc(OC)c3nc(C4CC4)nn23)c1,IC50,110.0,nM,6.958607314841775
CHEMBL4779112,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2cccc(C#N)c2)n2nc(C3(C(=O)NCC(C)C)CC3)nc12,IC50,2.1,nM,8.67778070526608
CHEMBL4748795,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2cccc(C#N)c2)n2nc(C3CC3)nc12,IC50,20.0,nM,7.698970004336019
CHEMBL4781717,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc3c(c2)CCC3=O)n2nc(C3CC3)nc12,IC50,18.0,nM,7.7447274948966935
CHEMBL4761621,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2cccc3c2CCC3=O)n2nc(C3CC3)nc12,IC50,19.0,nM,7.721246399047171
CHEMBL4786389,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc3c(c2)C(=O)CC3)n2nc(C3CC3)nc12,IC50,260.0,nM,6.585026652029182
CHEMBL4795111,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,CCCC(=O)c1ccc(-c2ccc(OC)c3nc(C4CC4)nn23)cc1,IC50,1300.0,nM,5.886056647693163
CHEMBL4745054,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,CCC(=O)c1ccc(-c2ccc(OC)c3nc(C4CC4)nn23)cc1,IC50,1060.0,nM,5.97469413473523
CHEMBL4757295,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccc(C(C)=O)cc2)n2nc(C3CC3)nc12,IC50,220.0,nM,6.657577319177793
CHEMBL4742306,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,CCCC(=O)c1cccc(-c2ccc(OC)c3nc(C4CC4)nn23)c1,IC50,170.0,nM,6.769551078621726
CHEMBL4741545,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,CCC(=O)c1cccc(-c2ccc(OC)c3nc(C4CC4)nn23)c1,IC50,310.0,nM,6.508638306165727
CHEMBL4743465,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2ccccc2)n2nc(C3CC3)nc12,IC50,290.0,nM,6.537602002101044
CHEMBL4796321,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D catalytic domain using cAMP and FAM-conjugated cAMP by IMAP FRET progressive binding assay,COc1ccc(-c2cccc(C(C)=O)c2)n2nc(C3CC3)nc12,IC50,8.0,nM,8.096910013008056
CHEMBL4792140,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc(C(=O)O)c(CO)c2)n2nc(C3(C(=O)NCC(C)C)CC3)nc12,IC50,17.0,nM,7.769551078621726
CHEMBL4743334,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc(C(=O)O)c(CO)c2)n2nc(C3CC3)nc12,IC50,2500.0,nM,5.6020599913279625
CHEMBL4744621,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc(C(=O)O)cc2)n2nc(C3(C(=O)NCC(C)C)CC3)nc12,IC50,34.0,nM,7.468521082957745
CHEMBL4760414,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc(C(=O)O)cc2)n2nc(C3CC3)nc12,IC50,120.0,nM,6.920818753952375
CHEMBL4797163,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2cccc(C(=O)O)c2CO)n2nc(C3CC3)nc12,IC50,3200.0,nM,5.494850021680094
CHEMBL4789407,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2cccc(C(=O)O)c2)n2nc(C3(C(=O)NCC(C)C)CC3)nc12,IC50,770.0,nM,6.113509274827518
CHEMBL4748344,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2cccc(C(=O)O)c2)n2nc(C3CC3)nc12,IC50,1000.0,nM,6.0
CHEMBL4750770,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc(C(=O)O)c(CO)c2)n2nc(C3(C(=O)OCC(C)C)CC3)nc12,IC50,260.0,nM,6.585026652029182
CHEMBL4791500,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OC[C@@H](C)CO)CC3)nc12,IC50,14.0,nM,7.853871964321762
CHEMBL4792758,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OC[C@H](C)CO)CC3)nc12,IC50,15.0,nM,7.823908740944319
CHEMBL4760404,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OCC(C)(C)O)CC3)nc12,IC50,16.0,nM,7.795880017344075
CHEMBL4757090,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OC4CCOCC4)CC3)nc12,IC50,1000.0,nM,6.0
CHEMBL4782606,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)O[C@H]4CCOC4)CC3)nc12,IC50,13.0,nM,7.886056647693163
CHEMBL4745639,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)O[C@@H]4CCOC4)CC3)nc12,IC50,17.0,nM,7.769551078621726
CHEMBL4753567,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OC4COC4)CC3)nc12,IC50,43.0,nM,7.366531544420413
CHEMBL4750576,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OC4CCCCCC4)CC3)nc12,IC50,3.9,nM,8.4089353929735
CHEMBL4740828,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OC4CCCCC4)CC3)nc12,IC50,2.9,nM,8.537602002101044
CHEMBL4740242,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OC4CCCC4)CC3)nc12,IC50,3.4,nM,8.468521082957745
CHEMBL4745874,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OC4CCC4)CC3)nc12,IC50,9.2,nM,8.036212172654444
CHEMBL4753953,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,CCCCOC(=O)C1(c2nc3c(OC)ccc(-c4ccc5c(c4)COC5=O)n3n2)CC1,IC50,12.0,nM,7.920818753952375
CHEMBL4747201,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OCC(C)C)CC3)nc12,IC50,6.0,nM,8.221848749616356
CHEMBL4764289,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,CC[C@H](C)OC(=O)C1(c2nc3c(OC)ccc(-c4ccc5c(c4)COC5=O)n3n2)CC1,IC50,6.4,nM,8.193820026016112
CHEMBL4739987,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,CC[C@@H](C)OC(=O)C1(c2nc3c(OC)ccc(-c4ccc5c(c4)COC5=O)n3n2)CC1,IC50,4.5,nM,8.346787486224656
CHEMBL4761069,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OC(C)(C)C)CC3)nc12,IC50,6.0,nM,8.221848749616356
CHEMBL4753380,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)OC(C)C)CC3)nc12,IC50,12.0,nM,7.920818753952375
CHEMBL4759431,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,CCCOC(=O)C1(c2nc3c(OC)ccc(-c4ccc5c(c4)COC5=O)n3n2)CC1,IC50,12.0,nM,7.920818753952375
CHEMBL4746850,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,CCOC(=O)C1(c2nc3c(OC)ccc(-c4ccc5c(c4)COC5=O)n3n2)CC1,IC50,60.0,nM,7.221848749616356
CHEMBL4741618,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COC(=O)C1(c2nc3c(OC)ccc(-c4ccc5c(c4)COC5=O)n3n2)CC1,IC50,210.0,nM,6.6777807052660805
CHEMBL4742661,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2cccc(C#N)c2)n2nc(C3(C(=O)OCC(C)C)CC3)nc12,IC50,31.0,nM,7.508638306165727
CHEMBL4753710,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2cccc(C#N)c2)n2nc(C3(CCC(=O)O)CC3)nc12,IC50,340.0,nM,6.468521082957745
CHEMBL4795307,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2cccc(C#N)c2)n2nc(C3(CC(=O)O)CC3)nc12,IC50,5100.0,nM,5.292429823902063
CHEMBL4741065,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2cccc(C#N)c2)n2nc(C3(COC(=O)C(C)C)CC3)nc12,IC50,27.0,nM,7.568636235841012
CHEMBL4754336,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2cccc(C#N)c2)n2nc(C3(CCCO)CC3)nc12,IC50,58.0,nM,7.236572006437063
CHEMBL4756569,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2cccc(C#N)c2)n2nc(C3(CCO)CC3)nc12,IC50,100.0,nM,7.0
CHEMBL4791895,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2cccc(C#N)c2)n2nc(C3(CO)CC3)nc12,IC50,400.0,nM,6.3979400086720375
CHEMBL4784121,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3(C(=O)NCC(C)C)CC3)nc12,IC50,0.68,nM,9.167491087293763
CHEMBL4748609,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc3c(c2)COC3=O)n2nc(C3CC3)nc12,IC50,17.0,nM,7.769551078621726
CHEMBL4791384,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COC(=O)c1ccc(-c2ccc(OC)c3nc(C4CC4)nn23)cc1,IC50,50.0,nM,7.301029995663981
CHEMBL4739866,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2cccc3c2COC3=O)n2nc(C3(C(=O)NCC(C)C)CC3)nc12,IC50,24.0,nM,7.619788758288394
CHEMBL4793156,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2cccc3c2COC3=O)n2nc(C3CC3)nc12,IC50,250.0,nM,6.6020599913279625
CHEMBL4795054,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COC(=O)c1cccc(-c2ccc(OC)c3nc(C4(C(=O)NCC(C)C)CC4)nn23)c1,IC50,14.0,nM,7.853871964321762
CHEMBL4755604,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COC(=O)c1cccc(-c2ccc(OC)c3nc(C4CC4)nn23)c1,IC50,140.0,nM,6.853871964321762
CHEMBL4779112,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2cccc(C#N)c2)n2nc(C3(C(=O)NCC(C)C)CC3)nc12,IC50,3.6,nM,8.443697499232712
CHEMBL4748795,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2cccc(C#N)c2)n2nc(C3CC3)nc12,IC50,54.0,nM,7.267606240177031
CHEMBL4781717,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc3c(c2)CCC3=O)n2nc(C3CC3)nc12,IC50,14.0,nM,7.853871964321762
CHEMBL4761621,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2cccc3c2CCC3=O)n2nc(C3CC3)nc12,IC50,36.0,nM,7.443697499232712
CHEMBL4786389,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc3c(c2)C(=O)CC3)n2nc(C3CC3)nc12,IC50,210.0,nM,6.6777807052660805
CHEMBL4795111,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,CCCC(=O)c1ccc(-c2ccc(OC)c3nc(C4CC4)nn23)cc1,IC50,1400.0,nM,5.853871964321762
CHEMBL4745054,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,CCC(=O)c1ccc(-c2ccc(OC)c3nc(C4CC4)nn23)cc1,IC50,1100.0,nM,5.958607314841775
CHEMBL4757295,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccc(C(C)=O)cc2)n2nc(C3CC3)nc12,IC50,170.0,nM,6.769551078621726
CHEMBL4742306,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,CCCC(=O)c1cccc(-c2ccc(OC)c3nc(C4CC4)nn23)c1,IC50,400.0,nM,6.3979400086720375
CHEMBL4741545,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,CCC(=O)c1cccc(-c2ccc(OC)c3nc(C4CC4)nn23)c1,IC50,380.0,nM,6.42021640338319
CHEMBL4796321,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2cccc(C(C)=O)c2)n2nc(C3CC3)nc12,IC50,24.0,nM,7.619788758288394
CHEMBL4743465,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D in human PBMC assessed as reduction in lipopolysaccharide-induced TNFalpha production pre-incubated for 30 mins before LPS stimulation for 18 hrs by AlphaLISA,COc1ccc(-c2ccccc2)n2nc(C3CC3)nc12,IC50,210.0,nM,6.6777807052660805
CHEMBL4762103,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86-413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]-cAMP substrate incubated for 15 mins by liquid scintillation counting method,C[C@@H](c1cc(OCC(F)F)ccn1)n1cnc2c(N)nc(Cl)nc21,IC50,7100.0,nM,5.1487416512809245
CHEMBL4748353,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 using FAM-cAMP as substrate measured after 1 hr by IMAP TR-FRET assay,COc1ccc(CCN(C)S(=O)(=O)c2ccc(-c3ccccc3)cc2)cc1OC,IC50,20800.0,nM,4.681936665037238
CHEMBL4785640,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 using FAM-cAMP as substrate measured after 1 hr by IMAP TR-FRET assay,COc1ccc(CCN(C)S(=O)(=O)c2ccc3ccccc3c2)cc1OC,IC50,35300.0,nM,4.452225294612178
CHEMBL4746166,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 using FAM-cAMP as substrate measured after 1 hr by IMAP TR-FRET assay,COc1ccc(/C=N/N(C)S(=O)(=O)c2cc3c(cc2C)OCO3)cc1OC,IC50,700.0,nM,6.154901959985743
CHEMBL511115,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 using FAM-cAMP as substrate measured after 1 hr by IMAP TR-FRET assay,COc1ccc([C@]2(C#N)CC[C@@H](C(=O)O)CC2)cc1OC1CCCC1,IC50,300.0,nM,6.522878745280337
CHEMBL4762291,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 using FAM-cAMP as substrate measured after 1 hr by IMAP TR-FRET assay,COc1ccc(CCNS(=O)(=O)c2cc3c(cc2C)OCO3)cc1OC,IC50,4700.0,nM,5.327902142064282
CHEMBL193240,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D using [3H]cAMP as substrate preincubated with enzyme for 10 mins followed by substrate addition and measured after 15 mins by SPA bead based scintillation counting analysis,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,IC50,0.13,nM,9.886056647693163
CHEMBL511115,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),COc1ccc([C@]2(C#N)CC[C@@H](C(=O)O)CC2)cc1OC1CCCC1,IC50,13.0,nM,7.886056647693163
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,79.0,nM,7.102372908709558
CHEMBL3182164,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),C[C@@H](Oc1ccc(CNC(=O)c2cccnc2Oc2ccc3c(c2)OCO3)c(F)c1)C(=O)O,IC50,3.0,nM,8.522878745280337
CHEMBL4209111,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),NC(=O)Cc1ccc(Nc2cc(C(F)(F)F)nc(-c3cccc(Cl)c3)n2)cc1,IC50,8.0,nM,8.096910013008056
CHEMBL3585874,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),CC1CN(C(=O)CO/N=C/c2ccc(OC(F)F)c(OC3CCCC3)c2)CC(C)O1,IC50,800.0,nM,6.096910013008056
CHEMBL3113734,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),Cc1ccc(O)c(C(=O)N[C@H]2CC[C@@H](NC(=O)c3cc(F)cnc3Oc3ccc(F)c(F)c3)CC2)c1,IC50,0.38,nM,9.42021640338319
CHEMBL4297287,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 (unknown origin),COc1ccc([C@H]2CNC(=O)[C@H](Cc3cccc(C)c3)C2)cc1OC1CCCC1,IC50,150.0,nM,6.823908740944319
CHEMBL356388,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 (unknown origin),CCOC(=O)c1cnc2c(cnn2CC)c1NN=C(C)C,IC50,390.0,nM,6.4089353929735005
CHEMBL458298,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (1 to 507 residues) (unknown origin) by liquid scintillation counting method,CC(C)CC(=O)c1ccc(OC(F)F)c(OC2CCOC2)c1,IC50,12.0,nM,7.920818753952375
CHEMBL193240,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D by scintillation counting method,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,IC50,0.68,nM,9.167491087293763
CHEMBL42126,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D by scintillation counting method,COc1ccc(C(=O)Nc2c(Cl)cncc2Cl)cc1OC1CCCC1,IC50,0.021,nM,10.67778070526608
CHEMBL4789722,CHEMBL288,Phosphodiesterase 4D,Inhibition of full length human PDE4D2 preincubated for 10 mins followed by cAMP addition and measured after 30 mins by fluorescence method,COc1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)cc4)n2)SCCC3)cc1F,IC50,440.0,nM,6.356547323513812
CHEMBL19449,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D expressed in insect sf9 cells using [3H]-cAMP as substrate,CC(C)C(=O)c1c(C(C)C)nn2ccccc12,IC50,166.0,nM,6.779891911959945
CHEMBL4751199,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D2 catalytic domain (86 to 413 residues) expressed in Escherichia coli BL21 cells using 3H-cGMP or 3H-cAMP as substrate by liquid scintillation counting method,COc1ccc([C@@]2(c3cccc(OC)c3)c3cc(O)ccc3-c3ccc(C=O)c(C#Cc4ccc(O)cc4)c32)cc1,IC50,11.0,nM,7.958607314841775
CHEMBL4764122,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human N-terminal GST-tagged PDE4D3 expressed in baculovirus infected Sf9 cells by radioligand binding assay,Cc1ccc(-n2c(C(=O)NC3CC3)nc3cccnc32)cc1Cl,IC50,8200.0,nM,5.086186147616283
CHEMBL4761224,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human N-terminal GST-tagged PDE4D3 expressed in baculovirus infected Sf9 cells by radioligand binding assay,O=C(c1nc2ccccc2n1-c1ccc(Cl)c(Cl)c1)N1CC(F)C1,IC50,2000.0,nM,5.698970004336019
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human N-terminal GST-tagged PDE4D3 expressed in baculovirus infected Sf9 cells by radioligand binding assay,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,110.0,nM,6.958607314841775
CHEMBL4762079,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human N-terminal GST-tagged PDE4D3 expressed in baculovirus infected Sf9 cells by radioligand binding assay,O=C(c1nc2cccnc2n1-c1ccc(Cl)c(Cl)c1)N1CCC1,IC50,450.0,nM,6.346787486224656
CHEMBL4783529,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human N-terminal GST-tagged PDE4D3 expressed in baculovirus infected Sf9 cells by radioligand binding assay,O=C(c1nc2cccnc2n1-c1ccc(Cl)c(Cl)c1)N1CC(F)(F)C1,IC50,880.0,nM,6.055517327849831
CHEMBL4759907,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human N-terminal GST-tagged PDE4D3 expressed in baculovirus infected Sf9 cells by radioligand binding assay,O=C(c1nc2cccnc2n1-c1ccc(Cl)c(Cl)c1)N1CC(C(F)(F)F)C1,IC50,1000.0,nM,6.0
CHEMBL4786718,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human N-terminal GST-tagged PDE4D3 expressed in baculovirus infected Sf9 cells by radioligand binding assay,O=C(c1nc2cccnc2n1-c1ccc(Cl)c(Cl)c1)N1CCC2(CCC2)C1,IC50,2300.0,nM,5.638272163982407
CHEMBL4786383,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human N-terminal GST-tagged PDE4D3 expressed in baculovirus infected Sf9 cells by radioligand binding assay,COc1ncc(-n2c(C(=O)N3CC(F)C3)cc3cccnc32)cc1Cl,IC50,1600.0,nM,5.795880017344075
CHEMBL4758348,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human N-terminal GST-tagged PDE4D3 expressed in baculovirus infected Sf9 cells by radioligand binding assay,O=C(c1cc2cccnc2n1-c1ccnc(F)c1)N1CC(F)C1,IC50,1900.0,nM,5.721246399047171
CHEMBL4793481,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human N-terminal GST-tagged PDE4D3 expressed in baculovirus infected Sf9 cells by radioligand binding assay,COc1c(F)cc(-n2c(C(=O)N3CC(F)C3)cc3cccnc32)cc1F,IC50,6300.0,nM,5.200659450546418
CHEMBL4785297,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U-937 cells derived PDE4D using [3H] cAMP as substrate measured after 30 mins,N#C/N=C1/SCCN1Cc1ccc(-c2ccc(Cl)cc2)o1,IC50,58300.0,nM,4.234331445240986
CHEMBL4786873,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U-937 cells derived PDE4D using [3H] cAMP as substrate measured after 30 mins,N#C/N=C1/SCCN1Cc1ccc(-c2ccc(F)cc2)o1,IC50,110500.0,nM,3.95663772197887
CHEMBL4789583,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U-937 cells derived PDE4D using [3H] cAMP as substrate measured after 30 mins,Cc1ccc(-c2ccc(CN3CCS/C3=N/C#N)o2)cc1,IC50,121500.0,nM,3.915423722065669
CHEMBL4793236,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U-937 cells derived PDE4D using [3H] cAMP as substrate measured after 30 mins,COc1ccc(-c2ccc(CN3CCS/C3=N/C#N)o2)cc1,IC50,32800.0,nM,4.484126156288321
CHEMBL4784174,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U-937 cells derived PDE4D using [3H] cAMP as substrate measured after 30 mins,N#C/N=C1/SCCN1Cc1ccc(-c2c(F)cccc2F)o1,IC50,159600.0,nM,3.796967112985289
CHEMBL4796681,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U-937 cells derived PDE4D using [3H] cAMP as substrate measured after 30 mins,N#C/N=C1/SCCN1C(=O)c1ccc(-c2cccc(Cl)c2)o1,IC50,99800.0,nM,4.000869458712629
CHEMBL4781821,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U-937 cells derived PDE4D using [3H] cAMP as substrate measured after 30 mins,N#C/N=C1/SCCN1C(=O)c1ccc(-c2ccc(Cl)cc2)o1,IC50,26400.0,nM,4.578396073130169
CHEMBL4794945,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U-937 cells derived PDE4D using [3H] cAMP as substrate measured after 30 mins,N#C/N=C1/SCCN1C(=O)c1ccc(-c2ccc(F)cc2)o1,IC50,55700.0,nM,4.2541448048262716
CHEMBL4792730,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U-937 cells derived PDE4D using [3H] cAMP as substrate measured after 30 mins,Cc1ccc(-c2ccc(C(=O)N3CCS/C3=N/C#N)o2)cc1,IC50,54300.0,nM,4.265200170411153
CHEMBL4799425,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U-937 cells derived PDE4D using [3H] cAMP as substrate measured after 30 mins,COc1ccc(-c2ccc(C(=O)N3CCS/C3=N/C#N)o2)cc1,IC50,18700.0,nM,4.728158393463501
CHEMBL4797637,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U-937 cells derived PDE4D using [3H] cAMP as substrate measured after 30 mins,N#C/N=C1/SCCN1C(=O)c1ccc(-c2c(F)cccc2F)o1,IC50,88600.0,nM,4.052566278112949
CHEMBL4789742,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U-937 cells derived PDE4D using [3H] cAMP as substrate measured after 30 mins,N#C/N=C1/SCCN1C(=O)c1coc(-c2cccc(Cl)c2)n1,IC50,102500.0,nM,3.989276134608227
CHEMBL4784653,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U-937 cells derived PDE4D using [3H] cAMP as substrate measured after 30 mins,N#C/N=C1/SCCN1C(=O)c1coc(-c2ccc(Cl)cc2)n1,IC50,26800.0,nM,4.5718652059712115
CHEMBL4798769,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U-937 cells derived PDE4D using [3H] cAMP as substrate measured after 30 mins,N#C/N=C1/SCCN1C(=O)c1coc(-c2ccc(F)cc2)n1,IC50,45900.0,nM,4.338187314462739
CHEMBL4780084,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U-937 cells derived PDE4D using [3H] cAMP as substrate measured after 30 mins,Cc1ccc(-c2nc(C(=O)N3CCS/C3=N/C#N)co2)cc1,IC50,66900.0,nM,4.174573882232177
CHEMBL4780773,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U-937 cells derived PDE4D using [3H] cAMP as substrate measured after 30 mins,COc1ccc(-c2nc(C(=O)N3CCS/C3=N/C#N)co2)cc1,IC50,15700.0,nM,4.804100347590766
CHEMBL4777148,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U-937 cells derived PDE4D using [3H] cAMP as substrate measured after 30 mins,N#C/N=C1/SCCN1C(=O)c1coc(-c2c(F)cccc2F)n1,IC50,98700.0,nM,4.005682847330363
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human U-937 cells derived PDE4D using [3H] cAMP as substrate measured after 30 mins,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,2800.0,nM,5.552841968657781
CHEMBL4466435,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (83 to 416 residues) expressed in Escherichia coli BL21 (DE3) assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay,COc1cc2c(cc1OC)[C@H](Cc1c[nH]c3ccccc13)N(C=O)CC2,IC50,140.0,nM,6.853871964321762
CHEMBL4874067,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (83 to 416 residues) expressed in Escherichia coli BL21 (DE3) assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay,COc1cc2c(cc1OC)C(Cc1c[nH]c3ccccc13)N(C=O)CC2,IC50,390.0,nM,6.4089353929735005
CHEMBL4871062,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (83 to 416 residues) expressed in Escherichia coli BL21 (DE3) assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay,COc1cc2c(cc1OC)[C@@H](Cc1c[nH]c3ccccc13)N(C=O)CC2,IC50,1810.0,nM,5.7423214251308154
CHEMBL4859761,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (83 to 416 residues) expressed in Escherichia coli BL21 (DE3) assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay,COc1cc2c(cc1OC)C(Cc1c[nH]c3ccccc13)N(C(C)=O)CC2,IC50,1130.0,nM,5.94692155651658
CHEMBL4859738,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (83 to 416 residues) expressed in Escherichia coli BL21 (DE3) assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay,COc1cc2c(cc1OC)[C@H](Cc1c[nH]c3ccccc13)N(C(C)=O)CC2,IC50,890.0,nM,6.050609993355087
CHEMBL4862887,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (83 to 416 residues) expressed in Escherichia coli BL21 (DE3) assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay,CCOc1cc2c(cc1OC)CCN(C=O)C2Cc1c[nH]c2ccccc12,IC50,75.0,nM,7.1249387366083
CHEMBL4865688,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (83 to 416 residues) expressed in Escherichia coli BL21 (DE3) assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay,CCOc1cc2c(cc1OC)CCN(C=O)[C@H]2Cc1c[nH]c2ccccc12,IC50,42.0,nM,7.376750709602099
CHEMBL4859162,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (83 to 416 residues) expressed in Escherichia coli BL21 (DE3) assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay,CCOc1cc2c(cc1OC)CCN(C(C)=O)[C@H]2Cc1c[nH]c2ccccc12,IC50,170.0,nM,6.769551078621726
CHEMBL4866565,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (83 to 416 residues) expressed in Escherichia coli BL21 (DE3) assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay,CCOc1cc2c(cc1OC)CCN(C(=O)OC)[C@H]2Cc1c[nH]c2ccccc12,IC50,2400.0,nM,5.619788758288394
CHEMBL4877238,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (83 to 416 residues) expressed in Escherichia coli BL21 (DE3) assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay,COc1cc2c(cc1OCc1ccccc1)C(Cc1c[nH]c3ccccc13)N(C=O)CC2,IC50,3570.0,nM,5.447331783887806
CHEMBL4875765,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (83 to 416 residues) expressed in Escherichia coli BL21 (DE3) assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay,COc1cc2c(cc1OC)[C@H](Cc1c[nH]c3cccc(Cl)c13)N(C=O)CC2,IC50,360.0,nM,6.443697499232712
CHEMBL4855517,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (83 to 416 residues) expressed in Escherichia coli BL21 (DE3) assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay,COc1cc2c(cc1OC)C(Cc1c[nH]c3cc(Cl)ccc13)N(C=O)CC2,IC50,610.0,nM,6.214670164989233
CHEMBL4865887,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (83 to 416 residues) expressed in Escherichia coli BL21 (DE3) assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay,COc1cc2c(cc1OC)[C@H](Cc1c[nH]c3cc(Cl)ccc13)N(C=O)CC2,IC50,550.0,nM,6.259637310505756
CHEMBL4848137,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (83 to 416 residues) expressed in Escherichia coli BL21 (DE3) assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay,COc1cc2c(cc1OC)[C@H](Cc1c[nH]c3c(Cl)cccc13)N(C=O)CC2,IC50,360.0,nM,6.443697499232712
CHEMBL4857463,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (83 to 416 residues) expressed in Escherichia coli BL21 (DE3) assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay,COc1cc2c(cc1OC)[C@H](Cc1c[nH]c3ccc(Br)cc13)N(C=O)CC2,IC50,1030.0,nM,5.987162775294828
CHEMBL4864866,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (83 to 416 residues) expressed in Escherichia coli BL21 (DE3) assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay,COc1cc2c(cc1OC)[C@H](Cc1c[nH]c3ccc(C)cc13)N(C=O)CC2,IC50,300.0,nM,6.522878745280337
CHEMBL4875548,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (83 to 416 residues) expressed in Escherichia coli BL21 (DE3) assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay,COc1ccc2[nH]cc(C[C@H]3c4cc(OC)c(OC)cc4CCN3C=O)c2c1,IC50,1160.0,nM,5.935542010773082
CHEMBL4876519,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (83 to 416 residues) expressed in Escherichia coli BL21 (DE3) assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay,COc1ccc2[nH]c(C)c(C[C@H]3c4cc(OC)c(OC)cc4CCN3C=O)c2c1,IC50,610.0,nM,6.214670164989233
CHEMBL4867813,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (83 to 416 residues) expressed in Escherichia coli BL21 (DE3) assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay,CCOc1cc2c(cc1OC)CCN(C=O)[C@H]2Cc1c[nH]c2cccc(Cl)c12,IC50,810.0,nM,6.0915149811213505
CHEMBL4863785,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (83 to 416 residues) expressed in Escherichia coli BL21 (DE3) assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay,CCOc1cc2c(cc1OC)CCN(C=O)[C@H]2Cc1c[nH]c2c(Cl)cccc12,IC50,630.0,nM,6.200659450546418
CHEMBL4853858,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (83 to 416 residues) expressed in Escherichia coli BL21 (DE3) assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay,CCOc1cc2c(cc1OC)CCN(C=O)[C@H]2Cc1c[nH]c2ccc(Br)cc12,IC50,1410.0,nM,5.85078088734462
CHEMBL4860020,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant human PDE4D (83 to 416 residues) expressed in Escherichia coli BL21 (DE3) assessed as hydrolysis of [3H]-cAMP measured after 30 mins by Scintillation proximity assay,CCOc1cc2c(cc1OC)CCN(C=O)[C@H]2Cc1c(C)[nH]c2ccc(OC)cc12,IC50,630.0,nM,6.200659450546418
CHEMBL4878615,CHEMBL288,Phosphodiesterase 4D,Binding affinity to PDE4d (unknown origin),Cc1ncc(-c2cc(-c3cc(S(=O)(=O)NCC(C)(C)O)ccc3C)cnc2N)o1,IC50,1100.0,nM,5.958607314841775
CHEMBL561643,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86-413) (unknown origin) expressed in Escherichia coli BL21 assessed as using [3H]-cAMP as substrate measured for 15 mins by liquid scintillation counting analysis,COc1c(O)cc2oc3cc4c(c(O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,420.0,nM,6.376750709602099
CHEMBL4874476,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86-413) (unknown origin) expressed in Escherichia coli BL21 assessed as using [3H]-cAMP as substrate measured for 15 mins by liquid scintillation counting analysis,COc1c(O)cc2oc3cc4c(c(OCC(=O)O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,17.0,nM,7.769551078621726
CHEMBL4852619,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86-413) (unknown origin) expressed in Escherichia coli BL21 assessed as using [3H]-cAMP as substrate measured for 15 mins by liquid scintillation counting analysis,COc1c(O)cc2oc3cc4c(c(OCCCCC(=O)O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,24.0,nM,7.619788758288394
CHEMBL4871033,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86-413) (unknown origin) expressed in Escherichia coli BL21 assessed as using [3H]-cAMP as substrate measured for 15 mins by liquid scintillation counting analysis,COc1c(O)cc2oc3cc4c(c(OCCCCCC(=O)O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,25.0,nM,7.6020599913279625
CHEMBL4846021,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86-413) (unknown origin) expressed in Escherichia coli BL21 assessed as using [3H]-cAMP as substrate measured for 15 mins by liquid scintillation counting analysis,COc1c(O)cc2oc3cc4c(c(OCCCCCCC(=O)O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,300.0,nM,6.522878745280337
CHEMBL4855047,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86-413) (unknown origin) expressed in Escherichia coli BL21 assessed as using [3H]-cAMP as substrate measured for 15 mins by liquid scintillation counting analysis,COc1c(O)cc2oc3cc4c(c(OC/C=C/C(=O)O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,494.0,nM,6.306273051076353
CHEMBL4860780,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86-413) (unknown origin) expressed in Escherichia coli BL21 assessed as using [3H]-cAMP as substrate measured for 15 mins by liquid scintillation counting analysis,COc1cc2oc3cc4c(c(OC/C=C/C(=O)O)c3c(=O)c2c(CC=C(C)C)c1OC)C=CC(C)(C)O4,IC50,30.0,nM,7.522878745280337
CHEMBL4860301,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86-413) (unknown origin) expressed in Escherichia coli BL21 assessed as using [3H]-cAMP as substrate measured for 15 mins by liquid scintillation counting analysis,CCOc1cc2oc3cc4c(c(OC/C=C/C(=O)O)c3c(=O)c2c(CC=C(C)C)c1OC)C=CC(C)(C)O4,IC50,48.0,nM,7.318758762624412
CHEMBL4876689,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86-413) (unknown origin) expressed in Escherichia coli BL21 assessed as using [3H]-cAMP as substrate measured for 15 mins by liquid scintillation counting analysis,COc1c(OC(C)C)cc2oc3cc4c(c(OC/C=C/C(=O)O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,31.0,nM,7.508638306165727
CHEMBL4871290,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86-413) (unknown origin) expressed in Escherichia coli BL21 assessed as using [3H]-cAMP as substrate measured for 15 mins by liquid scintillation counting analysis,COc1c(OCc2ccccc2)cc2oc3cc4c(c(OC/C=C/C(=O)O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,24.0,nM,7.619788758288394
CHEMBL4877549,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86-413) (unknown origin) expressed in Escherichia coli BL21 assessed as using [3H]-cAMP as substrate measured for 15 mins by liquid scintillation counting analysis,COc1c(OCc2ccc(F)cc2)cc2oc3cc4c(c(OC/C=C/C(=O)O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,15.0,nM,7.823908740944319
CHEMBL4866569,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86-413) (unknown origin) expressed in Escherichia coli BL21 assessed as using [3H]-cAMP as substrate measured for 15 mins by liquid scintillation counting analysis,COc1c(OCc2ccc(F)cc2)cc2oc3cc4c(c(OCCCC(=O)O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,4.2,nM,8.3767507096021
CHEMBL4877677,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86-413) (unknown origin) expressed in Escherichia coli BL21 assessed as using [3H]-cAMP as substrate measured for 15 mins by liquid scintillation counting analysis,COc1c(OCc2ccc(F)cc2)cc2oc3cc4c(c(OC/C=C\C(=O)O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,20.0,nM,7.698970004336019
CHEMBL4870288,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86-413) (unknown origin) expressed in Escherichia coli BL21 assessed as using [3H]-cAMP as substrate measured for 15 mins by liquid scintillation counting analysis,CCOC(=O)/C=C/COc1c2c(cc3oc4cc(OCc5ccc(F)cc5)c(OC)c(CC=C(C)C)c4c(=O)c13)OC(C)(C)C=C2,IC50,24.0,nM,7.619788758288394
CHEMBL4848450,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86-413) (unknown origin) expressed in Escherichia coli BL21 assessed as using [3H]-cAMP as substrate measured for 15 mins by liquid scintillation counting analysis,CCOC(=O)/C=C/COc1c2c(cc3oc4cc(OCc5cccc(F)c5)c(OC)c(CC=C(C)C)c4c(=O)c13)OC(C)(C)C=C2,IC50,6.5,nM,8.187086643357144
CHEMBL4852720,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86-413) (unknown origin) expressed in Escherichia coli BL21 assessed as using [3H]-cAMP as substrate measured for 15 mins by liquid scintillation counting analysis,COc1cccc(COc2cc3oc4cc5c(c(OC/C=C/C(=O)O)c4c(=O)c3c(CC=C(C)C)c2OC)C=CC(C)(C)O5)c1,IC50,16.0,nM,7.795880017344075
CHEMBL4878562,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86-413) (unknown origin) expressed in Escherichia coli BL21 assessed as using [3H]-cAMP as substrate measured for 15 mins by liquid scintillation counting analysis,COc1c(OCc2ccc(S(C)(=O)=O)cc2)cc2oc3cc4c(c(OC/C=C/C(=O)O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,18.0,nM,7.7447274948966935
CHEMBL4471352,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86-413) (unknown origin) expressed in Escherichia coli BL21 assessed as using [3H]-cAMP as substrate measured for 15 mins by liquid scintillation counting analysis,COc1c(OCCCCCCC(=O)O)cc2oc3cc4c(c(O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,19.0,nM,7.721246399047171
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86-413) (unknown origin) expressed in Escherichia coli BL21 assessed as using [3H]-cAMP as substrate measured for 15 mins by liquid scintillation counting analysis,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,590.0,nM,6.229147988357855
CHEMBL4853419,CHEMBL288,Phosphodiesterase 4D,Inhibition of C-terminal 6His-tagged human PDE4D catalytic domain (244 to 578 residues) expressed in Escherichia coli BL21(DE3) pLysS cells assessed as reduction in 5'-AMP formation using cAMP as substrate by NADPH-coupled assay,COc1ccc(/C(C)=N\OCC(=O)N2CCOCC2)cc1OC1CCCC1,IC50,2800.0,nM,5.552841968657781
CHEMBL4862157,CHEMBL288,Phosphodiesterase 4D,Inhibition of C-terminal 6His-tagged human PDE4D catalytic domain (244 to 578 residues) expressed in Escherichia coli BL21(DE3) pLysS cells assessed as reduction in 5'-AMP formation using cAMP as substrate by NADPH-coupled assay,COc1ccc(/C(C)=N\OCC(=O)N2CC(C)OC(C)C2)cc1OC1CCCC1,IC50,2500.0,nM,5.6020599913279625
CHEMBL4862518,CHEMBL288,Phosphodiesterase 4D,Inhibition of C-terminal 6His-tagged human PDE4D catalytic domain (244 to 578 residues) expressed in Escherichia coli BL21(DE3) pLysS cells assessed as reduction in 5'-AMP formation using cAMP as substrate by NADPH-coupled assay,COc1ccc(/C(C)=N\OCCC(=O)N2CCOCC2)cc1OC1CCCC1,IC50,33100.0,nM,4.480172006224281
CHEMBL4868872,CHEMBL288,Phosphodiesterase 4D,Inhibition of C-terminal 6His-tagged human PDE4D catalytic domain (244 to 578 residues) expressed in Escherichia coli BL21(DE3) pLysS cells assessed as reduction in 5'-AMP formation using cAMP as substrate by NADPH-coupled assay,COc1ccc(/C(C)=N\OCCC(=O)N2CC(C)OC(C)C2)cc1OC1CCCC1,IC50,4600.0,nM,5.337242168318426
CHEMBL4852484,CHEMBL288,Phosphodiesterase 4D,Inhibition of C-terminal 6His-tagged human PDE4D catalytic domain (244 to 578 residues) expressed in Escherichia coli BL21(DE3) pLysS cells assessed as reduction in 5'-AMP formation using cAMP as substrate by NADPH-coupled assay,COc1ccc(/C(C)=N\OCC(O)CN2CCOCC2)cc1OC1CCCC1,IC50,6900.0,nM,5.161150909262744
CHEMBL4876286,CHEMBL288,Phosphodiesterase 4D,Inhibition of C-terminal 6His-tagged human PDE4D catalytic domain (244 to 578 residues) expressed in Escherichia coli BL21(DE3) pLysS cells assessed as reduction in 5'-AMP formation using cAMP as substrate by NADPH-coupled assay,COc1ccc(/C(C)=N\OCC(O)CN2CC(C)OC(C)C2)cc1OC1CCCC1,IC50,4100.0,nM,5.3872161432802645
CHEMBL570803,CHEMBL288,Phosphodiesterase 4D,Inhibition of C-terminal 6His-tagged human PDE4D catalytic domain (244 to 578 residues) expressed in Escherichia coli BL21(DE3) pLysS cells assessed as reduction in 5'-AMP formation using cAMP as substrate by NADPH-coupled assay,COc1ccc(/C=N/OCC(=O)N2CC(C)OC(C)C2)cc1OC1CCCC1,IC50,16000.0,nM,4.795880017344075
CHEMBL4853419,CHEMBL288,Phosphodiesterase 4D,Inhibition of C-terminal 6His-tagged human PDE4D3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in 5'-AMP formation using cAMP as substrate by NADPH-coupled assay,COc1ccc(/C(C)=N\OCC(=O)N2CCOCC2)cc1OC1CCCC1,IC50,160.0,nM,6.795880017344075
CHEMBL4862157,CHEMBL288,Phosphodiesterase 4D,Inhibition of C-terminal 6His-tagged human PDE4D3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in 5'-AMP formation using cAMP as substrate by NADPH-coupled assay,COc1ccc(/C(C)=N\OCC(=O)N2CC(C)OC(C)C2)cc1OC1CCCC1,IC50,470.0,nM,6.327902142064282
CHEMBL4862518,CHEMBL288,Phosphodiesterase 4D,Inhibition of C-terminal 6His-tagged human PDE4D3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in 5'-AMP formation using cAMP as substrate by NADPH-coupled assay,COc1ccc(/C(C)=N\OCCC(=O)N2CCOCC2)cc1OC1CCCC1,IC50,11200.0,nM,4.950781977329818
CHEMBL4868872,CHEMBL288,Phosphodiesterase 4D,Inhibition of C-terminal 6His-tagged human PDE4D3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in 5'-AMP formation using cAMP as substrate by NADPH-coupled assay,COc1ccc(/C(C)=N\OCCC(=O)N2CC(C)OC(C)C2)cc1OC1CCCC1,IC50,3600.0,nM,5.443697499232712
CHEMBL4852484,CHEMBL288,Phosphodiesterase 4D,Inhibition of C-terminal 6His-tagged human PDE4D3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in 5'-AMP formation using cAMP as substrate by NADPH-coupled assay,COc1ccc(/C(C)=N\OCC(O)CN2CCOCC2)cc1OC1CCCC1,IC50,720.0,nM,6.142667503568731
CHEMBL4876286,CHEMBL288,Phosphodiesterase 4D,Inhibition of C-terminal 6His-tagged human PDE4D3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in 5'-AMP formation using cAMP as substrate by NADPH-coupled assay,COc1ccc(/C(C)=N\OCC(O)CN2CC(C)OC(C)C2)cc1OC1CCCC1,IC50,1100.0,nM,5.958607314841775
CHEMBL570803,CHEMBL288,Phosphodiesterase 4D,Inhibition of C-terminal 6His-tagged human PDE4D3 expressed in baculovirus infected Sf9 insect cells assessed as reduction in 5'-AMP formation using cAMP as substrate by NADPH-coupled assay,COc1ccc(/C=N/OCC(=O)N2CC(C)OC(C)C2)cc1OC1CCCC1,IC50,11000.0,nM,4.958607314841775
CHEMBL4856088,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),C=CCc1c(-c2cccc(NS(=O)(=O)c3ccccc3)c2)oc(=O)c2cc(F)ccc12,IC50,900.0,nM,6.045757490560675
CHEMBL4854331,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),C=CCc1c(-c2cccc(NS(=O)(=O)c3cccs3)c2)oc(=O)c2cc(F)ccc12,IC50,1340.0,nM,5.872895201635192
CHEMBL5088467,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 (unknown origin) assessed as conversion of cAMP to AMP measured after 30 mins by YSi scintillation proximity assay,Cc1cnc2c(-c3ccc(C(=O)N(c4ncccc4C)[C@@H]4CCCNC4)cc3F)cnn2c1,IC50,39000.0,nM,4.4089353929735005
CHEMBL5193314,CHEMBL288,Phosphodiesterase 4D,Displacement of [3H]-cAMP from full-length recombinant human PDE4D7 by fluorescence polarisation assay,CC(C)OCCOc1ncc(Oc2ccc3c(c2)B(O)OC3)cc1C#N,IC50,2.1,nM,8.67778070526608
CHEMBL77826,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),O=C(O)c1ccc(-c2cc3cccnc3c(-c3ccc4nonc4c3)n2)cc1,IC50,1.5,nM,8.823908740944319
CHEMBL4303204,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),O=C(O)C1CCC(c2cc3cccnc3c(-c3cccc(F)c3)n2)CC1,IC50,32.0,nM,7.494850021680094
CHEMBL1236215,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (unknown origin),CSc1nc2ccccc2c(=O)n1-c1c(F)cccc1F,IC50,3500.0,nM,5.455931955649724
CHEMBL4297287,CHEMBL288,Phosphodiesterase 4D,Inhibition of full-length PDE4D3 (unknown origin) using FAM-cAMP as substrate incubated for 5 mins followed by substrate addition measured after 30 mins by IMAP assay,COc1ccc([C@H]2CNC(=O)[C@H](Cc3cccc(C)c3)C2)cc1OC1CCCC1,IC50,150.0,nM,6.823908740944319
CHEMBL4541964,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE7D4,O=C(O)Cc1ccc(Cc2cc(-c3cccc(Cl)c3)nc(C(F)(F)F)c2)cc1,IC50,7.8,nM,8.10790539730952
CHEMBL502,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D7 (unknown origin),COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2,IC50,36000.0,nM,4.443697499232713
CHEMBL5189422,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D7 (unknown origin),COc1cc2c(cc1OC1CCCC1)C(=O)/C(=C/c1cccnc1)C2,IC50,4100.0,nM,5.3872161432802645
CHEMBL5191106,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D7 (unknown origin),COc1cc2c(cc1OC1CCCC1)C(=O)/C(=C/c1ccncc1)C2,IC50,3100.0,nM,5.508638306165727
CHEMBL5174492,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D7 (unknown origin),COc1cc2c(cc1OCC1CC1)C(=O)C(Cc1ccncc1)C2,IC50,6300.0,nM,5.200659450546418
CHEMBL5206189,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D7 (unknown origin),COc1cc2c(cc1OC1CCCC1)C(=O)C(Cc1ccncc1)C2,IC50,3400.0,nM,5.468521082957745
CHEMBL5174383,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D7 (unknown origin),COc1cc2c(cc1OC1CCCC1)CC(Cc1ccncc1)C2=O,IC50,5300.0,nM,5.275724130399211
CHEMBL5188404,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D7 (unknown origin),COc1cc2c(cc1OCC(C)C)CC(Cc1ccncc1)C2=O,IC50,4200.0,nM,5.376750709602099
CHEMBL5202380,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D7 (unknown origin),COc1cc2c(cc1OC1CCCC1)C(=O)C(Cc1cccnc1)C2,IC50,23000.0,nM,4.638272163982407
CHEMBL5194594,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D7 (unknown origin),COc1cc2c(cc1OC1CCCC1)C(=O)C(Cc1ccccn1)C2,IC50,8700.0,nM,5.060480747381382
CHEMBL5191933,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D7 (unknown origin),COc1cc2c(cc1OCCN1CCCCC1)C(=O)C(Cc1ccncc1)C2,IC50,16400.0,nM,4.785156151952302
CHEMBL5193506,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D7 (unknown origin),COc1cc2c(cc1OCCN1CCCCC1)C(=O)C(Cc1cccnc1)C2,IC50,1880.0,nM,5.72584215073632
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D7 (unknown origin),COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,130.0,nM,6.886056647693163
CHEMBL5172644,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,[11CH3]Oc1ccc(Cc2ccncc2)nc1-c1cccc(Cl)c1,IC50,5.12,nM,8.290730039024169
CHEMBL5184286,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,[11CH3]n1cc(Cc2ccc(OCF)c(-c3cccc(Cl)c3)n2)cn1,IC50,0.5,nM,9.301029995663981
CHEMBL5181462,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,[11CH3]Oc1ccc(Cc2cn[nH]c2)nc1-c1cccc([N+](=O)[O-])c1,IC50,3.9,nM,8.4089353929735
CHEMBL5207508,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D,[11CH3]Oc1ccc(Cc2ccncc2)nc1-c1cccc([N+](=O)[O-])c1,IC50,2.8,nM,8.55284196865778
CHEMBL193240,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,IC50,0.4,nM,9.397940008672037
CHEMBL484785,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1,IC50,490.0,nM,6.309803919971486
CHEMBL475165,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D expressed in human U-937 cells using cAMP as substrate,CCOc1cc(C(CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC,IC50,74.0,nM,7.130768280269024
CHEMBL5201432,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15 mins by liquid scintillation counting method,C=CC1(C)CC(C=C(C)C)c2c(c3ccccc3n(C)c2=O)O1,IC50,5300.0,nM,5.275724130399211
CHEMBL5202332,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15 mins by liquid scintillation counting method,CC(C)=CC1CC(C)(CCO)Oc2c1c(=O)n(C)c1ccccc21,IC50,7300.0,nM,5.136677139879544
CHEMBL5170835,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15 mins by liquid scintillation counting method,COc1cc(OC)c2ccc(=O)oc2c1/C=C/[C@@]1(C)C[C@@H](C=C(C)C)c2c(c3ccccc3n(C)c2=O)O1,IC50,180.0,nM,6.7447274948966935
CHEMBL5208713,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15 mins by liquid scintillation counting method,CC(C)=CC1CC(C)(CCO)Oc2c1c(=O)n(C)c1ncccc21,IC50,400.0,nM,6.3979400086720375
CHEMBL5178435,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15 mins by liquid scintillation counting method,CC(C)=CC1CC(C)(CCO)Oc2c1c(=O)n(C)c1ccncc21,IC50,7600.0,nM,5.119186407719209
CHEMBL5185722,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15 mins by liquid scintillation counting method,CC(C)=CC1CC(C)(CCO)Oc2c1c(=O)n(C)c1ncncc21,IC50,1700.0,nM,5.769551078621726
CHEMBL5188747,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15 mins by liquid scintillation counting method,CCn1c(=O)c2c(c3cccnc31)OC(C)(CCO)CC2C=C(C)C,IC50,80000.0,nM,4.096910013008056
CHEMBL5203549,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15 mins by liquid scintillation counting method,CCCn1c(=O)c2c(c3cccnc31)OC(C)(CCO)CC2C=C(C)C,IC50,68400.0,nM,4.164943898279883
CHEMBL5186911,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15 mins by liquid scintillation counting method,CC(C)=CC1CC(C)(CCO)Oc2c1c(=O)n(C(C)C)c1ncccc21,IC50,101100.0,nM,3.995248844408999
CHEMBL5193320,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15 mins by liquid scintillation counting method,CCCCn1c(=O)c2c(c3cccnc31)OC(C)(CCO)CC2C=C(C)C,IC50,177200.0,nM,3.751536282448968
CHEMBL5190912,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15 mins by liquid scintillation counting method,CC(C)=CC1CC(C)(CCO)Oc2c1c(=O)n(C1CC1)c1ncccc21,IC50,602800.0,nM,3.2198267563574055
CHEMBL5180007,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15 mins by liquid scintillation counting method,CC(C)=CC1CC(C)(CCO)Oc2c1c(=O)n(-c1ccccc1)c1ncccc21,IC50,371800.0,nM,3.4296906145641204
CHEMBL5205696,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15 mins by liquid scintillation counting method,CCn1c(=O)c2c(c3ccc(C)nc31)OC(C)(CCO)CC2C=C(C)C,IC50,4700.0,nM,5.327902142064282
CHEMBL5171560,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15 mins by liquid scintillation counting method,CCn1c(=O)c2c(c3ccc(C)nc31)O[C@@](C)(CCO)C[C@H]2C=C(C)C,IC50,3100.0,nM,5.508638306165727
CHEMBL5171119,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15 mins by liquid scintillation counting method,CCn1c(=O)c2c(c3ccc(C)nc31)O[C@](C)(CCO)C[C@@H]2C=C(C)C,IC50,98800.0,nM,4.005243055412372
CHEMBL5171883,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15 mins by liquid scintillation counting method,CCc1ccc2c3c(c(=O)n(CC)c2n1)C(C=C(C)C)CC(C)(CCO)O3,IC50,5700.0,nM,5.2441251443275085
CHEMBL5197754,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15 mins by liquid scintillation counting method,CCc1ccc2c3c(c(=O)n(CC)c2n1)[C@H](C=C(C)C)C[C@](C)(CCO)O3,IC50,3000.0,nM,5.522878745280337
CHEMBL5177463,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15 mins by liquid scintillation counting method,CCc1ccc2c3c(c(=O)n(CC)c2n1)[C@@H](C=C(C)C)C[C@@](C)(CCO)O3,IC50,72400.0,nM,4.140261433802853
CHEMBL5181558,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15 mins by liquid scintillation counting method,CCn1c(=O)c2c(c3ccc(C(F)(F)F)nc31)OC(C)(CCO)CC2C=C(C)C,IC50,12100.0,nM,4.91721462968355
CHEMBL5204540,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15 mins by liquid scintillation counting method,CCn1c(=O)c2c(c3ccc(C(F)(F)F)nc31)O[C@@](C)(CCO)C[C@H]2C=C(C)C,IC50,6200.0,nM,5.207608310501746
CHEMBL5188271,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15 mins by liquid scintillation counting method,CCn1c(=O)c2c(c3ccc(C(F)(F)F)nc31)O[C@](C)(CCO)C[C@@H]2C=C(C)C,IC50,133100.0,nM,3.875821944525325
CHEMBL5205327,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D,c1cncc(-c2cnc(NCc3cccc4c3CCO4)n3cnnc23)c1,IC50,2600.0,nM,5.585026652029182
CHEMBL5192635,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D,c1cc(CNc2ncc(-c3ccncc3)c3nncn23)c2c(c1)OCC2,IC50,10000.0,nM,5.0
CHEMBL4065484,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D,CS(=O)(=O)c1ccc(-c2cnc(NCc3ccco3)n3cnnc23)cc1,IC50,20000.0,nM,4.698970004336019
CHEMBL4755618,CHEMBL288,Phosphodiesterase 4D,Inhibition of human Phosphodiesterase 4D,Cc1ncccc1-c1cnc(NCc2c(F)ccc3c2CCO3)n2cnnc12,IC50,6400.0,nM,5.1938200260161125
CHEMBL5180169,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 [3H]-cAMP as substrate measured for 15 mins by liquid scintillation counter method,CC1=C(C(=O)O[C@H](C)c2ccccc2)C(c2ccc3c(cnn3C)c2)C(C(=O)O[C@H](C)c2ccccc2)=C(C)N1,IC50,948.0,nM,6.023191662661934
CHEMBL1428,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin) expressed in Escherichia coli BL21 [3H]-cAMP as substrate measured for 15 mins by liquid scintillation counter method,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1,IC50,7150.0,nM,5.145693958198919
CHEMBL5220884,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (unknown origin),Cn1ccc2cc(-c3cnc4ccc(C(=O)N5CCCCC5)cc4n3)ccc2c1=O,IC50,1200.0,nM,5.920818753952375
CHEMBL5287106,CHEMBL288,Phosphodiesterase 4D,Displacement of [3H]-cAMP from full-length recombinant human PDE4D7 by fluorescence polarisation assay,N#CC(c1ccc(OC(F)F)c(OC2CCCC2)c1)c1ccc(Cl)nn1,IC50,310.0,nM,6.508638306165727
CHEMBL5269997,CHEMBL288,Phosphodiesterase 4D,Inhibition of human C-terminal 6His-tagged PDE4D catalytic domain using cAMP as substrate,O[C@@H](CN1CCOCC1)Cn1ccc(-c2ccc(OC(F)F)c(OC3CCCC3)c2)n1,IC50,19500.0,nM,4.709965388637482
CHEMBL5286787,CHEMBL288,Phosphodiesterase 4D,Inhibition of human C-terminal 6His-tagged PDE4D catalytic domain using cAMP as substrate,O[C@H](CN1CCOCC1)Cn1ccc(-c2ccc(OC(F)F)c(OC3CCCC3)c2)n1,IC50,31800.0,nM,4.497572880015567
CHEMBL5269997,CHEMBL288,Phosphodiesterase 4D,Inhibition of human C-terminal 6His-tagged PDE4D3 using cAMP as substrate,O[C@@H](CN1CCOCC1)Cn1ccc(-c2ccc(OC(F)F)c(OC3CCCC3)c2)n1,IC50,2100.0,nM,5.6777807052660805
CHEMBL5286787,CHEMBL288,Phosphodiesterase 4D,Inhibition of human C-terminal 6His-tagged PDE4D3 using cAMP as substrate,O[C@H](CN1CCOCC1)Cn1ccc(-c2ccc(OC(F)F)c(OC3CCCC3)c2)n1,IC50,15500.0,nM,4.809668301829708
CHEMBL4541964,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D7,O=C(O)Cc1ccc(Cc2cc(-c3cccc(Cl)c3)nc(C(F)(F)F)c2)cc1,IC50,7.8,nM,8.10790539730952
CHEMBL4541964,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D3,O=C(O)Cc1ccc(Cc2cc(-c3cccc(Cl)c3)nc(C(F)(F)F)c2)cc1,IC50,7.4,nM,8.130768280269024
CHEMBL77826,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D,O=C(O)c1ccc(-c2cc3cccnc3c(-c3ccc4nonc4c3)n2)cc1,IC50,1.5,nM,8.823908740944319
CHEMBL2172374,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D,O=C(O)[C@H]1CC[C@H](c2cc3cccnc3c(-c3cccc(F)c3)n2)CC1,IC50,41.0,nM,7.3872161432802645
CHEMBL511115,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D,COc1ccc([C@]2(C#N)CC[C@@H](C(=O)O)CC2)cc1OC1CCCC1,IC50,63.0,nM,7.200659450546418
CHEMBL193240,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,IC50,0.3,nM,9.522878745280337
CHEMBL5283294,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D incubated for 30 mins by Scintillation Proximity Assay,O=C(NC1CC1)c1nc2cccnn2c1-c1cc(F)c(Cl)c(F)c1,IC50,145.0,nM,6.838631997765026
CHEMBL5395569,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (86 to 413 residues) (unknown origin) using 3H-cAMP as substrate incubated for 15 mins by liquid scintillation counter analysis,N#Cc1c(C2CCCC2)c2ccc(NCc3ccc(F)cn3)cc2n(CC2CCCC2)c1=O,IC50,610.0,nM,6.214670164989233
CHEMBL5420172,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin) assessed as enzyme activity by transcreener AMP2/GMP2 FP PDE assay,CNc1cc(Nc2cc(C)cc(C)c2)nc2c(C(=O)NC3CC3)cnn12,IC50,36.0,nM,7.443697499232712
CHEMBL5415951,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin) assessed as enzyme activity by transcreener AMP2/GMP2 FP PDE assay,CNc1cc(Nc2cccnc2OC)nc2c(C(=O)NC3CC3)cnn12,IC50,250.0,nM,6.6020599913279625
CHEMBL4518369,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),C[C@@H]1COCCN1c1nc(N2CCOC[C@@H]2C)nc2sc(-c3cc[nH]n3)nc12,IC50,210.0,nM,6.6777807052660805
CHEMBL5408310,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),C[C@@H]1COCCN1c1cc(N2CCOC[C@@H]2C)cc2sc(-c3cc[nH]n3)nc12,IC50,42.0,nM,7.376750709602099
CHEMBL5400858,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),C[C@@H]1COCCN1c1nc(N2CCOC[C@@H]2C)cc2sc(-c3cc[nH]n3)nc12,IC50,960.0,nM,6.017728766960431
CHEMBL4110496,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),C[C@@H]1COCCN1c1nc(N2CCOC[C@@H]2C)nc2[nH]c(-c3cc[nH]n3)nc12,IC50,4900.0,nM,5.309803919971486
CHEMBL5413477,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),C[C@@H]1COCCN1c1nc(N2CCOC[C@@H]2C)cc2[nH]c(-c3cc[nH]n3)nc12,IC50,11000.0,nM,4.958607314841775
CHEMBL5396249,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),C[C@@H]1COCCN1c1cc(N2CCOC[C@@H]2C)nc2[nH]c(-c3cc[nH]n3)cc12,IC50,16000.0,nM,4.795880017344075
CHEMBL5431805,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),C[C@@H]1COCCN1c1cc(N2CCOC[C@@H]2C)nc2[nH]c(-c3cc[nH]n3)nc12,IC50,18000.0,nM,4.7447274948966935
CHEMBL5408667,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),C[C@@H]1COCCN1c1cc(N2CCOC[C@@H]2C)nc2sc(-c3cc(O)ccc3F)nc12,IC50,6000.0,nM,5.221848749616356
CHEMBL5413317,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),C[C@@H]1COCCN1c1cc(N2CCOC[C@@H]2C)nc2sc(-c3ccccn3)nc12,IC50,17000.0,nM,4.769551078621726
CHEMBL5421758,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),C[C@@H]1COCCN1c1cc(N2CCOC[C@@H]2C)nc2sc(-c3nccs3)nc12,IC50,21000.0,nM,4.6777807052660805
CHEMBL5410401,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),C[C@@H]1COCCN1c1cc(N2CCOC[C@@H]2C)nc2sc(-c3cscn3)nc12,IC50,6300.0,nM,5.200659450546418
CHEMBL5431004,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),C[C@@H]1COCCN1c1cc(N2C3CCC2COC3)nc2[nH]c(-c3ccccn3)nc12,IC50,9200.0,nM,5.036212172654444
CHEMBL5402808,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),CC(C)c1cc(N2CCOC[C@H]2C)c2nc(-c3cc[nH]n3)sc2n1,IC50,4800.0,nM,5.318758762624412
CHEMBL5403444,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),C[C@@H]1COCCN1c1cc(C2(C#N)CC2)nc2sc(-c3cc[nH]n3)nc12,IC50,3400.0,nM,5.468521082957745
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (unknown origin),COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,590.0,nM,6.229147988357855
CHEMBL514800,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (unknown origin),CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC,IC50,500.0,nM,6.301029995663981
CHEMBL193240,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (unknown origin),O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,IC50,0.4,nM,9.397940008672037
CHEMBL932,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D2 (unknown origin),OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1,IC50,2800.0,nM,5.552841968657781
CHEMBL561643,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation method,COc1c(O)cc2oc3cc4c(c(O)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,420.0,nM,6.376750709602099
CHEMBL5428117,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation method,COc1c(O)cc2oc3cc4c(c(OCc5ccccn5)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,203.0,nM,6.692503962086787
CHEMBL5437810,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation method,COc1c(O)cc2oc3cc4c(c(OCc5ccncc5)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,25.0,nM,7.6020599913279625
CHEMBL5438159,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation method,COc1cc2oc3cc4c(c(OCc5ccncc5)c3c(=O)c2c(CC=C(C)C)c1OC)C=CC(C)(C)O4,IC50,11.7,nM,7.931814138253838
CHEMBL5434362,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation method,CCOc1cc2oc3cc4c(c(OCc5ccncc5)c3c(=O)c2c(CC=C(C)C)c1OC)C=CC(C)(C)O4,IC50,10.2,nM,7.991399828238082
CHEMBL5408080,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation method,COc1c(OC(C)C)cc2oc3cc4c(c(OCc5ccncc5)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,5.2,nM,8.2839966563652
CHEMBL5407967,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation method,COc1c(OCC2CC2)cc2oc3cc4c(c(OCc5ccncc5)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,3.5,nM,8.455931955649724
CHEMBL5400816,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation method,COc1c(OCc2ccccc2)cc2oc3cc4c(c(OCc5ccncc5)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,1.4,nM,8.853871964321762
CHEMBL5434713,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation method,COc1c(OCc2ccncc2)cc2oc3cc4c(c(OCc5ccncc5)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,10.6,nM,7.97469413473523
CHEMBL5431083,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation method,COc1c(OCc2ccc(F)cc2)cc2oc3cc4c(c(OCc5ccncc5)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,1.4,nM,8.853871964321762
CHEMBL5420700,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation method,COc1c(OCc2cccc(F)c2)cc2oc3cc4c(c(OCc5ccncc5)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,7.8,nM,8.10790539730952
CHEMBL5410553,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation method,COc1c(OCc2ccc(F)cc2)cc2oc3cc4c(c(OCC5CCNCC5)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,12.4,nM,7.906578314837764
CHEMBL5405731,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation method,COc1c(OCc2ccc(F)cc2)cc2oc3cc4c(c(OCc5ccccn5)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,20.2,nM,7.694648630553377
CHEMBL5435764,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation method,COc1c(OCc2cccc(F)c2)cc2oc3cc4c(c(OCc5ccccn5)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,9.3,nM,8.031517051446064
CHEMBL5421333,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation method,COc1c(OCc2ccccn2)cc2oc3cc4c(c(OCc5ccccn5)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,6.5,nM,8.187086643357144
CHEMBL5440771,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation method,COc1c(OCc2ccc(F)cc2)cc2oc3cc4c(c(OCc5cccnc5)c3c(=O)c2c1CC=C(C)C)C=CC(C)(C)O4,IC50,8.2,nM,8.086186147616283
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of recombinant PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]cAMP as substrate incubated for 15 mins by liquid scintillation method,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,IC50,590.0,nM,6.229147988357855
CHEMBL5417689,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 expressed in baculovirus expression system using cAMP as substrate by radiometric assay,CCOc1cc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CN[C@@](CO)(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)s2)ccc1OC,IC50,0.3981,nM,9.400007822415901
CHEMBL4541964,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),O=C(O)Cc1ccc(Cc2cc(-c3cccc(Cl)c3)nc(C(F)(F)F)c2)cc1,IC50,8.0,nM,8.096910013008056
CHEMBL193240,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D (unknown origin),O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1,IC50,0.68,nM,9.167491087293763
CHEMBL4789722,CHEMBL288,Phosphodiesterase 4D,Inhibition of human full length PDE4D2 assessed as cAMP by measuring fluorescence intensity preincubated for 10 mins followed by cAMP addition further incubated for 30 mins,COc1ccc(-c2nc3c(c(Nc4ccc(CC(=O)O)cc4)n2)SCCC3)cc1F,IC50,440.0,nM,6.356547323513812
CHEMBL3643413,CHEMBL288,Phosphodiesterase 4D,"Selectivity interaction (Phosphodiesterase 4D, human recombinant ) EUB0000877a PDE4D",CCC(=O)N1CC[C@H](Nc2ncnc3c2CN(c2cnc(OC)c(C(F)(F)F)c2)CC3)C1,IC50,4700.0,nM,5.327902142064282
CHEMBL360770,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(C)cc4)nc2-3)cc1OC1CCCC1,KI,347.0,nM,6.459670525209127
CHEMBL360770,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(C)cc4)nc2-3)cc1OC1CCCC1,KI,6.6,nM,8.18045606445813
CHEMBL360770,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(C)cc4)nc2-3)cc1OC1CCCC1,KI,7.6,nM,8.119186407719209
CHEMBL180015,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(Cl)cc4)nc2-3)cc1OC1CCCC1,KI,205.0,nM,6.688246138944246
CHEMBL180015,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(Cl)cc4)nc2-3)cc1OC1CCCC1,KI,5.8,nM,8.236572006437063
CHEMBL180015,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(Cl)cc4)nc2-3)cc1OC1CCCC1,KI,4.8,nM,8.318758762624412
CHEMBL178460,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccccc4F)nc2-3)cc1OC1CCCC1,KI,427.0,nM,6.369572124974976
CHEMBL178460,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccccc4F)nc2-3)cc1OC1CCCC1,KI,11.0,nM,7.958607314841775
CHEMBL178460,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccccc4F)nc2-3)cc1OC1CCCC1,KI,6.8,nM,8.167491087293763
CHEMBL361201,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4cccc(F)c4)nc2-3)cc1OC1CCCC1,KI,369.0,nM,6.432973633840939
CHEMBL361201,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4cccc(F)c4)nc2-3)cc1OC1CCCC1,KI,7.4,nM,8.130768280269024
CHEMBL361201,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4cccc(F)c4)nc2-3)cc1OC1CCCC1,KI,8.4,nM,8.075720713938118
CHEMBL178099,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1ccc(OCC(C)(C)c2nc3c(N)ncn(Cc4ccc(OC)c(OC5CCCC5)c4)c-3n2)cc1OC,KI,2640.0,nM,5.578396073130168
CHEMBL178099,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1ccc(OCC(C)(C)c2nc3c(N)ncn(Cc4ccc(OC)c(OC5CCCC5)c4)c-3n2)cc1OC,KI,15.0,nM,7.823908740944319
CHEMBL178099,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1ccc(OCC(C)(C)c2nc3c(N)ncn(Cc4ccc(OC)c(OC5CCCC5)c4)c-3n2)cc1OC,KI,7.8,nM,8.10790539730952
CHEMBL178712,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1cc(OC)cc(OCC(C)(C)c2nc3c(N)ncn(Cc4ccc(OC)c(OC5CCCC5)c4)c-3n2)c1,KI,340.0,nM,6.468521082957745
CHEMBL178712,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1cc(OC)cc(OCC(C)(C)c2nc3c(N)ncn(Cc4ccc(OC)c(OC5CCCC5)c4)c-3n2)c1,KI,9.0,nM,8.045757490560675
CHEMBL178712,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1cc(OC)cc(OCC(C)(C)c2nc3c(N)ncn(Cc4ccc(OC)c(OC5CCCC5)c4)c-3n2)c1,KI,7.9,nM,8.102372908709558
CHEMBL369134,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(F)c(F)c4)nc2-3)cc1OC1CCCC1,KI,459.0,nM,6.338187314462739
CHEMBL369134,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(F)c(F)c4)nc2-3)cc1OC1CCCC1,KI,13.0,nM,7.886056647693163
CHEMBL369134,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(F)c(F)c4)nc2-3)cc1OC1CCCC1,KI,13.3,nM,7.876148359032914
CHEMBL367846,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(OCC=O)c(OCC=O)c4)nc2-3)cc1OC1CCCC1,KI,218.0,nM,6.661543506395395
CHEMBL367846,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(OCC=O)c(OCC=O)c4)nc2-3)cc1OC1CCCC1,KI,6.6,nM,8.18045606445813
CHEMBL367846,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(OCC=O)c(OCC=O)c4)nc2-3)cc1OC1CCCC1,KI,3.7,nM,8.431798275933005
CHEMBL360285,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(C#N)cc4)nc2-3)cc1OC1CCCC1,KI,1840.0,nM,5.735182176990463
CHEMBL360285,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(C#N)cc4)nc2-3)cc1OC1CCCC1,KI,33.4,nM,7.476253533188435
CHEMBL360285,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(C#N)cc4)nc2-3)cc1OC1CCCC1,KI,19.4,nM,7.7121982700697735
CHEMBL433774,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(Cl)c(Cl)c4)nc2-3)cc1OC1CCCC1,KI,355.0,nM,6.449771646944906
CHEMBL433774,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(Cl)c(Cl)c4)nc2-3)cc1OC1CCCC1,KI,10.6,nM,7.97469413473523
CHEMBL433774,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(Cl)c(Cl)c4)nc2-3)cc1OC1CCCC1,KI,6.6,nM,8.18045606445813
CHEMBL360481,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(C(C)(C)C)cc4)nc2-3)cc1OC1CCCC1,KI,255.0,nM,6.5934598195660445
CHEMBL360481,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(C(C)(C)C)cc4)nc2-3)cc1OC1CCCC1,KI,5.0,nM,8.301029995663981
CHEMBL360481,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(C(C)(C)C)cc4)nc2-3)cc1OC1CCCC1,KI,4.3,nM,8.366531544420413
CHEMBL360932,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(OC(F)(F)F)cc4)nc2-3)cc1OC1CCCC1,KI,782.0,nM,6.106793246940152
CHEMBL360932,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(OC(F)(F)F)cc4)nc2-3)cc1OC1CCCC1,KI,6.5,nM,8.187086643357144
CHEMBL360932,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(OC(F)(F)F)cc4)nc2-3)cc1OC1CCCC1,KI,7.2,nM,8.142667503568731
CHEMBL362175,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COC(=O)c1ccc(OCC(C)(C)c2nc3c(N)ncn(Cc4ccc(OC)c(OC5CCCC5)c4)c-3n2)cc1,KI,246.0,nM,6.609064892896621
CHEMBL362175,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COC(=O)c1ccc(OCC(C)(C)c2nc3c(N)ncn(Cc4ccc(OC)c(OC5CCCC5)c4)c-3n2)cc1,KI,3.0,nM,8.522878745280337
CHEMBL362175,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COC(=O)c1ccc(OCC(C)(C)c2nc3c(N)ncn(Cc4ccc(OC)c(OC5CCCC5)c4)c-3n2)cc1,KI,5.5,nM,8.259637310505756
CHEMBL178801,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(C(N)=O)cc4)nc2-3)cc1OC1CCCC1,KI,312.0,nM,6.505845405981557
CHEMBL178801,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(C(N)=O)cc4)nc2-3)cc1OC1CCCC1,KI,8.0,nM,8.096910013008056
CHEMBL178801,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(C(N)=O)cc4)nc2-3)cc1OC1CCCC1,KI,4.9,nM,8.309803919971486
CHEMBL434332,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(C(=O)O)cc4)nc2-3)cc1OC1CCCC1,KI,4300.0,nM,5.366531544420413
CHEMBL368739,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(C(F)(F)F)cc4)nc2-3)cc1OC1CCCC1,KI,580.0,nM,6.236572006437063
CHEMBL368739,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(C(F)(F)F)cc4)nc2-3)cc1OC1CCCC1,KI,9.9,nM,8.00436480540245
CHEMBL368739,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccc(C(F)(F)F)cc4)nc2-3)cc1OC1CCCC1,KI,10.3,nM,7.987162775294828
CHEMBL433757,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccccc4-c4cccs4)nc2-3)cc1OC1CCCC1,KI,412.0,nM,6.3851027839668655
CHEMBL433757,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccccc4-c4cccs4)nc2-3)cc1OC1CCCC1,KI,7.0,nM,8.154901959985743
CHEMBL433757,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4ccccc4-c4cccs4)nc2-3)cc1OC1CCCC1,KI,6.3,nM,8.200659450546418
CHEMBL179321,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4cccc(-c5ccsc5)c4)nc2-3)cc1OC1CCCC1,KI,2680.0,nM,5.571865205971211
CHEMBL179321,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4cccc(-c5ccsc5)c4)nc2-3)cc1OC1CCCC1,KI,9.0,nM,8.045757490560675
CHEMBL179321,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)COc4cccc(-c5ccsc5)c4)nc2-3)cc1OC1CCCC1,KI,6.6,nM,8.18045606445813
CHEMBL179868,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc([C@@H](C)COc4ccccc4)nc2-3)cc1OC1CCCC1,KI,4450.0,nM,5.351639989019068
CHEMBL179868,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc([C@@H](C)COc4ccccc4)nc2-3)cc1OC1CCCC1,KI,640.0,nM,6.1938200260161125
CHEMBL179868,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc([C@@H](C)COc4ccccc4)nc2-3)cc1OC1CCCC1,KI,590.0,nM,6.229147988357855
CHEMBL444808,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1cccc(OC[C@H](C)c2nc3c(N)ncn(Cc4ccc(OC)c(OC5CCCC5)c4)c-3n2)c1,KI,5050.0,nM,5.296708621881338
CHEMBL444808,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1cccc(OC[C@H](C)c2nc3c(N)ncn(Cc4ccc(OC)c(OC5CCCC5)c4)c-3n2)c1,KI,493.0,nM,6.30715308072277
CHEMBL444808,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1cccc(OC[C@H](C)c2nc3c(N)ncn(Cc4ccc(OC)c(OC5CCCC5)c4)c-3n2)c1,KI,322.0,nM,6.492144128304169
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,KI,8460.0,nM,5.0726296369609765
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,KI,382.0,nM,6.417936637088291
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,KI,375.0,nM,6.425968732272281
CHEMBL28079,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,CCCOc1ccccc1-c1nc2[nH]nnc2c(=O)[nH]1,KI,8760.0,nM,5.05749589383192
CHEMBL362652,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,CCNc1ncn(Cc2ccc(OC)c(OC3CCCC3)c2)c2nc(C(C)C)nc1-2,KI,2890.0,nM,5.539102157243452
CHEMBL362652,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,CCNc1ncn(Cc2ccc(OC)c(OC3CCCC3)c2)c2nc(C(C)C)nc1-2,KI,172.0,nM,6.764471553092451
CHEMBL362652,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,CCNc1ncn(Cc2ccc(OC)c(OC3CCCC3)c2)c2nc(C(C)C)nc1-2,KI,141.0,nM,6.85078088734462
CHEMBL1203921,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)O)nc2-3)cc1OC1CCCC1.Cl,KI,413.0,nM,6.384049948343598
CHEMBL1203921,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)O)nc2-3)cc1OC1CCCC1.Cl,KI,5.7,nM,8.244125144327509
CHEMBL1203921,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc(C(C)(C)O)nc2-3)cc1OC1CCCC1.Cl,KI,4.1,nM,8.387216143280265
CHEMBL360527,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1ccccc1OCC(C)(C)c1nc2c(N)ncn(Cc3ccc(OC)c(OC4CCCC4)c3)c-2n1,KI,255.0,nM,6.5934598195660445
CHEMBL360527,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1ccccc1OCC(C)(C)c1nc2c(N)ncn(Cc3ccc(OC)c(OC4CCCC4)c3)c-2n1,KI,7.1,nM,8.148741651280925
CHEMBL360527,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1ccccc1OCC(C)(C)c1nc2c(N)ncn(Cc3ccc(OC)c(OC4CCCC4)c3)c-2n1,KI,5.1,nM,8.292429823902063
CHEMBL433761,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1cccc(OCC(C)(C)c2nc3c(N)ncn(Cc4ccc(OC)c(OC5CCCC5)c4)c-3n2)c1,KI,296.0,nM,6.528708288941061
CHEMBL433761,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1cccc(OCC(C)(C)c2nc3c(N)ncn(Cc4ccc(OC)c(OC5CCCC5)c4)c-3n2)c1,KI,6.0,nM,8.221848749616356
CHEMBL433761,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1cccc(OCC(C)(C)c2nc3c(N)ncn(Cc4ccc(OC)c(OC5CCCC5)c4)c-3n2)c1,KI,5.1,nM,8.292429823902063
CHEMBL368696,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1ccc(OCC(C)(C)c2nc3c(N)ncn(Cc4ccc(OC)c(OC5CCCC5)c4)c-3n2)cc1,KI,347.0,nM,6.459670525209127
CHEMBL368696,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1ccc(OCC(C)(C)c2nc3c(N)ncn(Cc4ccc(OC)c(OC5CCCC5)c4)c-3n2)cc1,KI,5.6,nM,8.2518119729938
CHEMBL368696,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1ccc(OCC(C)(C)c2nc3c(N)ncn(Cc4ccc(OC)c(OC5CCCC5)c4)c-3n2)cc1,KI,8.1,nM,8.09151498112135
CHEMBL361104,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4DE (PDE4DE) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc([C@@H](C)COc4cccc(F)c4)nc2-3)cc1OC1CCCC1,KI,4300.0,nM,5.366531544420413
CHEMBL361104,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D3 (PDE4D3) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc([C@@H](C)COc4cccc(F)c4)nc2-3)cc1OC1CCCC1,KI,114.7,nM,6.940436582098732
CHEMBL361104,CHEMBL288,Phosphodiesterase 4D,Inhibition of [3H]cAMP binding to recombinant human Phosphodiesterase 4D5 (PDE4D5) in baculovirus expression system,COc1ccc(Cn2cnc(N)c3nc([C@@H](C)COc4cccc(F)c4)nc2-3)cc1OC1CCCC1,KI,231.0,nM,6.636388020107855
CHEMBL313041,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3,COc1ccc(C2=NNC(=O)C3CC=CCC23)cc1OC,KI,6.3,nM,8.200659450546418
CHEMBL463431,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3,COc1ccc(C2=NN(CCCCCBr)C(=O)[C@@H]3CC=CC[C@H]23)cc1OC,KI,2.3,nM,8.638272163982407
CHEMBL505431,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3,COc1ccc(F)cc1CCC1CCC(CCNCCCCCN2N=C(c3ccc(OC)c(OC)c3)[C@H]3CC=CC[C@H]3C2=O)O1,KI,2.0,nM,8.698970004336019
CHEMBL451500,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3,COc1ccc(F)c(CCCC2CCC(CCNCCCCCN3N=C(c4ccc(OC)c(OC)c4)[C@H]4CC=CC[C@H]4C3=O)O2)c1,KI,1.2,nM,8.920818753952375
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,KI,58.9,nM,7.229884705212898
CHEMBL569624,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 expressed in baculovirus system by radiometric assay,COc1ccc(/C=N/OCC(O)CN2CC(C)OC(C)C2)cc1OC1CCCC1,KI,1550.0,nM,5.809668301829708
CHEMBL569624,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 expressed in baculovirus system by radiometric assay,COc1ccc(/C=N/OCC(O)CN2CC(C)OC(C)C2)cc1OC1CCCC1,KI,9180.0,nM,5.037157318798758
CHEMBL569624,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D1 expressed in baculovirus system by radiometric assay,COc1ccc(/C=N/OCC(O)CN2CC(C)OC(C)C2)cc1OC1CCCC1,KI,3860.0,nM,5.413412695328245
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D1 expressed in baculovirus system by radiometric assay,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,KI,490.0,nM,6.309803919971486
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D2 expressed in baculovirus system by radiometric assay,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,KI,930.0,nM,6.031517051446064
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of human recombinant PDE4D3 expressed in baculovirus system by radiometric assay,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,KI,300.0,nM,6.522878745280337
CHEMBL1091451,CHEMBL288,Phosphodiesterase 4D,Displacement of [methyl-3H]rolipram from PDE4D4 expressed in CHO cells after 1 hr by scintillation counting,c1ccc(-c2nnc(NCCCN3CCN(c4ncccn4)CC3)c3cc4ccccn4c23)cc1,KI,59000.0,nM,4.229147988357856
CHEMBL1091807,CHEMBL288,Phosphodiesterase 4D,Displacement of [methyl-3H]rolipram from PDE4D4 expressed in CHO cells after 1 hr by scintillation counting,Cc1cccc(-c2nnc(NCCCN3CCN(c4ncccn4)CC3)c3cc4ccccn4c23)c1,KI,54400.0,nM,4.2644011003018205
CHEMBL1092142,CHEMBL288,Phosphodiesterase 4D,Displacement of [methyl-3H]rolipram from PDE4D4 expressed in CHO cells after 1 hr by scintillation counting,Brc1cccc(-c2nnc(NCCCN3CCN(c4ncccn4)CC3)c3cc4ccccn4c23)c1,KI,17500.0,nM,4.756961951313706
CHEMBL1092165,CHEMBL288,Phosphodiesterase 4D,Displacement of [methyl-3H]rolipram from PDE4D4 expressed in CHO cells after 1 hr by scintillation counting,Clc1cccc(-c2nnc(NCCCN3CCN(c4ncccn4)CC3)c3cc4ccccn4c23)c1,KI,14200.0,nM,4.847711655616943
CHEMBL1092166,CHEMBL288,Phosphodiesterase 4D,Displacement of [methyl-3H]rolipram from PDE4D4 expressed in CHO cells after 1 hr by scintillation counting,Fc1cccc(-c2nnc(NCCCN3CCN(c4ncccn4)CC3)c3cc4ccccn4c23)c1,KI,83000.0,nM,4.080921907623926
CHEMBL1089686,CHEMBL288,Phosphodiesterase 4D,Displacement of [methyl-3H]rolipram from PDE4D4 expressed in CHO cells after 1 hr by scintillation counting,N#Cc1cccc(-c2nnc(NCCCN3CCN(c4ncccn4)CC3)c3cc4ccccn4c23)c1,KI,3350.0,nM,5.474955192963154
CHEMBL1089687,CHEMBL288,Phosphodiesterase 4D,Displacement of [methyl-3H]rolipram from PDE4D4 expressed in CHO cells after 1 hr by scintillation counting,O=[N+]([O-])c1cccc(-c2nnc(NCCCN3CCN(c4ncccn4)CC3)c3cc4ccccn4c23)c1,KI,2400.0,nM,5.619788758288394
CHEMBL1090031,CHEMBL288,Phosphodiesterase 4D,Displacement of [methyl-3H]rolipram from PDE4D4 expressed in CHO cells after 1 hr by scintillation counting,O=C(C1CCCC1)N1CCN(CCCNc2nnc(-c3cccc(F)c3)c3c2cc2ccccn23)CC1,KI,61000.0,nM,4.214670164989233
CHEMBL1090032,CHEMBL288,Phosphodiesterase 4D,Displacement of [methyl-3H]rolipram from PDE4D4 expressed in CHO cells after 1 hr by scintillation counting,O=C(c1ccccc1)N1CCN(CCCNc2nnc(-c3cccc(F)c3)c3c2cc2ccccn23)CC1,KI,22200.0,nM,4.653647025549361
CHEMBL1094023,CHEMBL288,Phosphodiesterase 4D,Displacement of [methyl-3H]rolipram from PDE4D4 expressed in CHO cells after 1 hr by scintillation counting,Cn1cccc1C(=O)N1CCN(CCCNc2nnc(-c3cccc(F)c3)c3c2cc2ccccn23)CC1,KI,65000.0,nM,4.187086643357144
CHEMBL1092794,CHEMBL288,Phosphodiesterase 4D,Displacement of [methyl-3H]rolipram from PDE4D4 expressed in CHO cells after 1 hr by scintillation counting,O=C(c1cccnc1)N1CCN(CCCNc2nnc(-c3cccc(F)c3)c3c2cc2ccccn23)CC1,KI,19000.0,nM,4.721246399047171
CHEMBL1093070,CHEMBL288,Phosphodiesterase 4D,Displacement of [methyl-3H]rolipram from PDE4D4 expressed in CHO cells after 1 hr by scintillation counting,O=C(c1ccccn1)N1CCN(CCCNc2nnc(-c3cccc(F)c3)c3c2cc2ccccn23)CC1,KI,18000.0,nM,4.7447274948966935
CHEMBL1093094,CHEMBL288,Phosphodiesterase 4D,Displacement of [methyl-3H]rolipram from PDE4D4 expressed in CHO cells after 1 hr by scintillation counting,Cc1cc2c(NCCCN3CCN(C(=O)c4ncccn4)CC3)nnc(-c3cccc(Cl)c3)c2n1C,KI,80900.0,nM,4.092051478387727
CHEMBL1091062,CHEMBL288,Phosphodiesterase 4D,Displacement of [methyl-3H]rolipram from PDE4D4 expressed in CHO cells after 1 hr by scintillation counting,Cc1cc2c(NCCCN3CCN(C(=O)c4cccnc4)CC3)nnc(-c3cccc([N+](=O)[O-])c3)c2n1C,KI,15300.0,nM,4.815308569182402
CHEMBL1091447,CHEMBL288,Phosphodiesterase 4D,Displacement of [methyl-3H]rolipram from PDE4D4 expressed in CHO cells after 1 hr by scintillation counting,Cc1cc2c(NCCCN3CCN(C(=O)c4ccccn4)CC3)nnc(-c3cccc([N+](=O)[O-])c3)c2n1C,KI,11500.0,nM,4.939302159646388
CHEMBL1090048,CHEMBL288,Phosphodiesterase 4D,Displacement of [methyl-3H]rolipram from PDE4D4 expressed in CHO cells after 1 hr by scintillation counting,Cc1cc2c(NCCCN3CCN(C(=O)c4csnn4)CC3)nnc(-c3cccc([N+](=O)[O-])c3)c2n1C,KI,48600.0,nM,4.313363730737707
CHEMBL1090049,CHEMBL288,Phosphodiesterase 4D,Displacement of [methyl-3H]rolipram from PDE4D4 expressed in CHO cells after 1 hr by scintillation counting,Cc1cc2c(NCCCN3CCN(C(=O)c4cncs4)CC3)nnc(-c3cccc([N+](=O)[O-])c3)c2n1C,KI,12700.0,nM,4.896196279044043
CHEMBL1090405,CHEMBL288,Phosphodiesterase 4D,Displacement of [methyl-3H]rolipram from PDE4D4 expressed in CHO cells after 1 hr by scintillation counting,Cc1cc2c(NCCCN3CCN(C(=O)c4ccnnc4)CC3)nnc(-c3cccc([N+](=O)[O-])c3)c2n1C,KI,51200.0,nM,4.29073003902417
CHEMBL1092099,CHEMBL288,Phosphodiesterase 4D,Displacement of [methyl-3H]rolipram from PDE4D4 expressed in CHO cells after 1 hr by scintillation counting,Cc1cc2c(NCCCN3CCN(C(=O)c4cnccn4)CC3)nnc(-c3cccc([N+](=O)[O-])c3)c2n1C,KI,4440.0,nM,5.35261702988538
CHEMBL1090016,CHEMBL288,Phosphodiesterase 4D,Displacement of [methyl-3H]rolipram from PDE4D4 expressed in CHO cells after 1 hr by scintillation counting,O=C(c1cnccn1)N1CCN(CCCNc2nnc(-c3ccccc3)c3c2cc2ccccn23)CC1,KI,8370.0,nM,5.07727454200674
CHEMBL1090373,CHEMBL288,Phosphodiesterase 4D,Displacement of [methyl-3H]rolipram from PDE4D4 expressed in CHO cells after 1 hr by scintillation counting,O=C(c1cnccn1)N1CCN(CCCNc2nnc(-c3cccc([N+](=O)[O-])c3)c3c2cc2ccccn23)CC1,KI,147.0,nM,6.8326826652518236
CHEMBL2180408,CHEMBL288,Phosphodiesterase 4D,hPDE4D3 PDE scan,COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1,KI,15000.0,nM,4.823908740944319
CHEMBL599326,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D in U937 cells assessed as cAMP accumulation,[O-][n+]1cccc(-c2cc3nccc(-c4ccc(OC(F)F)c(OCC5CC5)c4)n3n2)c1,EC50,1610.0,nM,5.79317412396815
CHEMBL604519,CHEMBL288,Phosphodiesterase 4D,Inhibition of human PDE4D in U937 cells assessed as cAMP accumulation,FC(F)Oc1ccc(-c2ccnc3cc(-c4cccnc4)nn23)cc1OCC1CC1,EC50,66900.0,nM,4.174573882232177
CHEMBL3221631,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 (unknown origin) transfected in HEK293 cells assessed as forskolin-induced cAMP accumulation pretreated for 30 mins before forskolin challenge by luciferase reporter gene assay,NC(=O)c1cccc(-c2c(-c3ccccc3)oc(=O)c3c2nn2c(-c4ccccc4)ccnc32)c1,EC50,9620.0,nM,5.016824927962187
CHEMBL63,CHEMBL288,Phosphodiesterase 4D,Inhibition of PDE4D3 (unknown origin) transfected in HEK293 cells assessed as forskolin-induced cAMP accumulation pretreated for 30 mins before forskolin challenge by luciferase reporter gene assay,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1,EC50,670.0,nM,6.173925197299173
CHEMBL5407478,CHEMBL288,Phosphodiesterase 4D,Activation of PDE4D5 (unknown origin),CCc1nc(-c2ccc(Cl)c(F)c2)nn1CC(=O)NCc1cc(Cl)cc(Cl)c1,EC50,1200.0,nM,5.920818753952375
CHEMBL189963,CHEMBL288,Phosphodiesterase 4D,Selectivity interaction (CEREP ligand displacement assays (non-kinase proteins)) EUB0001326b PDE4D,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,EC50,3400.0,nM,5.468521082957745
CHEMBL1077126,CHEMBL288,Phosphodiesterase 4D,Binding affinity to recombinant PDE4D by surface plasmon resonance assay,C=CCC(=C)/C=C/[C@@](C)(O)[C@H]1O[C@@H]2C[C@@H]3O[C@@H]4C[C@@H]5O[C@@H]6C[C@@H]7O[C@@H]8C[C@@H]9O[C@@H]%10C[C@@H]%11O[C@](C)(CCOS(=O)(=O)[O-])[C@@H](OS(=O)(=O)[O-])C[C@H]%11O[C@H]%10C[C@H]9O[C@H]8CC[C@@]7(C)O[C@@]6(C)CC[C@H](C)[C@H]5O[C@H]4C[C@@]3(C)O[C@H]2CC1=C.[Na+].[Na+],KD,1000.0,nM,6.0
CHEMBL1077121,CHEMBL288,Phosphodiesterase 4D,Binding affinity to recombinant PDE4D by surface plasmon resonance assay,C=CCC(=C)/C=C/[C@@](C)(O)[C@H]1O[C@@H]2C[C@@H]3O[C@@H]4C[C@@H]5O[C@@H]6C[C@@H]7O[C@@H]8C[C@@H]9O[C@@H]%10C[C@@H]%11O[C@](C)(CCO)[C@@H](O)C[C@H]%11O[C@H]%10C[C@H]9O[C@H]8CC[C@@]7(C)O[C@@]6(C)CC[C@H](C)[C@H]5O[C@H]4C[C@@]3(C)O[C@H]2CC1=C,KD,2000.0,nM,5.698970004336019
CHEMBL1077122,CHEMBL288,Phosphodiesterase 4D,Binding affinity to recombinant PDE4D by surface plasmon resonance assay,C=C(C=O)C[C@@H]1C[C@H](O)[C@]2(C)O[C@@H]3C[C@@H]4O[C@@H]5C[C@]6(C)O[C@]7(C)CC[C@@H]8O[C@@H]9C[C@]%10(C)O[C@@H]%11C(C)=CC(=O)O[C@H]%11C[C@H]%10O[C@H]9C[C@@H](C)[C@H]8O[C@H]7C[C@H]6O[C@H]5C/C=C\[C@H]4O[C@H]3C[C@H]2O1,KD,3800.0,nM,5.42021640338319
CHEMBL1088484,CHEMBL288,Phosphodiesterase 4D,Binding affinity to recombinant PDE4D by surface plasmon resonance assay,OC[C@H]1O[C@@H](CCOCc2ccccc2)[C@H](OCc2ccccc2)C[C@@H]1O,KD,80000.0,nM,4.096910013008056
CHEMBL1086786,CHEMBL288,Phosphodiesterase 4D,Binding affinity to recombinant PDE4D by surface plasmon resonance assay,C[C@@]12CC[C@@H]3O[C@H](CO)[C@@H](O)C[C@H]3O[C@H]1C[C@H]1O[C@@H](CCO)[C@H](O)C[C@@H]1O2,KD,29000.0,nM,4.537602002101044
CHEMBL1077119,CHEMBL288,Phosphodiesterase 4D,Binding affinity to recombinant PDE4D by surface plasmon resonance assay,C[C@@]12CC[C@@H]3O[C@H](CO)[C@@H](O)C[C@H]3O[C@H]1C[C@H]1O[C@@H](CCOCc3ccccc3)[C@H](OCc3ccccc3)C[C@@H]1O2,KD,11000.0,nM,4.958607314841775
CHEMBL500181,CHEMBL288,Phosphodiesterase 4D,Binding affinity to recombinant PDE4D by surface plasmon resonance assay,C[C@@]12CC[C@@H]3O[C@@H]4C[C@@H]5O[C@@H]6C[C@H](O)[C@@H](CO)O[C@H]6CC[C@@]5(C)O[C@H]4C[C@H]3O[C@H]1C[C@H]1O[C@@H](CCOCc3ccccc3)[C@H](OCc3ccccc3)C[C@@H]1O2,KD,4800.0,nM,5.318758762624412
